<html class="gs_el_sm gs_pfcs"><head><title>‪Ernest Choy‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=OziPPvMAAAAJ&amp;hl=en"><meta name="description" content="‪Cardiff University‬ - ‪‪Cited by 27,842‬‬ - ‪Rheumatology‬"><meta property="og:description" content="‪Cardiff University‬ - ‪‪Cited by 27,842‬‬ - ‪Rheumatology‬"><meta property="og:title" content="Ernest Choy"><meta property="og:image" content="https://scholar.google.com/citations/images/avatar_scholar_256.png"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"6oM9YcWsNMLMsQKvlwo"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=OziPPvMAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT7Vamv6vKOC0x2YSP0jUnoY88yqabve"><input type="hidden" name="user" value="OziPPvMAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">27842</td><td class="gsc_rsb_std">13592</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">79</td><td class="gsc_rsb_std">63</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">231</td><td class="gsc_rsb_std">183</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:870px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:824px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">2600</div><div class="gsc_g_xtl" style="top:73px;">1300</div><div class="gsc_g_xtl" style="top:113px;">650</div><div class="gsc_g_xtl" style="top:33px;">1950</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:155px;height:5px;z-index:25"><span class="gsc_g_al">89</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:155px;height:5px;z-index:24"><span class="gsc_g_al">92</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:154px;height:6px;z-index:23"><span class="gsc_g_al">109</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:155px;height:5px;z-index:22"><span class="gsc_g_al">94</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:152px;height:8px;z-index:21"><span class="gsc_g_al">141</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:150px;height:10px;z-index:20"><span class="gsc_g_al">173</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:146px;height:14px;z-index:19"><span class="gsc_g_al">243</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:140px;height:20px;z-index:18"><span class="gsc_g_al">336</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:137px;height:23px;z-index:17"><span class="gsc_g_al">377</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:130px;height:30px;z-index:16"><span class="gsc_g_al">500</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:123px;height:37px;z-index:15"><span class="gsc_g_al">603</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:112px;height:48px;z-index:14"><span class="gsc_g_al">791</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:100px;height:60px;z-index:13"><span class="gsc_g_al">985</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:88px;height:72px;z-index:12"><span class="gsc_g_al">1173</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:82px;height:78px;z-index:11"><span class="gsc_g_al">1270</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:74px;height:86px;z-index:10"><span class="gsc_g_al">1408</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:65px;height:95px;z-index:9"><span class="gsc_g_al">1545</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:51px;height:109px;z-index:8"><span class="gsc_g_al">1779</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:45px;height:115px;z-index:7"><span class="gsc_g_al">1880</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:36px;height:124px;z-index:6"><span class="gsc_g_al">2031</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:25px;height:135px;z-index:5"><span class="gsc_g_al">2200</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:24px;height:136px;z-index:4"><span class="gsc_g_al">2222</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:18px;height:142px;z-index:3"><span class="gsc_g_al">2309</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:4px;height:156px;z-index:2"><span class="gsc_g_al">2546</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:26px;height:134px;z-index:1"><span class="gsc_g_al">2180</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=OziPPvMAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dOziPPvMAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>79 articles</span></div><div class="gsc_rsb_m_na"><div>11 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:12%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="Ernest Choy" sizes="print 80px,128px" src="/citations/images/avatar_scholar_128.png" id="gsc_prf_pup-img" srcset="/citations/images/avatar_scholar_128.png 128w,/citations/images/avatar_scholar_256.png 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Ernest Choy</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=9175319048828668389" class="gsc_prf_ila">Cardiff University</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at cardiff.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:rheumatology" class="gsc_prf_inta gs_ibl">Rheumatology</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT7Vamv6vKOC0x2YSP0jUnoY88yqabve"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=OziPPvMAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Cytokine pathways and joint inflammation in rheumatoid arthritis</a><div class="gs_gray">EHS Choy, GS Panayi</div><div class="gs_gray">New England Journal of Medicine 344 (12), 907-916<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9467778914126641947" class="gsc_a_ac gs_ibl">2961</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double‐blind, randomized, placebo‐controlled trial</a><div class="gs_gray">PJ Mease, DD Gladman, CT Ritchlin, EM Ruderman, SD Steinfeld, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism: Official Journal of the American College of&nbsp;…<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5413101114778690086" class="gsc_a_ac gs_ibl">1052</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">EULAR evidence-based recommendations for the management of fibromyalgia syndrome</a><div class="gs_gray">SF Carville, S Arendt-Nielsen, H Bliddal, F Blotman, JC Branco, D Buskila, ...</div><div class="gs_gray">Annals of the rheumatic diseases 67 (4), 536-541<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=73597391845926969" class="gsc_a_ac gs_ibl">1016</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Rheumatology 51 (suppl_5), v3-v11<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13794658414342450248" class="gsc_a_ac gs_ibl">796</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The&nbsp;…</a><div class="gs_gray">JE Hoogendijk, AA Amato, BR Lecky, EH Choy, IE Lundberg, MR Rose, ...</div><div class="gs_gray">Neuromuscular Disorders 14 (5), 337-345<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10309809137371481815" class="gsc_a_ac gs_ibl">778</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">EULAR revised recommendations for the management of fibromyalgia</a><div class="gs_gray">GJ Macfarlane, C Kronisch, LE Dean, F Atzeni, W Häuser, E Fluß, E Choy, ...</div><div class="gs_gray">Annals of the rheumatic diseases 76 (2), 318-328<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6096078974737315683" class="gsc_a_ac gs_ibl">745</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study</a><div class="gs_gray">A Naranjo, T Sokka, MA Descalzo, J Calvo-Alén, K Hørslev-Petersen, ...</div><div class="gs_gray">Arthritis research &amp; therapy 10 (2), 1-10<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15396662070767546409" class="gsc_a_ac gs_ibl">618</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:hNSvKAmkeYkC" class="gsc_a_at">Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double‐blind, placebo&nbsp;…</a><div class="gs_gray">EHS Choy, DA Isenberg, T Garrood, S Farrow, Y Ioannou, H Bird, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 46 (12), 3143-3150<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12832533507538934321" class="gsc_a_ac gs_ibl">594</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Integrated management of childhood illness by outpatient health workers: technical basis and overview. The WHO Working Group on Guidelines for Integrated Management of the Sick&nbsp;…</a><div class="gs_gray">S Gove</div><div class="gs_gray">Bulletin of the World Health Organization 75 (Suppl 1), 7<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14033688764244540207" class="gsc_a_ac gs_ibl">569</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:qjMakFHDy7sC" class="gsc_a_at">EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases</a><div class="gs_gray">JN Hoes, JWG Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, ...</div><div class="gs_gray">Annals of the rheumatic diseases 66 (12), 1560-1567<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=508945018539426811" class="gsc_a_ac gs_ibl">487</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Fatigue in rheumatoid arthritis reflects pain, not disease activity</a><div class="gs_gray">LC Pollard, EH Choy, J Gonzalez, B Khoshaba, DL Scott</div><div class="gs_gray">Rheumatology 45 (7), 885-889<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2996687456729361036" class="gsc_a_ac gs_ibl">444</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Interleukin-6 as a key player in systemic inflammation and joint destruction</a><div class="gs_gray">JE Fonseca, MJ Santos, H Canhao, E Choy</div><div class="gs_gray">Autoimmunity reviews 8 (7), 538-542<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2596890351327005650" class="gsc_a_ac gs_ibl">429</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review</a><div class="gs_gray">SL Westlake, AN Colebatch, J Baird, P Kiely, M Quinn, E Choy, AJK Ostor, ...</div><div class="gs_gray">Rheumatology 49 (2), 295-307<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2911047080512258810" class="gsc_a_ac gs_ibl">402</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions</a><div class="gs_gray">E Choy, N Sattar</div><div class="gs_gray">Annals of the rheumatic diseases 68 (4), 460-469<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9978860382050466398" class="gsc_a_ac gs_ibl">380</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis</a><div class="gs_gray">ECC Rankin, EHS Choy, D Kassimos, GH Kingsley, AM Sopwtth, ...</div><div class="gs_gray">Rheumatology 34 (4), 334-342<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2213254585679459495" class="gsc_a_ac gs_ibl">375</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain</a><div class="gs_gray">KB Jensen, E Kosek, F Petzke, S Carville, P Fransson, H Marcus, ...</div><div class="gs_gray">PAIN® 144 (1-2), 95-100<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17665314603909941290" class="gsc_a_ac gs_ibl">367</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Adalimumab for long‐term treatment of psoriatic arthritis: forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial</a><div class="gs_gray">DD Gladman, PJ Mease, CT Ritchlin, EHS Choy, JT Sharp, PA Ory, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism: Official Journal of the American College of&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3114557987766611071" class="gsc_a_ac gs_ibl">353</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor</a><div class="gs_gray">JM Dayer, E Choy</div><div class="gs_gray">Rheumatology 49 (1), 15-24<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4638308658817517064" class="gsc_a_ac gs_ibl">327</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.</a><div class="gs_gray">JR Kirwan, P Minnock, A Adebajo, B Bresnihan, E Choy, M De Wit, ...</div><div class="gs_gray">The Journal of rheumatology 34 (5), 1174-1177<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11953397341515921443" class="gsc_a_ac gs_ibl">324</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;citation_for_view=OziPPvMAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Consensus on a core set of domains for psoriatic arthritis.</a><div class="gs_gray">DD Gladman, PJ Mease, V Strand, P Healy, PS Helliwell, O Fitzgerald, ...</div><div class="gs_gray">The Journal of rheumatology 34 (5), 1167-1170<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5326357338195189262" class="gsc_a_ac gs_ibl">315</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Cognitive behavioural therapies for fibromyalgia</a><div class="gs_gray">K Bernardy, P Klose, AJ Busch, EHS Choy, W Häuser</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8141413767045250094" class="gsc_a_ac gs_ibl">314</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:qmtmRrLr0tkC" class="gsc_a_at">Efficacy of a novel PEGylated humanized anti‐TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double‐blinded, randomized, dose‐escalating trial</a><div class="gs_gray">EHS Choy, B Hazleman, M Smith, K Moss, L Lisi, DGI Scott, J Patel, ...</div><div class="gs_gray">Rheumatology 41 (10), 1133-1137<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11740449939204384909" class="gsc_a_ac gs_ibl">284</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment</a><div class="gs_gray">E Choy, K Ganeshalingam, AG Semb, Z Szekanecz, M Nurmohamed</div><div class="gs_gray">Rheumatology 53 (12), 2143-2154<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3386128929470789178" class="gsc_a_ac gs_ibl">283</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:rOcdG6UcVlcC" class="gsc_a_at">All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists</a><div class="gs_gray">L Carmona, MA Descalzo, E Perez-Pampin, D Ruiz-Montesinos, A Erra, ...</div><div class="gs_gray">Annals of the rheumatic diseases 66 (7), 880-885<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=841932003184556395,10671399816987136141" class="gsc_a_ac gs_ibl">277</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="OziPPvMAAAAJ:rOcdG6UcVlcC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:ndLnGcHYRF0C" class="gsc_a_at">The role of interleukin 6 in the pathophysiology of rheumatoid arthritis</a><div class="gs_gray">S Srirangan, EH Choy</div><div class="gs_gray">Therapeutic advances in musculoskeletal disease 2 (5), 247-256<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14733731738060520320" class="gsc_a_ac gs_ibl">268</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Fibromyalgia syndrome.</a><div class="gs_gray">P Mease, LM Arnold, R Bennett, A Boonen, D Buskila, S Carville, ...</div><div class="gs_gray">The Journal of Rheumatology 34 (6), 1415-1425<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=599890754945988169" class="gsc_a_ac gs_ibl">266</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:ji7lAbPyDbYC" class="gsc_a_at">Fibromyalgia syndrome module at OMERACT 9: domain construct</a><div class="gs_gray">P Mease, LM Arnold, EH Choy, DJ Clauw, LJ Crofford, JM Glass, ...</div><div class="gs_gray">The Journal of rheumatology 36 (10), 2318-2329<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11448588223503257340" class="gsc_a_ac gs_ibl">261</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">The consequences of rheumatoid arthritis: quality of life measures in the individual patient</a><div class="gs_gray">L Pollard, EH Choy, DL Scott</div><div class="gs_gray">Clinical and experimental rheumatology 23 (5), S43<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17393950186068918892" class="gsc_a_ac gs_ibl">245</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:5nxA0vEk-isC" class="gsc_a_at">A patient survey of the impact of fibromyalgia and the journey to diagnosis</a><div class="gs_gray">E Choy, S Perrot, T Leon, J Kaplan, D Petersel, A Ginovker, E Kramer</div><div class="gs_gray">BMC health services research 10 (1), 1-9<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16725639779002032887" class="gsc_a_ac gs_ibl">242</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review</a><div class="gs_gray">SL Westlake, AN Colebatch, J Baird, N Curzen, P Kiely, M Quinn, E Choy, ...</div><div class="gs_gray">Rheumatology 50 (3), 518-531<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13597076264234250213" class="gsc_a_ac gs_ibl">237</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Non‐pharmacological interventions for fatigue in rheumatoid arthritis</a><div class="gs_gray">F Cramp, S Hewlett, C Almeida, JR Kirwan, EHS Choy, T Chalder, ...</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12620823365577292196" class="gsc_a_ac gs_ibl">225</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network</a><div class="gs_gray">KB Jensen, R Loitoile, E Kosek, F Petzke, S Carville, P Fransson, ...</div><div class="gs_gray">Molecular pain 8, 1744-8069-8-32<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5550075638032924995,8253739406140516183" class="gsc_a_ac gs_ibl">222</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Fatigue in rheumatoid arthritis: time for a conceptual model</a><div class="gs_gray">S Hewlett, T Chalder, E Choy, F Cramp, B Davis, E Dures, C Nicholls, ...</div><div class="gs_gray">Rheumatology 50 (6), 1004-1006<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7254667787458882603" class="gsc_a_ac gs_ibl">211</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Remission and rheumatoid arthritis: data on patients receiving usual care in twenty‐four countries</a><div class="gs_gray">T Sokka, ML Hetland, H Mäkinen, H Kautiainen, K Hørslev‐Petersen, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 58 (9), 2642-2651<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=399581562764860558" class="gsc_a_ac gs_ibl">202</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:LGlY6t8CeOMC" class="gsc_a_at">A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal</a><div class="gs_gray">EHS Choy, C Smith, CJ Dore, DL Scott</div><div class="gs_gray">Rheumatology 44 (11), 1414-1421<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6455427631354854749" class="gsc_a_ac gs_ibl">197</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis</a><div class="gs_gray">PA Gordon, JB Winer, JE Hoogendijk, EHS Choy</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17102066592076475865" class="gsc_a_ac gs_ibl">189</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Overlapping structural and functional brain changes in patients with long‐term exposure to fibromyalgia pain</a><div class="gs_gray">KB Jensen, P Srinivasan, R Spaeth, Y Tan, E Kosek, F Petzke, S Carville, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 65 (12), 3293-3303<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4994110876072375775" class="gsc_a_ac gs_ibl">174</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:NhqRSupF_l8C" class="gsc_a_at">The role of sleep in pain and fibromyalgia</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">Nature Reviews Rheumatology 11 (9), 513-520<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9483948826825273389" class="gsc_a_ac gs_ibl">168</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:AZju0d2GQJ0C" class="gsc_a_at">Treatment of dermatomyositis and polymyositis</a><div class="gs_gray">EHS Choy, DA Isenberg</div><div class="gs_gray">Rheumatology 41 (1), 7-13<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10417656449875080021" class="gsc_a_ac gs_ibl">152</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">The problem of choice: current biologic agents and future prospects in RA</a><div class="gs_gray">EH Choy, AF Kavanaugh, SA Jones</div><div class="gs_gray">Nature Reviews Rheumatology 9 (3), 154-163<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14474245327243733665" class="gsc_a_ac gs_ibl">148</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:_AeoHAGD03cC" class="gsc_a_at">Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis</a><div class="gs_gray">EHS Choy, CM Smith, V Farewell, D Walker, A Hassell, L Chau, DL Scott, ...</div><div class="gs_gray">Annals of the rheumatic diseases 67 (5), 656-663<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7411945244270489924" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus</a><div class="gs_gray">SJ Bartlett, S Hewlett, CO Bingham, TG Woodworth, R Alten, C Pohl, ...</div><div class="gs_gray">Annals of the rheumatic diseases 71 (11), 1855-1860<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9694490866432956474" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis</a><div class="gs_gray">LK Mercer, M Lunt, ALS Low, WG Dixon, KD Watson, DPM Symmons, ...</div><div class="gs_gray">Annals of the rheumatic diseases 74 (6), 1087-1093<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10874540790487395013" class="gsc_a_ac gs_ibl">143</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:m4fbC6XIj1kC" class="gsc_a_at">Fibromyalgic rheumatoid arthritis and disease assessment</a><div class="gs_gray">LC Pollard, GH Kingsley, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 49 (5), 924-928<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10725950812354067752" class="gsc_a_ac gs_ibl">143</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions</a><div class="gs_gray">JS Smolen, MM Schoels, N Nishimoto, FC Breedveld, GR Burmester, ...</div><div class="gs_gray">Annals of the rheumatic diseases 72 (4), 482-492<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7346563320233261632" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Xz60mAmATU4C" class="gsc_a_at">Synovial tissue research: a state-of-the-art review</a><div class="gs_gray">C Orr, E Vieira-Sousa, DL Boyle, MH Buch, CD Buckley, JD Cañete, ...</div><div class="gs_gray">Nature Reviews Rheumatology 13 (8), 463-475<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15264549276180074158" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Joint inflammation and cytokine inhibition in rheumatoid arthritis</a><div class="gs_gray">C Christodoulou, EH Choy</div><div class="gs_gray">Clinical and experimental medicine 6 (1), 13-19<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17546340738257553485" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:In6cVmBjs0IC" class="gsc_a_at">Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study</a><div class="gs_gray">HK Lempp, SL Hatch, SF Carville, EH Choy</div><div class="gs_gray">BMC Musculoskeletal Disorders 10 (1), 1-11<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18265879071259721894" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:4DMP91E08xMC" class="gsc_a_at">Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the&nbsp;…</a><div class="gs_gray">MC Van der Goes, JWG Jacobs, M Boers, T Andrews, MAM Blom-Bakkers, ...</div><div class="gs_gray">Annals of the rheumatic diseases 69 (6), 1015-1021<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16151177713062035956" class="gsc_a_ac gs_ibl">128</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis</a><div class="gs_gray">EHS Choy, JE Hoogendijk, B Lecky, JB Winer</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15167975029128661304" class="gsc_a_ac gs_ibl">125</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:UebtZRa9Y70C" class="gsc_a_at">A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis</a><div class="gs_gray">V Ravindran, DL Scott, EH Choy</div><div class="gs_gray">Annals of the rheumatic diseases 67 (6), 855-859<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8932005434460134785" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica</a><div class="gs_gray">A Hutchings, J Hollywood, DL Lamping, CT Pease, K Chakravarty, ...</div><div class="gs_gray">Arthritis Care &amp; Research: Official Journal of the American College of&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3004912133583710598" class="gsc_a_ac gs_ibl">122</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:dMpQl7XwOw4C" class="gsc_a_at">Translating IL-6 biology into effective treatments</a><div class="gs_gray">EH Choy, F De Benedetti, T Takeuchi, M Hashizume, MR John, ...</div><div class="gs_gray">Nature Reviews Rheumatology 16 (6), 335-345<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16266444166141633150" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Zh0EY9V9P6UC" class="gsc_a_at">Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations</a><div class="gs_gray">AM Taylor, K Phillips, KV Patel, DC Turk, RH Dworkin, D Beaton, ...</div><div class="gs_gray">Pain 157 (9), 1836<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3838330300076716976" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Anxiety and depressive symptoms in fibromyalgia are related to poor perception of health but not to pain sensitivity or cerebral processing of pain</a><div class="gs_gray">KB Jensen, F Petzke, S Carville, P Fransson, H Marcus, SCR Williams, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 62 (11), 3488-3495<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9580490958811089431" class="gsc_a_ac gs_ibl">114</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses</a><div class="gs_gray">EAT Ghogomu, LJ Maxwell, R Buchbinder, T Rader, JP Pardo, ...</div><div class="gs_gray">The Journal of rheumatology 41 (2), 194-205<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1024641905674616715" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials</a><div class="gs_gray">PA Scott, GH Kingsley, CM Smith, EH Choy, DL Scott</div><div class="gs_gray">Annals of the Rheumatic Diseases 66 (10), 1296-1304<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11142013982373257326" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:pQTOvowfQioC" class="gsc_a_at">Control of rheumatoid arthritis by oral tolerance</a><div class="gs_gray">EHS Choy, DL Scott, GH Kingsley, S Thomas, AGV Murphy, N Staines, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism: Official Journal of the American College of&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8657978502069905280" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III&nbsp;…</a><div class="gs_gray">S Cohen, MC Genovese, E Choy, F Perez-Ruiz, A Matsumoto, K Pavelka, ...</div><div class="gs_gray">Annals of the rheumatic diseases 76 (10), 1679-1687<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11203049658010199955" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non&nbsp;…</a><div class="gs_gray">D Porter, J Van Melckebeke, J Dale, CM Messow, A McConnachie, ...</div><div class="gs_gray">The Lancet 388 (10041), 239-247<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5941888475663045981" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study</a><div class="gs_gray">D Bouhassira, S Wilhelm, A Schacht, S Perrot, E Kosek, G Cruccu, ...</div><div class="gs_gray">Pain® 155 (10), 2171-2179<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12045842491281466467" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Psychological factors and their relation to osteoarthritis pain</a><div class="gs_gray">BL Wise, J Niu, Y Zhang, N Wang, JM Jordan, E Choy, DJ Hunter</div><div class="gs_gray">Osteoarthritis and cartilage 18 (7), 883-887<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3674131195788924234" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomes.</a><div class="gs_gray">A Hutchings, M Calloway, E Choy, M Hooper, DJ Hunter, JM Jordan, ...</div><div class="gs_gray">The Journal of rheumatology 34 (11), 2291-2300<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11010176975155792717" class="gsc_a_ac gs_ibl">97</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:jq04SsiGh3QC" class="gsc_a_at">Course and prognosis of elbow complaints: a cohort study in general practice</a><div class="gs_gray">SDM Bot, JM van der Waal, CB Terwee, D Van Der Windt, LM Bouter, ...</div><div class="gs_gray">Annals of the rheumatic diseases 64 (9), 1331-1336<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8450896957351245231" class="gsc_a_ac gs_ibl">97</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:4QKQTXcH0q8C" class="gsc_a_at">Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients</a><div class="gs_gray">F Humby, M Lewis, N Ramamoorthi, JA Hackney, MR Barnes, ...</div><div class="gs_gray">Annals of the rheumatic diseases 78 (6), 761-772<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3778088606699858836" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:YlPif8NxrbYC" class="gsc_a_at">The safety and immunogenicity of live zoster vaccination in patients with rheumatoid arthritis before starting tofacitinib: a randomized phase II trial</a><div class="gs_gray">KL Winthrop, AG Wouters, EH Choy, K Soma, JA Hodge, CI Nduaka, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 69 (10), 1969-1977<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6235555182490890105" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT</a><div class="gs_gray">DD Gladman, PJ Mease, EHS Choy, CT Ritchlin, RJ Perdok, EH Sasso</div><div class="gs_gray">Arthritis research &amp; therapy 12 (3), 1-9<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10482060840141699723" class="gsc_a_ac gs_ibl">93</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:d4tt_xEv1X8C" class="gsc_a_at">Clinical significance of Janus Kinase inhibitor selectivity</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Rheumatology 58 (6), 953-962<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17921979749165820717" class="gsc_a_ac gs_ibl">92</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study</a><div class="gs_gray">A van der Maas, E Lie, R Christensen, E Choy, YA de Man, P van Riel, ...</div><div class="gs_gray">Annals of the rheumatic diseases 72 (11), 1800-1805<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10395596875770460487" class="gsc_a_ac gs_ibl">92</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:naSTrk-c4S8C" class="gsc_a_at">Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome</a><div class="gs_gray">EH Choy, LM Arnold, DJ Clauw, LJ Crofford, JM Glass, LS Simon, ...</div><div class="gs_gray">The Journal of rheumatology 36 (10), 2330-2334<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10067627994126819176" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:yZoBfgUKqwcC" class="gsc_a_at">Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology</a><div class="gs_gray">S Kia, E Choy</div><div class="gs_gray">Biomedicines 5 (2), 20<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10244304040088992079" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia</a><div class="gs_gray">S Perrot, E Choy, D Petersel, A Ginovker, E Kramer</div><div class="gs_gray">BMC health services research 12 (1), 1-8<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7625540712528811972" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">Standardising joint assessment in rheumatoid arthritis</a><div class="gs_gray">DL Scott, EHS Choy, A Greeves, D Isenberg, D Kassinor, E Rankin, ...</div><div class="gs_gray">Clinical rheumatology 15 (6), 579-582<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2758220864577903321" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:AzKEL7Gb_04C" class="gsc_a_at">Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti‐CD4 monoclonal antibody</a><div class="gs_gray">EHS Choy, IC Chikanza, GH Kingsley, V Corrigall, GS Panayi</div><div class="gs_gray">Scandinavian journal of immunology 36 (2), 291-298<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1729088404678285605" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:kWvqk_afx_IC" class="gsc_a_at">Use of “spydergrams” to present and interpret SF-36 health-related quality of life data across rheumatic diseases</a><div class="gs_gray">V Strand, B Crawford, J Singh, E Choy, JS Smolen, D Khanna</div><div class="gs_gray">Annals of the Rheumatic Diseases 68 (12), 1800-1804<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4681912084172398476" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:27LrP4qxOz0C" class="gsc_a_at">A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia</a><div class="gs_gray">E Choy, D Marshall, ZL Gabriel, SA Mitchell, E Gylee, HA Dakin</div><div class="gs_gray">Seminars in arthritis and rheumatism 41 (3), 335-345. e6<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6495645605560628282,13707750486154732039" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX</a><div class="gs_gray">E Choy, F McKenna, J Vencovsky, R Valente, N Goel, B VanLunen, ...</div><div class="gs_gray">Rheumatology 51 (7), 1226-1234<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5152103851182586508" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:_IsBomjs8bsC" class="gsc_a_at">Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes</a><div class="gs_gray">MJ Lewis, MR Barnes, K Blighe, K Goldmann, S Rana, JA Hackney, ...</div><div class="gs_gray">Cell reports 28 (9), 2455-2470. e5<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13951346956289206776" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:jgBuDB5drN8C" class="gsc_a_at">Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis</a><div class="gs_gray">LK Mercer, JB Galloway, M Lunt, R Davies, ALS Low, WG Dixon, ...</div><div class="gs_gray">Annals of the rheumatic diseases 76 (3), 497-503<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2303917681312208529" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Education, self‐management, and upper extremity exercise training in people with rheumatoid arthritis: a randomized controlled trial</a><div class="gs_gray">VL Manning, MV Hurley, DL Scott, B Coker, E Choy, LM Bearne</div><div class="gs_gray">Arthritis care &amp; research 66 (2), 217-227<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1936498881591912965" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:GFxP56DSvIMC" class="gsc_a_at">Fibromyalgia: management strategies for primary care providers</a><div class="gs_gray">LM Arnold, KB Gebke, EHS Choy</div><div class="gs_gray">International journal of clinical practice 70 (2), 99-112<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9647925474551723563" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Percentage of anti‐CD4 monoclonal antibody‐coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of&nbsp;…</a><div class="gs_gray">EHS Choy, C Pitzalis, A Cauli, JA Bijl, A Schantz, J Woody, GH Kingsley, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism: Official Journal of the American College of&nbsp;…<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18312633716251074641" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Gb6Hms-Uo9kC" class="gsc_a_at">Primary results from SAUL, a multinational single-arm safety study of atezolizumab therapy for locally advanced or metastatic urothelial or nonurothelial carcinoma of the&nbsp;…</a><div class="gs_gray">CN Sternberg, Y Loriot, N James, E Choy, D Castellano, F Lopez-Rios, ...</div><div class="gs_gray">European urology 76 (1), 73-81<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11392403763235623800" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:5MTHONV0fEkC" class="gsc_a_at">Fibromyalgia and chronic pain syndromes: a white paper detailing current challenges in the field</a><div class="gs_gray">LM Arnold, E Choy, DJ Clauw, DL Goldenberg, RE Harris, ...</div><div class="gs_gray">The Clinical journal of pain 32 (9), 737<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7199298164391786930" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:WwIwg2wKZ0QC" class="gsc_a_at">Safety of medium-to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis</a><div class="gs_gray">V Ravindran, S Rachapalli, EH Choy</div><div class="gs_gray">Rheumatology 48 (7), 807-811<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13486273636071474637" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:k_IJM867U9cC" class="gsc_a_at">Alterations in resting‐state regional cerebral blood flow demonstrate ongoing pain in osteoarthritis: An arterial spin‐labeled magnetic resonance imaging study</a><div class="gs_gray">MA Howard, D Sanders, K Krause, J O'Muircheartaigh, A Fotopoulou, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 64 (12), 3936-3946<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9249672330064033531" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe</a><div class="gs_gray">P Emery, R Van Vollenhoven, M Ostergaard, E Choy, B Combe, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 68 (4), 456-459<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14522133506783482277" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease&nbsp;…</a><div class="gs_gray">EH Choy, GH Kingsley, B Khoshaba, N Pipitone, DL Scott</div><div class="gs_gray">Annals of the rheumatic diseases 64 (9), 1288-1293<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3553512856605191167,14192444738394122590" class="gsc_a_ac gs_ibl">71</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="OziPPvMAAAAJ:OBSaB-F7qqsC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis</a><div class="gs_gray">EHS Choy, LH Calabrese</div><div class="gs_gray">Rheumatology 57 (11), 1885-1895<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13648820951400851816" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:R22Rs3tN8aoC" class="gsc_a_at">Interleukin-6 as a multifunctional regulator: inflammation, immune response, and fibrosis</a><div class="gs_gray">E Choy, S Rose-John</div><div class="gs_gray">Journal of Scleroderma and Related Disorders 2 (2_suppl), S1-S5<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=870364408482642781" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop</a><div class="gs_gray">VP Bykerk, E Lie, SJ Bartlett, R Alten, A Boonen, R Christensen, DE Furst, ...</div><div class="gs_gray">The Journal of rheumatology 41 (4), 799-809<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14909287625113776172" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:TQgYirikUcIC" class="gsc_a_at">Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial</a><div class="gs_gray">M Spaeth, RM Bennett, BA Benson, YG Wang, C Lai, EH Choy</div><div class="gs_gray">Annals of the rheumatic diseases 71 (6), 935-942<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6260431464612047862" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Biologic interventions for fatigue in rheumatoid arthritis</a><div class="gs_gray">C Almeida, EHS Choy, S Hewlett, JR Kirwan, F Cramp, T Chalder, ...</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12634278069510723185" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine</a><div class="gs_gray">LB Marangell, DJ Clauw, E Choy, F Wang, S Shoemaker, L Bradley, ...</div><div class="gs_gray">PAIN® 152 (1), 31-37<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4433594145023623225" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">Enhanced and persistent levels of interleukin (IL)‐17<sup>+</sup>CD4<sup>+</sup> T cells and serum IL‐17 in patients with early inflammatory arthritis</a><div class="gs_gray">NJ Gullick, HS Abozaid, DM Jayaraj, HG Evans, DL Scott, EH Choy, ...</div><div class="gs_gray">Clinical &amp; Experimental Immunology 174 (2), 292-301<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4451601078039854639" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Clinical experience with inhibition of interleukin-6</a><div class="gs_gray">E Choy</div><div class="gs_gray">Rheumatic Disease Clinics 30 (2), 405-415<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1313257571209732846" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group</a><div class="gs_gray">R Alten, C Pohl, EH Choy, R Christensen, DE Furst, SE Hewlett, A Leong, ...</div><div class="gs_gray">The Journal of Rheumatology 38 (8), 1745-1750<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13114296369158573098" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials</a><div class="gs_gray">EHS Choy, PJ Mease, DK Kajdasz, MM Wohlreich, P Crits-Christoph, ...</div><div class="gs_gray">Clinical rheumatology 28 (9), 1035-1044<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1907301046681141403" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Low immunogenicity of tocilizumab in patients with rheumatoid arthritis</a><div class="gs_gray">GR Burmester, E Choy, A Kivitz, A Ogata, M Bao, A Nomura, S Lacey, ...</div><div class="gs_gray">Annals of the rheumatic diseases 76 (6), 1078-1085<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12093219914195720426" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=OziPPvMAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Joint counts in routine practice</a><div class="gs_gray">DL Scott, C Antoni, EH Choy, P Van Riel</div><div class="gs_gray">Rheumatology 42 (8), 919-923<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5188649663246084268" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hMod-77fHWUC" class="gsc_a_at">Updating the OMERACT filter: implications for patient-reported outcomes</a><div class="gs_gray">JR Kirwan, SJ Bartlett, DE Beaton, M Boers, A Bosworth, PM Brooks, ...</div><div class="gs_gray">The Journal of rheumatology 41 (5), 1011-1015<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14313869821564089057" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:QVtou7C4vgoC" class="gsc_a_at">Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti‐CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients</a><div class="gs_gray">EHS Choy, DJA Connolly, N Rapson, S Jeal, JCC Brown, GH Kingsley, ...</div><div class="gs_gray">Rheumatology 39 (10), 1139-1146<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9326389098244562469" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:6VlyvFCUEfcC" class="gsc_a_at">Repeat‐cycle study of high‐dose intravenous 4162W94 anti‐CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo‐controlled trial</a><div class="gs_gray">EHS Choy, GS Panayi, P Emery, S Madden, FC Breedveld, MC Kraan, ...</div><div class="gs_gray">Rheumatology 41 (10), 1142-1148<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15572067157164533230" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:EaFouW7jFu4C" class="gsc_a_at">Remission in early rheumatoid arthritis: predicting treatment response</a><div class="gs_gray">MHY Ma, F Ibrahim, D Walker, A Hassell, EH Choy, PDW Kiely, ...</div><div class="gs_gray">The Journal of rheumatology 39 (3), 470-475<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16127180928312296992" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eI34FqJmdUoC" class="gsc_a_at">Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium</a><div class="gs_gray">EHS Choy, DL Scott, GH Kingsley, P Williams, J Wojtulewski, ...</div><div class="gs_gray">Clinical and experimental rheumatology 20 (3), 351-358<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10714283993071722755" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RMgMIBzvq-4C" class="gsc_a_at">Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis.</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Clinical and experimental rheumatology 27 (3), 510-518<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12780810064751366953" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">The pathogenesis of dermatomyositis</a><div class="gs_gray">C Thompson, V Piguet, E Choy</div><div class="gs_gray">British Journal of Dermatology 179 (6), 1256-1262<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1248805545054632862" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Drug use and toxicity in psoriatic disease: focus on methotrexate</a><div class="gs_gray">WJ Taylor, E Korendowych, P Nash, PS Helliwell, E Choy, GG Krueger, ...</div><div class="gs_gray">The Journal of rheumatology 35 (7), 1454-1457<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5180529486002046785" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Monoclonal antibody therapy in rheumatoid arthritis.</a><div class="gs_gray">EH Choy, GH Kingsley, GS Panayi</div><div class="gs_gray">British journal of rheumatology 37 (5), 484-490<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15416050173917272985" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Defining disease phenotypes in primary care electronic health records by a machine learning approach: a case study in identifying rheumatoid arthritis</a><div class="gs_gray">SM Zhou, F Fernandez-Gutierrez, J Kennedy, R Cooksey, M Atkinson, ...</div><div class="gs_gray">PloS one 11 (5), e0154515<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10937831059717908670" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">The biology behind interleukin-6 targeted interventions</a><div class="gs_gray">X Liu, GW Jones, EH Choy, SA Jones</div><div class="gs_gray">Current opinion in rheumatology 28 (2), 152-160<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11099972652927668465" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eflP2zaiRacC" class="gsc_a_at">Feasibility and domain validation of rheumatoid arthritis (RA) flare core domain set: report of the OMERACT 2014 RA Flare Group Plenary</a><div class="gs_gray">SJ Bartlett, VP Bykerk, R Cooksey, EH Choy, R Alten, R Christensen, ...</div><div class="gs_gray">The Journal of rheumatology 42 (11), 2185-2189<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16719886044627163257" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:7Frjd3zlGBUC" class="gsc_a_at">Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration</a><div class="gs_gray">LC Pollard, F Ibrahim, EH Choy, DL Scott</div><div class="gs_gray">The Journal of rheumatology 39 (1), 28-31<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15232296154596977298" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:mB3voiENLucC" class="gsc_a_at">Systematic review of discriminating power of outcome measures used in clinical trials of fibromyalgia</a><div class="gs_gray">SF Carville, EHS Choy</div><div class="gs_gray">The Journal of rheumatology 35 (11), 2094-2105<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12778766580109061041" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NMlhSUseqAsC" class="gsc_a_at">Development and validation of a patient‐based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice</a><div class="gs_gray">EH Choy, B Khoshaba, D Cooper, A MacGregor, DL Scott</div><div class="gs_gray">Arthritis Care &amp; Research 59 (2), 192-199<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2120919127525762906" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set</a><div class="gs_gray">VP Bykerk, CO Bingham, EH Choy, D Lin, R Alten, R Christensen, ...</div><div class="gs_gray">Rmd Open 2 (1), e000225<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9886770069923339254" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop</a><div class="gs_gray">CO Bingham, R Alten, SJ Bartlett, VP Bykerk, PM Brooks, E Choy, ...</div><div class="gs_gray">The Journal of Rheumatology 38 (8), 1751-1758<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9537054504456651302" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:dhFuZR0502QC" class="gsc_a_at">Chimaeric anti‐CD4 monoclonal antibody cross‐linked by monocyte Fcγ receptor mediates apoptosis of human CD4 lymphocytes</a><div class="gs_gray">EHS Choy, J Adjaye, L Forrest, GH Kingsley, GS Panayi</div><div class="gs_gray">European journal of immunology 23 (10), 2676-2681<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10117970727275840873" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4</a><div class="gs_gray">MA Smith, SK Bains, JC Betts, EHS Choy, ED Zanders</div><div class="gs_gray">Clinical Diagnostic Laboratory Immunology 8 (1), 105-111<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6688086891490059950" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Intramuscular methylprednisolone is superior to pulse oral methylprednisolone during the introduction phase of chrysotherapy</a><div class="gs_gray">EHS CHOY, GH KINGSLEY, MM Corkill, GS Panayi</div><div class="gs_gray">Rheumatology 32 (8), 734-739<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13500337783696405175" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tz746QTLzJkC" class="gsc_a_at">Chimaeric anti-CD4 monoclonal antibody for relapsing polychondritis</a><div class="gs_gray">EHS CHOY, IC Chikanza, GH Kingsley, GS Panayi</div><div class="gs_gray">Lancet (British edition) 338 (8764)<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18007885295941281548" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Defective CD8<sup>+</sup>CD28<sup>−</sup> regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy</a><div class="gs_gray">S Ceeraz, C Hall, EH Choy, J Spencer, VM Corrigall</div><div class="gs_gray">Clinical &amp; Experimental Immunology 174 (1), 18-26<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4940716228269674006" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled&nbsp;…</a><div class="gs_gray">JI Hudson, LM Arnold, LA Bradley, EHS Choy, PJ Mease, F Wang, J Ahl, ...</div><div class="gs_gray">The journal of Rheumatology 36 (11), 2517-2522<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4156930187069557648" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Anti cytokine therapy in chronic inflammatory arthritis</a><div class="gs_gray">C Thompson, R Davies, E Choy</div><div class="gs_gray">Cytokine 86, 92-99<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10046041032670194021" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:DXE8ND7PrJAC" class="gsc_a_at">Adalimumab therapy in patients with psoriatic arthritis: 24-week results of a phase III study</a><div class="gs_gray">PJ Mease, DD Gladman, CT Ritchlin, EM Ruderman, SED Steinfeld, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 50 (12), 4097-4097<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13811965241320760915" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9CGX2owmTHMC" class="gsc_a_at">EULAR definition of difficult-to-treat rheumatoid arthritis</a><div class="gs_gray">G Nagy, NMT Roodenrijs, PMJ Welsing, M Kedves, A Hamar, ...</div><div class="gs_gray">Annals of the rheumatic diseases 80 (1), 31-35<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2868291646916750623" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oXKBmVzQOggC" class="gsc_a_at">EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors</a><div class="gs_gray">M Kostine, A Finckh, CO Bingham, K Visser, J Leipe, H Schulze-Koops, ...</div><div class="gs_gray">Annals of the rheumatic diseases 80 (1), 36-48<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11402778794455738279" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:wvYxNZNCP7wC" class="gsc_a_at">Treatment of Rheumatoid Arthritis With Anti–Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study</a><div class="gs_gray">EH Choy, C Bernasconi, M Aassi, JF Molina, OM Epis</div><div class="gs_gray">Arthritis care &amp; research 69 (10), 1484-1494<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3449608669074294385" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Pharmacotherapy of fibromyalgia</a><div class="gs_gray">PJ Mease, EH Choy</div><div class="gs_gray">Rheumatic Disease Clinics 35 (2), 359-372<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15293182384341002763" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of “truth”: content, face, and construct validity</a><div class="gs_gray">P Tugwell, M Boers, MA D’Agostino, D Beaton, A Boonen, CO Bingham, ...</div><div class="gs_gray">The Journal of rheumatology 41 (5), 1000-1004<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11483415434575644981" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oPLKW5k6eA4C" class="gsc_a_at">Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials).</a><div class="gs_gray">EH Choy, PJ Mease</div><div class="gs_gray">Rheumatic diseases clinics of North America 35 (2), 329-337<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6659205474337301817" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:xm0LlTxljI0C" class="gsc_a_at">Rheumatoid arthritis: non-tumor necrosis factor targets</a><div class="gs_gray">L Pollard, E Choy</div><div class="gs_gray">Current opinion in rheumatology 17 (3), 242-246<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15226018306983496162" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Drug treatment of rheumatic diseases in the 1990s</a><div class="gs_gray">EHS Choy, DL Scott</div><div class="gs_gray">Drugs 53 (3), 337-348<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5642256572698628807" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:zzCxg_vo7cAC" class="gsc_a_at">The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib</a><div class="gs_gray">EHS Choy, C Miceli-Richard, MA González-Gay, SL Sinigaglia, ...</div><div class="gs_gray">Clinical and experimental rheumatology 37 (4), 694-407<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5407475976731454004" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?</a><div class="gs_gray">P Sarzi-Puttini, F Atzeni, IF Masala, F Salaffi, J Chapman, E Choy</div><div class="gs_gray">Autoimmunity reviews 17 (1), 33-35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13483970731534562817" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:L7vk9XBBNxgC" class="gsc_a_at">Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent&nbsp;…</a><div class="gs_gray">G Lliso-Ribera, F Humby, M Lewis, A Nerviani, D Mauro, F Rivellese, ...</div><div class="gs_gray">Annals of the rheumatic diseases 78 (12), 1642-1652<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4965112783940976459" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:orDZ08hpP44C" class="gsc_a_at">Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis</a><div class="gs_gray">JL Giles, E Choy, C Van Den Berg, BP Morgan, CL Harris</div><div class="gs_gray">The Journal of Immunology 194 (7), 3029-3034<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13983815362372992424" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK</a><div class="gs_gray">R Davies, WG Dixon, KD Watson, M Lunt, DPM Symmons, KL Hyrich</div><div class="gs_gray">Annals of the rheumatic diseases 72 (3), 461-462<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9744630742228973447" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:JP7YXuLIOvAC" class="gsc_a_at">Isolated ACTH deficiency presenting with bilateral frozen shoulder</a><div class="gs_gray">EHS Choy, MM Corkill, T Gibson, BH Hicks</div><div class="gs_gray">Rheumatology 30 (3), 226-227<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2320197133031002923" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:7H_jS4BsgvYC" class="gsc_a_at">Cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment. 1. Suppression of disease activity and acute phase&nbsp;…</a><div class="gs_gray">GS Panayi, EHS Choy, DJA Connolly, T Regan, VK Manna, N Rapson, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 39 (9), 1300-1300<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16685702418550389345,2390490782509814151" class="gsc_a_ac gs_ibl">35</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="OziPPvMAAAAJ:7H_jS4BsgvYC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ShjGdcaqzI0C" class="gsc_a_at">Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT)</a><div class="gs_gray">S Hewlett, C Almeida, N Ambler, PS Blair, EH Choy, E Dures, ...</div><div class="gs_gray">Annals of the rheumatic diseases 78 (4), 465-472<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8533459502506547539" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:A8cqit5AE6sC" class="gsc_a_at">Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries</a><div class="gs_gray">E Choy, R Caporali, R Xavier, B Fautrel, R Sanmarti, M Bao, ...</div><div class="gs_gray">Rheumatology 57 (3), 499-507<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14248766324696750416" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti-oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo&nbsp;…</a><div class="gs_gray">EH Choy, M Bendit, D McAleer, F Liu, M Feeney, S Brett, S Zamuner, ...</div><div class="gs_gray">Arthritis research &amp; therapy 15 (5), 1-10<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16272826866459465813" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Annals of the rheumatic diseases 62 (suppl 2), ii68-ii69<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17525425100601523976" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:XAp-VaTZjjwC" class="gsc_a_at">Optimized peptide–MHC multimer protocols for detection and isolation of autoimmune T-cells</a><div class="gs_gray">G Dolton, E Zervoudi, C Rius, A Wall, HL Thomas, A Fuller, L Yeo, ...</div><div class="gs_gray">Frontiers in immunology 9, 1378<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13672445709818750341" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Clinical experience of IL-6 blockade in rheumatic diseases—implications on IL-6 biology and disease pathogenesis</a><div class="gs_gray">R Davies, E Choy</div><div class="gs_gray">Seminars in immunology 26 (1), 97-104<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15074684855510205885" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WM2K3OHRCGMC" class="gsc_a_at">Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case–control comparison</a><div class="gs_gray">JC Demmler, MD Atkinson, EJ Reinhold, E Choy, RA Lyons, ST Brophy</div><div class="gs_gray">BMJ open 9 (11), e031365<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15799650555735716045" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rLGzs9wiiwIC" class="gsc_a_at">EULAR recommendations for management of fibromyalgia</a><div class="gs_gray">GJ Macfarlane, C Kronisch, F Atzeni, W Häuser, EH Choy, K Amris, ...</div><div class="gs_gray">Annals of the rheumatic diseases, annrheumdis-2017-211587<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11454188720340929214" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia</a><div class="gs_gray">KB Jensen, F Petzke, S Carville, E Choy, P Fransson, RH Gracely, ...</div><div class="gs_gray">The Journal of Pain 15 (12), 1328-1337<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17840108335477815515" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis</a><div class="gs_gray">E Choy, D Aletaha, F Behrens, A Finckh, J Gomez-Reino, JE Gottenberg, ...</div><div class="gs_gray">Rheumatology 56 (5), 689-697<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17539486853437948289" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study</a><div class="gs_gray">E Lie, TG Woodworth, R Christensen, TK Kvien, V Bykerk, DE Furst, ...</div><div class="gs_gray">Annals of the rheumatic diseases 73 (10), 1781-1787<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12381834035930532588" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database.</a><div class="gs_gray">A Naranjo, S Toloza, I Guimaraes da Silveira, J Lazovskis, ML Hetland, ...</div><div class="gs_gray">Clinical and experimental rheumatology 28 (6), 820-827<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8381795142340862800" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-95Q15plzcUC" class="gsc_a_at">Lower placebo responses after long-term exposure to fibromyalgia pain</a><div class="gs_gray">E Kosek, A Rosen, S Carville, E Choy, RH Gracely, H Marcus, F Petzke, ...</div><div class="gs_gray">The Journal of Pain 18 (7), 835-843<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8733695580281594547" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1r-w4gtu6w8C" class="gsc_a_at">Therapeutic monoclonal antibodies</a><div class="gs_gray">EHS Choy, GS Panayi, GH Kingsley</div><div class="gs_gray">Rheumatology 34 (8), 707-715<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12057584241500498568" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:l6Q3WhenKVUC" class="gsc_a_at">Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis</a><div class="gs_gray">IB McInnes, P Nash, C Ritchlin, EH Choy, S Kanters, H Thom, K Gandhi, ...</div><div class="gs_gray">Journal of comparative effectiveness research 7 (11), 1107-1123<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11296188775188523937" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria</a><div class="gs_gray">GH Kingsley, B Khoshaba, CM Smith, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 44 (5), 629-632<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7011128850858772769" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:YPNY0knpFBYC" class="gsc_a_at">The impact of biologics and tofacitinib on cardiovascular risk factors and outcomes in patients with rheumatic disease: a systematic literature review</a><div class="gs_gray">M Nurmohamed, E Choy, S Lula, B Kola, R DeMasi, P Accossato</div><div class="gs_gray">Drug safety 41 (5), 473-488<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7317732690275903584" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:v6i8RKmR8ToC" class="gsc_a_at">Content and construct validity, reliability, and responsiveness of the rheumatoid arthritis flare questionnaire: OMERACT 2016 workshop report</a><div class="gs_gray">SJ Bartlett, SP Barbic, VP Bykerk, EH Choy, R Alten, R Christensen, ...</div><div class="gs_gray">The Journal of rheumatology 44 (10), 1536-1543<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10932865825185371279" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ</a><div class="gs_gray">DL Scott, B Khoshaba, EH Choy, GH Kingsley</div><div class="gs_gray">Annals of the rheumatic diseases 66 (11), 1534-1537<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13390254633819924892" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiences</a><div class="gs_gray">T Rader, JP Pardo, D Stacey, E Ghogomu, LJ Maxwell, VA Welch, ...</div><div class="gs_gray">The Journal of rheumatology 41 (2), 206-215<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7039951288329200564" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine</a><div class="gs_gray">R Bennett, IJ Russell, E Choy, M Spaeth, P Mease, D Kajdasz, D Walker, ...</div><div class="gs_gray">Clinical therapeutics 34 (4), 824-837<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9929262117645226673" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:maZDTaKrznsC" class="gsc_a_at">Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective</a><div class="gs_gray">E Choy, S Richards, K Bowrin, P Watson, A Lloyd, A Sadosky, G Zlateva</div><div class="gs_gray">Current medical research and opinion 26 (4), 965-975<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14017515201115851790" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Two is better than one? Combination therapy in rheumatoid arthritis</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Rheumatology 43 (10), 1205-1207<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17888996008776924362" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:7VEv-pLvLSsC" class="gsc_a_at">Evaluation of the short‐, mid‐, and long‐term effects of tofacitinib on lymphocytes in patients with rheumatoid arthritis</a><div class="gs_gray">R van Vollenhoven, EB Lee, S Strengholt, C Mojcik, H Valdez, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 71 (5), 685-695<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10276410118460341604" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Defining the optimal biological monotherapy in rheumatoid arthritis: a systematic review and meta-analysis of randomised trials</a><div class="gs_gray">S Tarp, DE Furst, A Dossing, M Østergaard, T Lorenzen, MS Hansen, ...</div><div class="gs_gray">Seminars in arthritis and rheumatism 46 (6), 699-708<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15352966089873965556" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Evaluation of minimally invasive, ultrasound-guided synovial biopsy techniques by the OMERACT filter—determining validation requirements</a><div class="gs_gray">F Humby, S Kelly, S Bugatti, A Manzo, A Filer, A Mahto, JE Fonseca, ...</div><div class="gs_gray">The Journal of rheumatology 43 (1), 208-213<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16487591364141972002" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the fibromyalgia Detection (FibroDetect®) screening tool</a><div class="gs_gray">R Baron, S Perrot, I Guillemin, C Alegre, C Dias-Barbosa, E Choy, H Gilet, ...</div><div class="gs_gray">Health and quality of life outcomes 12 (1), 1-11<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14736478184471019854" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis</a><div class="gs_gray">AP Malaviya, J Ledingham, J Bloxham, A Bosworth, M Buch, E Choy, ...</div><div class="gs_gray">Rheumatology 53 (7), 1344-1346<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4171054379452766189" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oTdOBqtIf_kC" class="gsc_a_at">Chronic sialadenitis in patients with nodal osteoarthritis.</a><div class="gs_gray">DG Kassimos, PJ Shirlaw, EH Choy, K Hockey, PR Morgan, ...</div><div class="gs_gray">British journal of rheumatology 36 (12), 1312-1317<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14836093447343162674" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1_W9tMSvGuwC" class="gsc_a_at">Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study</a><div class="gs_gray">E Monnet, EH Choy, I McInnes, T Kobakhidze, K de Graaf, P Jacqmin, ...</div><div class="gs_gray">Annals of the rheumatic diseases 79 (3), 316-323<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1816571836484554075" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:qCpRzq7zkD8C" class="gsc_a_at">Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and&nbsp;…</a><div class="gs_gray">SA Just, F Humby, H Lindegaard, LM de Bellefon, P Durez, ...</div><div class="gs_gray">RMD open 4 (2), e000799<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11226796752404823573" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Pharmacologic modulation of hand pain in osteoarthritis: A double‐blind placebo‐controlled functional magnetic resonance imaging study using naproxen</a><div class="gs_gray">D Sanders, K Krause, J O'Muircheartaigh, MA Thacker, JP Huggins, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67 (3), 741-751<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10790618704209221516" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Updating the OMERACT filter: core areas as a basis for defining core outcome sets</a><div class="gs_gray">JR Kirwan, M Boers, S Hewlett, D Beaton, CO Bingham, E Choy, ...</div><div class="gs_gray">The Journal of rheumatology 41 (5), 994-999<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18061006595705126908" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Review of treatment response in rheumatoid arthritis: assessment of heterogeneity</a><div class="gs_gray">I Goetz, GC Carter, M Lucero, V Zarotsky, CI Alatorre, RA Cantrell, ...</div><div class="gs_gray">Current medical research and opinion 27 (4), 697-711<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17874550217414366844,9311236045744440350" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:sfnaS5RM6jYC" class="gsc_a_at">A randomised, double-blind, placebo-controlled trial of a recombinant version of human α-fetoprotein (MM-093) in patients with active rheumatoid arthritis</a><div class="gs_gray">LC Pollard, J Murray, M Moody, EJ Stewart, EHS Choy</div><div class="gs_gray">Annals of the rheumatic diseases 66 (5), 687-689<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11636408836953844262" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Adalimumab treatment effects on radiographic progression of joint disease in patients with psoriatic arthritis: results from ADEPT P06. 12</a><div class="gs_gray">P Mease, J Sharp, P Ory, D Gladman, C Ritchlin, E Choy, M Weinberg</div><div class="gs_gray">Journal of the European Academy of Dermatology &amp; Venereology 19<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6734463442895074119,6247564045946818324" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:pYKElYtJMmwC" class="gsc_a_at">First-line DMARD choice in early rheumatoid arthritis—do prognostic factors play a role?</a><div class="gs_gray">SM Rachapalli, R Williams, DA Walsh, A Young, PDW Kiely, EH Choy</div><div class="gs_gray">Rheumatology 49 (7), 1267-1271<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15197147473169714784" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ukw-9cB-YDkC" class="gsc_a_at">Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register</a><div class="gs_gray">GJ Macfarlane, RIR MacDonald, E Pathan, S Siebert, K Gaffney, E Choy, ...</div><div class="gs_gray">Rheumatology 57 (11), 1982-1990<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17412895610281666566" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Y9VhQm-5nPIC" class="gsc_a_at">An evidence-based review of pregabalin for the treatment of fibromyalgia</a><div class="gs_gray">LM Arnold, E Choy, DJ Clauw, H Oka, E Whalen, D Semel, L Pauer, ...</div><div class="gs_gray">Current medical research and opinion 34 (8), 1397-1409<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6323661904195474436" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:z_wVstp3MssC" class="gsc_a_at">Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?</a><div class="gs_gray">P Marchettini, S Wilhelm, H Petto, S Tesfaye, T Tölle, D Bouhassira, ...</div><div class="gs_gray">European Journal of Pain 20 (3), 472-482<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10951006070244556993" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">More than just minutes of stiffness in the morning: report from the OMERACT Rheumatoid Arthritis Flare Group stiffness breakout sessions</a><div class="gs_gray">AM Orbai, S Halls, S Hewlett, SJ Bartlett, AL Leong, CO Bingham, ...</div><div class="gs_gray">The Journal of rheumatology 42 (11), 2182-2184<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16646323475688128881" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Randomized, Double-Blind, Phase 3 Study of Efficacy and Safety of ABP 501 Compared with Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis: Abstract Number: 2054</a><div class="gs_gray">S Cohen, M Genovese, E Choy, F Perez-Ruiz, J Pablos, N Zhang, P Kaur</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 2443-2444<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5673057510631574389" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Is chronic pain a disease in its own right? Discussions from a pre-OMERACT 2014 workshop on chronic pain</a><div class="gs_gray">AM Taylor, K Phillips, JO Taylor, JA Singh, PG Conaghan, EH Choy, ...</div><div class="gs_gray">The Journal of rheumatology 42 (10), 1947-1953<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6921754834036650587" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids</a><div class="gs_gray">F Ibrahim, E Choy, P Gordon, CJ Dore, A Hakim, G Kitas, D Isenberg, ...</div><div class="gs_gray">Rheumatology 54 (6), 1050-1055<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4226953633146222309" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lSLTfruPkqcC" class="gsc_a_at">The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective</a><div class="gs_gray">A Lloyd, CS Boomershine, EH Choy, A Chandran, G Zlateva</div><div class="gs_gray">Journal of medical economics 15 (3), 481-492<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7471196235204939448" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis</a><div class="gs_gray">JP Jansen, S Gaugris, EH Choy, A Ostor, JT Nash, W Stam</div><div class="gs_gray">Pharmacoeconomics 28 (4), 323-344<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4311793047207411286" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Anti-CD4 monoclonal antibodies in rheumatoid arthritis</a><div class="gs_gray">EHS Choy, GH Kingsley, GS Panayi</div><div class="gs_gray">Springer seminars in immunopathology 20 (1), 261-273<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14301305544009475536" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Inhibiting interleukin-6 in rheumatoid arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Current rheumatology reports 10 (5), 413-417<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6983090149687494785" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:uAPFzskPt0AC" class="gsc_a_at">Identifying the unmet information and support needs of women with autoimmune rheumatic diseases during pregnancy planning, pregnancy and early parenting: mixed-methods study</a><div class="gs_gray">R Phillips, B Pell, A Grant, D Bowen, J Sanders, A Taylor, A Edwards, ...</div><div class="gs_gray">BMC rheumatology 2 (1), 1-18<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12765376184985153541" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:XDrR66g3YHsC" class="gsc_a_at">Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis</a><div class="gs_gray">R Cooksey, S Brophy, J Kennedy, FF Gutierrez, T Pickles, R Davies, ...</div><div class="gs_gray">Seminars in arthritis and rheumatism 48 (3), 367-373<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3501921350519104376" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:D_sINldO8mEC" class="gsc_a_at">Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis</a><div class="gs_gray">VL Manning, B Kaambwa, J Ratcliffe, DL Scott, E Choy, MV Hurley, ...</div><div class="gs_gray">Rheumatology 54 (2), 302-309<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8288934352588038940" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:37Fl7vPTsUIC" class="gsc_a_at">B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure</a><div class="gs_gray">F Rivellese, F Humby, S Bugatti, L Fossati‐Jimack, H Rizvi, D Lucchesi, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 72 (5), 714-725<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16878762340711303382" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:i8eIfGGcn98C" class="gsc_a_at">Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open&nbsp;…</a><div class="gs_gray">F Humby, P Durez, MH Buch, MJ Lewis, H Rizvi, F Rivellese, A Nerviani, ...</div><div class="gs_gray">The Lancet 397 (10271), 305-317<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4021253401350026377,4658726511923118909" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Protocol for a randomised controlled trial for Reducing Arthritis Fatigue by clinical Teams (RAFT) using cognitive–behavioural approaches</a><div class="gs_gray">S Hewlett, N Ambler, C Almeida, PS Blair, E Choy, E Dures, A Hammond, ...</div><div class="gs_gray">BMJ open 5 (8), e009061<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5713436095844521280" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia</a><div class="gs_gray">F Petzke, KB Jensen, E Kosek, E Choy, S Carville, P Fransson, ...</div><div class="gs_gray">Scandinavian journal of pain 4 (2), 65-74<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4204993168073451663" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Furthering our understanding of fatigue in rheumatoid arthritis</a><div class="gs_gray">S Hewlett, E Choy, J Kirwan</div><div class="gs_gray">The Journal of rheumatology 39 (9), 1775-1777<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10719527552777754595" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:70eg2SAEIzsC" class="gsc_a_at">T cells in psoriatic arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Current rheumatology reports 9 (6), 437-441<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11050152119227214225" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:blknAaTinKkC" class="gsc_a_at">Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">Drugs &amp; aging 12 (2), 139-148<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10691833790449820486" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:gmHTDCtJMcoC" class="gsc_a_at">Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying&nbsp;…</a><div class="gs_gray">E Choy, N Freemantle, C Proudfoot, CI Chen, L Pollissard, A Kuznik, ...</div><div class="gs_gray">RMD open 5 (1), e000798<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7898109702575885441" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">" Flare" and disease worsening in rheumatoid arthritis: Time for a definition</a><div class="gs_gray">CO Bingham, C Pohl, R Alten, R Christensen, EH Choy, SE Hewlett, ...</div><div class="gs_gray">International Journal of Advances in Rheumatology 7 (3), 85-91<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2849440299534643675" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">CDP870, A NOVEL, PEGYLATED, HUMANIZED TNF-α INHIBITOR, IS EFFECTIVE IN TREATING THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS (RA)</a><div class="gs_gray">E Keystone, E Choy, J Kalden, L Klareskog, J Sany, J Smolen, J Smith, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 44 (12)<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=206709512261329128" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:wLxue7F8ec0C" class="gsc_a_at">The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis.</a><div class="gs_gray">EH Choy, EC Rankin, D Kassimos, O Vetterlein, A Garyfallos, ...</div><div class="gs_gray">The Journal of rheumatology 26 (11), 2310-2317<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9794237594311919010" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Mechanisms of action of second-line agents and choice of drugs in combination therapy</a><div class="gs_gray">E Choy, G Panayi</div><div class="gs_gray">Clinical and experimental rheumatology 17, S-20<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2415177021335794888" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8dzOF9BpDQoC" class="gsc_a_at">Endogenous opioid tone in patients with rheumatoid arthritis</a><div class="gs_gray">D Kassimos, EHS Choy, AB Grossman, IC Chikanza, GS Panayi</div><div class="gs_gray">Rheumatology 35 (5), 436-440<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4081204714118389630" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Cellular immunity to cartilage proteoglycans: relevance to the pathogenesis of ankylosing spondylitis.</a><div class="gs_gray">P Jobanputra, EH Choy, GH Kingsley, J Sieper, AA Palacios-Boix, ...</div><div class="gs_gray">Annals of the rheumatic diseases 51 (8), 959-962<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16379421505937362520" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:pUxgyZctzPYC" class="gsc_a_at">Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis</a><div class="gs_gray">V Strand, I McInnes, P Mease, P Nash, H Thom, C Kalyvas, M Hunger, ...</div><div class="gs_gray">Journal of comparative effectiveness research 8 (7), 497-510<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3754892412317034645" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:0N-VGjzr574C" class="gsc_a_at">AB0451 NI-0101, a monoclonal antibody targeting toll like receptor 4 (TLR4) being developed for rheumatoid arthritis (RA) treatment with a potential for personalized medicine</a><div class="gs_gray">E Monnet, L Shang, G Lapeyre, K Degraaf, E Hatterer, V Buatois, G Elson, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 74 (Suppl 2), 1046-1046<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15385915437063207155" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Fibromyalgia syndrome</a><div class="gs_gray">E Choy</div><div class="gs_gray">Oxford Rheumatology Library<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4530099451697128639" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">SEROLOGICAL EFFECTS OF REPEATED DOSES OF AN ENGINEERED HUMAN ANTI-TNF-ALPHA-ANTIBODY, CDP571, IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA)</a><div class="gs_gray">ECC Rankin, EHS Choy, MR Ehrenstein, CT Ravirajan, M Sopwith, ...</div><div class="gs_gray">Arthritis Rheum 38 (9), 758-758<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=442403981310341151" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:YTuZlYwrTOUC" class="gsc_a_at">THE IMPORTANCE OF DOSE AND DOSING REGIMEN OF ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA)</a><div class="gs_gray">EHS Choy, C Pitzalis, JA Bijl, GH Kingsley, GS Panayi</div><div class="gs_gray">Arthritis and Rheumatism 36 (9), S129-S129<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6207693932779730108" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Systemic sclerosis occurring in a patient with Adamantiades-Behçet's disease</a><div class="gs_gray">E Choy, G Kingsley, G Panayi</div><div class="gs_gray">Rheumatology 32 (2), 160-161<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4432991291509519573" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:KTwcwpFFj4wC" class="gsc_a_at">Degenerative joint disease</a><div class="gs_gray">BS Beale, RL Goring, MJ Bojrab</div><div class="gs_gray">Disease mechanisms in small animal surgery. Malvern: Lea &amp; Febiger, 727-736<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3135250041072026005,16670258857156699852" class="gsc_a_ac gs_ibl">14</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="OziPPvMAAAAJ:KTwcwpFFj4wC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Consensus decision models for biologics in rheumatoid and psoriatic arthritis: recommendations of a multidisciplinary working party</a><div class="gs_gray">J Madan, T Ades, P Barton, L Bojke, E Choy, P Helliwell, P Jobanputra, ...</div><div class="gs_gray">Rheumatology and therapy 2 (2), 113-125<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3997933860667464208" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:FsLZdJ3BAzkC" class="gsc_a_at">Clinical and radiological features of rheumatoid arthritis in British black Africans</a><div class="gs_gray">V Ravindran, M Seah, DA Elias, EH Choy, DL Scott, PA Gordon</div><div class="gs_gray">Clinical rheumatology 27 (1), 97-100<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16300088064690555214" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BqipwSGYUEgC" class="gsc_a_at">The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.</a><div class="gs_gray">EH Choy, A Schantz, C Pitzalis, GH Kingsley, GS Panayi</div><div class="gs_gray">British journal of rheumatology 37 (7), 801-802<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5284074471630387500" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:UKB2i6g6GNMC" class="gsc_a_at">Transforming clinical trials in rheumatology: towards patient-centric precision medicine</a><div class="gs_gray">C Pitzalis, EHS Choy, MH Buch</div><div class="gs_gray">Nature Reviews Rheumatology 16 (10), 590-599<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1166221019269127908" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:iKswqCX-FLkC" class="gsc_a_at">Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients</a><div class="gs_gray">PDH Hamann, JD Pauling, N McHugh, G Shaddick, K Hyrich</div><div class="gs_gray">Rheumatology 58 (12), 2162-2169<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12895079538295596607" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rFyVMFCKTwsC" class="gsc_a_at">Interleukin 6: The biology behind the therapy</a><div class="gs_gray">SA Jones, T Takeuchi, D Aletaha, J Smolen, EH Choy, I McInnes</div><div class="gs_gray">Considerations in Medicine 2 (1), 2-6<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9428737669946409234" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients</a><div class="gs_gray">IA Lipkovich, EH Choy, P Van Wambeke, W Deberdt, D Sagman</div><div class="gs_gray">BMC musculoskeletal disorders 15 (1), 1-11<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12504254912237239365" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:a0OBvERweLwC" class="gsc_a_at">Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK</a><div class="gs_gray">JP Jansen, J Pellissier, EH Choy, A Ostor, JT Nash, P Bacon, E Hunsche</div><div class="gs_gray">Current medical research and opinion 23 (12), 3069-3078<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2367435323265380103,18210467687525769460" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SxCCDk4iOpsC" class="gsc_a_at">Effect of a humanised non-depleting anti-CD4 monoclonal antibody (mAb) on synovial fluid (SF) in rheumatoid arthritis (RA).</a><div class="gs_gray">EHS Choy, DJA Connolly, N Rapson, GH Kingsley, JM Johnston, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 40 (9)<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5119017917042546945" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:w7CBUyPWg-0C" class="gsc_a_at">Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Rheumatology 58 (Supplement_5), v51-v55<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15803319835970564870" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">Participants’ experiences of an Education, self-management and upper extremity eXercise Training for people with Rheumatoid Arthritis programme (EXTRA)</a><div class="gs_gray">LM Bearne, VL Manning, E Choy, DL Scott, MV Hurley</div><div class="gs_gray">Physiotherapy 103 (4), 430-438<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8515971280087825251" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:5awf1xo2G04C" class="gsc_a_at">Evaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial</a><div class="gs_gray">M Dougados, TWJ Huizinga, EH Choy, CO Bingham III, M Aassi, ...</div><div class="gs_gray">Arthritis care &amp; research 67 (12), 1762-1766<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12823916301379819037" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Variation in the use of biologics in the management of rheumatoid arthritis across the UK</a><div class="gs_gray">E Choy, P Taylor, S McAuliffe, K Roberts, I Sargeant</div><div class="gs_gray">Current medical research and opinion 28 (10), 1733-1741<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10221003989102491829" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">RADIATE: more treatment options for patients with an inadequate response to tumor necrosis factor antagonists</a><div class="gs_gray">E Choy</div><div class="gs_gray">Nature Clinical Practice Rheumatology 5 (2), 66-67<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18177249941901984210" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Oral toleragens in rheumatoid arthritis.</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Current opinion in investigational drugs (London, England: 2000) 1 (1), 58-62<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9167468801854435362" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Death receptor 3 (TNFRSF25) increases mineral apposition by osteoblasts and region specific new bone formation in the axial skeleton of male DBA/1 mice</a><div class="gs_gray">FL Collins, JO Williams, AC Bloom, MD Stone, E Choy, ECY Wang, ...</div><div class="gs_gray">Journal of immunology research 2015<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4504432910592565410" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:2vr6o8x5NLkC" class="gsc_a_at">Clinical efficacy and safety of adalimumab for psoriatic arthritis: 48-week results of ADEPT</a><div class="gs_gray">PJ Mease, DD Gladman, CT Ritchlin, EM Ruderman, EHS Choy, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 52 (9), S215-S215<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10680074917511742526" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:35N4QoGY0k4C" class="gsc_a_at">T-cell regulation</a><div class="gs_gray">EHS Choy, GH Kingsley, GS Panayi</div><div class="gs_gray">Baillière's clinical rheumatology 9 (4), 653-671<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10780377388030767621" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:wSy_KLzO7YEC" class="gsc_a_at">THE AMOUNT OF ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) ENTERING THE RHEUMATOID (RA) JOINT MAY DETERMINE CLINICAL EFFICACY</a><div class="gs_gray">EHS Choy, C Pitzalis, JA Bill, GH Kingsley, GS Panayi</div><div class="gs_gray">Arthritis and Rheumatism 36 (9), S39-S39<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10385552767782074036" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9o6PfxSMcEIC" class="gsc_a_at">Differential Binding of Sarilumab and Tocilizumab to IL‐6Rα and Effects of Receptor Occupancy on Clinical Parameters</a><div class="gs_gray">C Xu, A Rafique, T Potocky, A Paccaly, P Nolain, Q Lu, ...</div><div class="gs_gray">The Journal of Clinical Pharmacology 61 (5), 714-724<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=90061108332794153" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Og1tA8FjbJAC" class="gsc_a_at">Who is referred for specialist rheumatology care?</a><div class="gs_gray">J Guilar, I Wamuo, EHS Choy, M Hossain, DL Scott</div><div class="gs_gray">Rheumatology 39 (11), 1292-1294<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10403946680842926574" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies</a><div class="gs_gray">EHS Choy, DL Scott</div><div class="gs_gray">Drugs 50 (1), 15-25<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11505505025422564998" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Vr2j17o0sqMC" class="gsc_a_at">REPEATED DOSES OF 10 MG/KG OF AN ENGINEERED HUMAN ANTI-TNF-ALPHA ANTIBODY, CDP571, IN RA PATIENTS ARE SAFE AND EFFECTIVE</a><div class="gs_gray">ECC Rankin, EHS Choy, M Sopwith, O Vetterlein, GS Panayi, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 38 (9), 197-197<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13557116996656415000" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:R6EwkKsDylYC" class="gsc_a_at">The Jak/STAT pathway: A focus on pain in rheumatoid arthritis</a><div class="gs_gray">LS Simon, PC Taylor, EH Choy, A Sebba, A Quebe, KL Knopp, F Porreca</div><div class="gs_gray">Seminars in arthritis and rheumatism<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8204547717113243347" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RVqaWcrwK10C" class="gsc_a_at">Association of High Serum Interleukin‐6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or&nbsp;…</a><div class="gs_gray">A Boyapati, S Schwartzman, J Msihid, E Choy, MC Genovese, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 72 (9), 1456-1466<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17452624194940935832" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WMtz-WDmgKQC" class="gsc_a_at">AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS)</a><div class="gs_gray">GJ Macfarlane, E Pathan, S Siebert, J Packham, K Gaffney, E Choy, ...</div><div class="gs_gray">BMC rheumatology 3 (1), 1-11<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8794036283686289974" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Cvh0bltMcLgC" class="gsc_a_at">Neuropathic-like pain in psoriatic arthritis: evidence of abnormal pain processing</a><div class="gs_gray">A Ramjeeawon, E Choy</div><div class="gs_gray">Clinical rheumatology 38 (11), 3153-3159<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=400124956826199256" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4n0clTBhZ78C" class="gsc_a_at">Inhibition of CCL3 abrogated precursor cell fusion and bone erosions in human osteoclast cultures and murine collagen-induced arthritis</a><div class="gs_gray">LA Jordan, MC Erlandsson, BF Fenner, R Davies, AK Harvey, EH Choy, ...</div><div class="gs_gray">Rheumatology 57 (11), 2042-2052<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6535100962116776856" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Long-term maintenance of certolizumab pegol safety and efficacy, in combination with methotrexate and as monotherapy, in rheumatoid arthritis patients</a><div class="gs_gray">R Fleischmann, RF van Vollenhoven, J Vencovský, R Alten, O Davies, ...</div><div class="gs_gray">Rheumatology and therapy 4 (1), 57-69<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8503366218285773283" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rbGdIwl2e6cC" class="gsc_a_at">Secukinumab for the treatment of psoriatic arthritis: comparative effectiveness versus infliximab using a matching-adjusted indirect comparison</a><div class="gs_gray">V Strand, PJ Mease, IB McInnes, P Nash, H Thom, M Hunger, K Gandhi, ...</div><div class="gs_gray">Arthritis Rheumatol 68<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2512535094511759701" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">THU0199 Tofacitinib, an oral Janus kinase inhibitor, in the treatment of rheumatoid arthritis: changes in lymphocytes and lymphocyte subset counts and reversibility after up to&nbsp;…</a><div class="gs_gray">R Van Vollenhoven, E Choy, EB Lee, A Hazra, A Anisfeld, I Lazariciu, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 258-258<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15581744410718754663" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:5LPo_wSKItgC" class="gsc_a_at">Non-Pharmacological Interventions for Fatigue in Rheumatoid Arthritis: A Cochrane Review.</a><div class="gs_gray">F Cramp, S Hewlett, C Almeida, JR Kirwan, E Choy, T Chalder, J Pollock, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 63 (10), S608-S608<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17776096946709661041" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Safety update on certolizumab pegol (CZP) in patients with active rheumatoid arthritis (RA)</a><div class="gs_gray">R van Vollenhoven, J Smolen, M Schiff, R Fleischmann, B Combe, N Goel, ...</div><div class="gs_gray">Rheumatology 49, I102-I103<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8731533134476493760" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">DAS28 (ESR) response at week 12 is predictive of long-term disease activity in rheumatoid arthritis patients treated with certolizumab pegol</a><div class="gs_gray">M Schiff, E Keystone, T Kvien, J Curtis, P Emery, K Luijtens, E Choy</div><div class="gs_gray">Journal of Rheumatology 37 (6), 1332-1332<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2479421588673248124" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarctions (MI): systematic assessment of the available evidence</a><div class="gs_gray">PA Scott, G Kingsley, C Smith, E Choy, DL Scott</div><div class="gs_gray">Arthritis &amp; Rheumatism 54 (9), S109-S109<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2725004081277129474" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rO6llkc54NcC" class="gsc_a_at">The blossoming of evidence‐based clinical rheumatology: The Arthritis Research Campaign's Clinical Trials Collaboration in association with the MRC Clinical Trials Unit, BSR&nbsp;…</a><div class="gs_gray">C Cooper, E Choy</div><div class="gs_gray">Rheumatology 42 (6), 713-715<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15326481697070744001" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">A double-blind, randomised, placebo-controlled trial of anti-interleukin-6 (IL-6) receptor monoclonal antibody in rheumatoid arthritis (RA).</a><div class="gs_gray">EH Choy, DA Isenberg, S Farrow, T Garrood, Y Ioannou, HA Bird, ...</div><div class="gs_gray">Arthritis Rheum 44 (9), S274-S274<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7897361918556923013" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:wUn16MOA3RoC" class="gsc_a_at">Treatment with anti‐cd4 monoclonal antibody and acute interstitial nephritis</a><div class="gs_gray">EHS Choy, GH Kingsley, GS Panayi</div><div class="gs_gray">Arthritis &amp; Rheumatism: Official Journal of the American College of&nbsp;…<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11434724226400110604" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">Anti-CD4 therapy in rheumatoid arthritis</a><div class="gs_gray">EHS CHOY, GH Kingsley</div><div class="gs_gray">Clinical and experimental rheumatology (Testo stampato) 11, S147-S149<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16692285275202825941" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BW2nPTmhBn4C" class="gsc_a_at">Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.</a><div class="gs_gray">S Hewlett, C Almeida, N Ambler, PS Blair, E Choy, E Dures, A Hammond, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 23 (57), 1<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13002717918693359961,2358324811926211332" class="gsc_a_ac gs_ibl">7</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="OziPPvMAAAAJ:BW2nPTmhBn4C">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LWqeokA2EBkC" class="gsc_a_at">069 High baseline serum IL-6 identifies a subgroup of rheumatoid arthritis patients with rapid joint damage and clinical progression and predicts increased sarilumab treatment&nbsp;…</a><div class="gs_gray">A Boyapati, J Msihid, S Schwartzman, E Choy, GR Burmester, G Lam, ...</div><div class="gs_gray">Rheumatology 58 (Supplement_3), kez106. 068<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8432481521865221063" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:C-Rn0OCouf8C" class="gsc_a_at">Indirect treatment comparison of the efficacy and safety of sarilumab monotherapy in rheumatoid arthritis patients with inadequate response to conventional disease-modifying&nbsp;…</a><div class="gs_gray">E Choy, N Freemantle, C Proudfoot, CI Chen, L Pollissard, A Kuznik, ...</div><div class="gs_gray">Advances in therapy 36 (4), 817-827<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9601122412430140868" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:idthP5jqfYAC" class="gsc_a_at">Reaching a consensus on research priorities for supporting women with autoimmune rheumatic diseases during pre-conception, pregnancy and early parenting: A Nominal Group&nbsp;…</a><div class="gs_gray">R Phillips, D Williams, D Bowen, D Morris, A Grant, B Pell, J Sanders, ...</div><div class="gs_gray">Wellcome open research 3<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4193743966514854148,12207038438715459744" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:anDooRL1HQEC" class="gsc_a_at">Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines, 5 (2), 20</a><div class="gs_gray">S Kia, E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13628423554069080692" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8xutWZnSdmoC" class="gsc_a_at">Assessment of Immunogenicity of Live Zoster Vaccination (Zostavax®) in Rheumatoid Arthritis Patients on Background Methotrexate before and after Initiating Tofacitinib or&nbsp;…</a><div class="gs_gray">K Winthrop, A Wouters, E Choy, K Soma, J Hodge, C Nduaka, P Biswas, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 3959-3960<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=823971392000110422" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Efficacy of adalimumab by disease duration in psoriatic arthritis: Subanalysis of ADEPT P2748</a><div class="gs_gray">E Choy, D Gladman, E Sasso</div><div class="gs_gray">Journal of the American Academy of Dermatology 56 (2)<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6076486979472847852" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Inhibition of joint destruction in PsA with adalimumab: 48-week results of ADEPT.</a><div class="gs_gray">P Mease, J Sharp, P Ory, D Gladman, C Ritchlin, E Choy, R Perdok, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 52 (9), S631-S631<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7202592211836087802" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Cytokine 28 (4-5), 158-161<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3583637306387813462" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:w0F2JDEymm0C" class="gsc_a_at">Connective tissue diseases</a><div class="gs_gray">MJ Wright, H Dietz III</div><div class="gs_gray">Oski's Principles and Practice of Pediatrics, McMillan, J, Oski, F (Eds&nbsp;…<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6508412827902992456" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Nickel contamination of gold salts: link with gold-induced skin rash.</a><div class="gs_gray">EH Choy, L Gambling, SL Best, RE Jenkins, E Kondeatis, R Vaughan, ...</div><div class="gs_gray">British journal of rheumatology 36 (10), 1054-1058<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17205514414184902599" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:CC3C2HR4nz8C" class="gsc_a_at">C-reactive protein and implications in rheumatoid arthritis and associated comorbidities</a><div class="gs_gray">JE Pope, EH Choy</div><div class="gs_gray">Seminars in Arthritis and Rheumatism<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8159605227425643747" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Oo_WeVVXg5wC" class="gsc_a_at">Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma</a><div class="gs_gray">Y Loriot, CN Sternberg, D Castellano, SF Oosting, H Dumez, R Huddart, ...</div><div class="gs_gray">European Journal of Cancer 138, 202-211<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1711863522292125252" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:J4E9jCG1tHUC" class="gsc_a_at">“Nobody knows, or seems to know how rheumatology and breastfeeding works”: Women's experiences of breastfeeding whilst managing a long-term limiting condition–A qualitative&nbsp;…</a><div class="gs_gray">D Williams, J Webber, B Pell, A Grant, J Sanders, E Choy, A Edwards, ...</div><div class="gs_gray">Midwifery 78, 91-96<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10872854382142679871" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Alterations to adipose tissue morphology during inflammatory arthritis is indicative of vasculopathology in DBA/1 mice</a><div class="gs_gray">K Sime, EH Choy, AS Williams</div><div class="gs_gray">Adipocyte 6 (2), 87-101<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12723607654432867391" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Current treatments to counter sleep dysfunction as a pathogenic stimulus of fibromyalgia</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Pain management 6 (4), 339-346<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3134031689192785591" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Recent orthopedic surgeries aiming to improve quality of life for patients with rheumatoid arthritis</a><div class="gs_gray">S Momohara, K Yano, Y Sakuma, K Ikari</div><div class="gs_gray">The Journal of rheumatology 43 (1), 245-246<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8388969870521895258" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_B80troHkn4C" class="gsc_a_at">Harmonizing pain outcome measures: results of the pre-OMERACT meeting on partnerships for consensus on patient-important pain outcome domains between the Cochrane&nbsp;…</a><div class="gs_gray">K Phillips, A Taylor, PJ Mease, LS Simon, PG Conaghan, EH Choy, ...</div><div class="gs_gray">The Journal of rheumatology 42 (10), 1943-1946<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2356675680289795856" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">T-cell costimulation and other directed therapies</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Rheumatology, 468-471<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18106871223043988100" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Safety, efficacy, and sustained improvements in household productivity and daily activities with certolizumab pegol monotherapy over 2 years in patients with active rheumatoid&nbsp;…</a><div class="gs_gray">R Fleischmann, E Choy, R Van Vollenhoven</div><div class="gs_gray">Arthritis Rheum 62 (Suppl)), s765-6<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1715244487309580680" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:abG-DnoFyZgC" class="gsc_a_at">A multistate transition model for osteoarthritis pain change</a><div class="gs_gray">B Zhang, H Lin, DJ Hunter, T Neogi, B Wise, E Choy, J Niu, Y Zhang</div><div class="gs_gray">Communications in Statistics—Theory and Methods 38 (18), 3297-3306<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6575149639411137901" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Mortality rate is reduced in RA patients treated with TNF antagonists. Data from Biobadaser</a><div class="gs_gray">JJ Gomez-Reino, B Dasgupta, G Haugeberg, MA Descalzo, A Hutchings, ...</div><div class="gs_gray">Annals of the rheumatic diseases 65, 318-318<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12443823640980319890" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Clinical outcomes, quality of life and diagnostic uncertainty in the first year in polymyalgia rheumatica: a prospective cohort study</a><div class="gs_gray">B Dasgupta, A Hutchings, J Hollywood, C Pease, K Chakravarty, ...</div><div class="gs_gray">Rheumatology (Oxford, England) 45, I170-I170<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=318625673641682319" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">How do second-line agents work?</a><div class="gs_gray">E Choy, G Kingsley</div><div class="gs_gray">British medical bulletin 51 (2), 472-491<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3243896249572282107" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Monoclonal antibody therapy in rheumatic disease.</a><div class="gs_gray">C Pitzalis, E Choy, G Kingsley</div><div class="gs_gray">Presse medicale (Paris, France: 1983) 23 (11), 532-539<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12020443708144042773" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:5bfplxN71z4C" class="gsc_a_at">Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib</a><div class="gs_gray">KL Winthrop, A Wouters, EH Choy, C Chen, P Biswas, L Wang, K Soma, ...</div><div class="gs_gray">Annals of the rheumatic diseases 79 (5), 669-671<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7795847055644267105" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:nroGzMJTTpEC" class="gsc_a_at">MACE and VTE across multiple upadacitinib studies in rheumatoid arthritis: integrated analysis from the SELECT phase 3 clinical program</a><div class="gs_gray">E Choy, LB McInnes, J Cush, J Aelion, Y Zhang, N Khan, J Liu, HS Camp, ...</div><div class="gs_gray">JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 26, 11-11<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4542130841597201071" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LlXTz_FrCmAC" class="gsc_a_at">Practice advisory on the appropriate use of NSAIDs in primary care</a><div class="gs_gray">KY Ho, MS Cardosa, S Chaiamnuay, R Hidayat, HQT Ho, O Kamil, ...</div><div class="gs_gray">Journal of pain research 13, 1925<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3426051996068587142" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:pxXbYLTb8EgC" class="gsc_a_at">Fatigue in rheumatoid arthritis</a><div class="gs_gray">EH Choy, E Dures</div><div class="gs_gray">Rheumatology 58 (Supplement_5), v1-v2<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=379779524227149579" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ujxm2eEBZHIC" class="gsc_a_at">EULAR recommendations for the diagnosis and the management of rheumatic immune-related adverse events due to cancer immunotherapy</a><div class="gs_gray">M Kostine, A Finckh, CO Bingham, K Visser, J Leipe, H Schulze-Koops, ...</div><div class="gs_gray">Annals of Oncology 30, v528<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5011247557299598810" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:IT1MJ6E3JesC" class="gsc_a_at">FRI0106 Sarilumab and tocilizumab receptor occupancy (RO), and effects on C-reactive protein (CRP) levels, in patients with rheumatoid arthritis (RA)</a><div class="gs_gray">C Xu, P Nolain, Q Lu, A Paccaly, M Iglesias-Rodriguez, G St John, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 78 (Suppl 2), 719-720<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1580918748370511386" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:3vbIHxFL9FgC" class="gsc_a_at">Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis</a><div class="gs_gray">E Choy, R Caporali, R Xavier, B Fautrel, R Sanmarti, M Bao, J Devenport, ...</div><div class="gs_gray">Rheumatology 58 (6), 1056-1064<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16518675984607887854" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SP6oXDckpogC" class="gsc_a_at">Consensus Among Patients and Health Care Professionals for Essential Domains to Assess Disease Flares in Rheumatoid Arthritis: Results of Final OMERACT Delphi.</a><div class="gs_gray">S Woodworth, T Bingham, C Alten, R Pohl, C Choy, E Hewlett</div><div class="gs_gray">Arthritis &amp; Rheumatism 63<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10597495338629272212" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hQUaER0FWQ4C" class="gsc_a_at">Clinical domains of fibromyalgia syndrome: determination through the OMERACT process</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Journal of Musculoskeletal Pain 18 (4), 380-386<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6919592852425126127" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:m92CDrhVnKEC" class="gsc_a_at">A systematic review of the effects of anti-TNF agents on lipid profile</a><div class="gs_gray">SM Rachapalli, R Malaiya, EH Choy</div><div class="gs_gray">RHEUMATOLOGY 47, II45-II45<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11008745244001169904" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:L1USKYWJimsC" class="gsc_a_at">Repeat-cycle study of high-dose intravenous (iv) 4162w94 anti-CD4 monoclonal antibody (mAb) in rheumatoid arthritis (RA)</a><div class="gs_gray">G Panayi, E Choy, P Emery, S Madden, F Breedveld, M Kraan, J Kalden, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 41 (9)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3759487209939876967" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:f2IySw72cVMC" class="gsc_a_at">New prospects for the treatment of rheumatoid arthritis</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">Expert opinion on investigational drugs 7 (7), 1087-1097<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16163584880526985417" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Azgs6IHzeyYC" class="gsc_a_at">T cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment. 3. Immunological effects.</a><div class="gs_gray">DJA Connolly, EHS Choy, N Rapson, T Regan, GH Kingsley, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 39 (9), 1302-1302<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15377105668440544312" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:mgoTDWlsYNUC" class="gsc_a_at">THU0195 INCIDENCE AND RISK OF VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE UPADACITINIB SELECT CLINICAL TRIAL PROGRAM</a><div class="gs_gray">E Choy, I McInnes, J Cush, J Aelion, W Rigby, Y Song, S Meerwein, J Liu, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 79 (Suppl 1), 317-318<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4750181320174579745" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:UarirCmVI0EC" class="gsc_a_at">Using visual timelines in telephone interviews: Reflections and lessons learned from the star family study</a><div class="gs_gray">B Pell, D Williams, R Phillips, J Sanders, A Edwards, E Choy, A Grant</div><div class="gs_gray">International Journal of Qualitative Methods 19, 1609406920913675<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11588888531237598300" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eFf2swCANGcC" class="gsc_a_at">Adaptive trial designs in rheumatology: report from the OMERACT special interest group</a><div class="gs_gray">T Pickles, R Alten, M Boers, V Bykerk, J Christensen, R Christensen, ...</div><div class="gs_gray">The Journal of rheumatology 46 (10), 1406-1408<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=655652844653541981" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:cF7EPgIk0B4C" class="gsc_a_at">Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison</a><div class="gs_gray">P Mease, E Choy, P Nash, C Kalyvas, M Hunger, L Pricop, KK Gandhi, ...</div><div class="gs_gray">European journal of rheumatology 6 (3), 113<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6760786374290137747" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:sgsej9ZJWHMC" class="gsc_a_at">Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of&nbsp;…</a><div class="gs_gray">S Tarp, TS Jørgensen, DE Furst, A Dossing, PC Taylor, EH Choy, ...</div><div class="gs_gray">Seminars in arthritis and rheumatism 48 (6), 958-966<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6566650645683566168" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:GJVTs2krol4C" class="gsc_a_at">Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study</a><div class="gs_gray">JD Isaacs, A Salih, T Sheeran, YI Patel, K Douglas, ND McKay, ...</div><div class="gs_gray">Rheumatology advances in practice 3 (1), rkz010<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14437251633422611827" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8VtEwCQfWZkC" class="gsc_a_at">Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate</a><div class="gs_gray">A O’Mahony, MR John, H Cho, M Hashizume, EH Choy</div><div class="gs_gray">Journal of translational medicine 16 (1), 1-9<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13671229665735179947" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Vztgr1qGG8IC" class="gsc_a_at">Change in disease activity after switching etanercept (originator) to biosimilar (Benepali) is associated with active disease at baseline</a><div class="gs_gray">K Rajamani</div><div class="gs_gray">2018 ACR/ARHP Annual Meeting<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12100324393900816067" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tBlTYpvFGQIC" class="gsc_a_at">Functional MRI in rheumatic disease with a focus on fibromyalgia</a><div class="gs_gray">C Pamfil, E Choy</div><div class="gs_gray">Clinical and experimental rheumatology 36 (5), 82-85<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12378336838988504822" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Hck25ST_3aIC" class="gsc_a_at">AB0707 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data</a><div class="gs_gray">W Maksymowych, E Choy, Y Yazici, J Walsh, H Thom, C Kalyvas, T Fox, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 1301-1301<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7416233131092951736" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">OP0139-HPR Reducing arthritis fatigue-clinical teams (RAFT) using cognitive-behavioural approaches: an rct</a><div class="gs_gray">S Hewlett, N Ambler, C Almeida, P Blair, E Choy, E Dures, W Hollingworth, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 110-110<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5105648617025720865,1648921361269562837" class="gsc_a_ac gs_ibl">4</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="OziPPvMAAAAJ:IsPWOBWtZBwC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ifOnle78iJkC" class="gsc_a_at">The effectiveness of Zoster vaccine in RA patients subsequently treated up to 19 months with tofacitinib</a><div class="gs_gray">KL Winthrop, A Wouters, EH Choy, C Nduaka, S Abramsky, P Biswas, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 68<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1491894133562185867" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">FRI0215 Subcutaneous Tocilizumab as Monotherapy or in Combination with A csDMARDs in Patients with Rheumatoid Arthritis–Interim Analysis of A Large Phase IV International&nbsp;…</a><div class="gs_gray">E Choy, R Caporali, R Xavier, B Fautrel, R Sanmarti, C Bernasconi, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 509-510<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1083332230599971724" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_TjUWtciUekC" class="gsc_a_at">Education, self-management and upper limb eXercise Training in people with Rheumatoid Arthritis (the EXTRA Programme): a randomised controlled trial</a><div class="gs_gray">V Manning, M Hurley, D Scott, B Coker, ES Choy, L Bearne</div><div class="gs_gray">Arthritis Care and Research 66 (2), 217-227<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13001341641988949015" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Primary Human Cell BioMAP (R) Profiling Of Methotrexate, Tocilizumab, Adalimumab, and Tofacitinib Reveals Different Mechanisms Of Action With Distinct Phenotypic Signatures</a><div class="gs_gray">SL Tan, A O'Mahony, EL Berg, K Ganeshalingam, EH Choy</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 65, S795-S796<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5670719925522904686" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Probiotics for fibromyalgia</a><div class="gs_gray">V Supraha, DK Francis, A Utrobicic, EHS Choy, D Tenzera, A Kordic</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9093334574336471685" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Basic science 232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function</a><div class="gs_gray">S Heathfield, B Parker, L Zeef, I Bruce, Y Alexander, F Collins, M Stone, ...</div><div class="gs_gray">Rheumatology 51 (suppl_3), iii140-iii184<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18149992059020423367,3787220272589436237" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:silx2ntsSuwC" class="gsc_a_at">Western Consortium of Practicing Rheumatologists Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort</a><div class="gs_gray">VK Ranganath, J Yoon, D Khanna, GS Park, DE Furst, DA Elashoff, ...</div><div class="gs_gray">Ann Rheum Dis 66, 1633-1640<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12550154985452931958" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:M0leSnx2MbUC" class="gsc_a_at">Non‐tumor necrosis factor biological therapies for rheumatoid arthritis</a><div class="gs_gray">LSY Chau, CC Mok, E Choy</div><div class="gs_gray">APLAR Journal of Rheumatology 8 (2), 77-83<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12948568932499444659" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:jlhcAiayVhoC" class="gsc_a_at">Foot involvement, disease activity and disability in rheumatoid arthritis</a><div class="gs_gray">SJ Farrow, B Khoshaba, DL Scott, EHS Choy</div><div class="gs_gray">Rheumatology 43, 140-140<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12274706527351695602" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oynPyU19kbsC" class="gsc_a_at">T CELL HYPOTHESIS IN RHEUMATOID ARTHRITIS (RA) TESTED BY HUMANISED NON-DEPLETING ANTI-CD4 MONOCLONAL ANTIBODY (mAb) TREATMENT I: SUPPRESSION OF DISEASE ACTIVITY AND ACUTE PHASE&nbsp;…</a><div class="gs_gray">G Panayi, E Choy, D Connolly, V Manna, T Regan, N Rapson, G Kingsley, ...</div><div class="gs_gray">Immunology-Supplement 89<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12156559445745909263" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:UxriW0iASnsC" class="gsc_a_at">Synovial fluid lymphocyte proliferation to tuberculin protein product derivative: a novel way of diagnosing tuberculous arthritis.</a><div class="gs_gray">EH Choy, F Chieco-Bianchi, GS Panayi, GH Kingsley</div><div class="gs_gray">Clinical and experimental rheumatology 12 (2), 187-190<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15953708882721781928" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Immunotherapy, past, present and future.</a><div class="gs_gray">EH Choy, GH Kingsley</div><div class="gs_gray">British journal of rheumatology 32 (2), 89-91<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17953921991833403455" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RJujIP1NYNUC" class="gsc_a_at">Herpes zoster and vaccination strategies in inflammatory bowel diseases: a practical guide</a><div class="gs_gray">L Guillo, C Rabaud, EH Choy, F D’Amico, S Danese, SC Ng, ...</div><div class="gs_gray">Clinical Gastroenterology and Hepatology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17120614205866801643" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:I2jIoRS3jIgC" class="gsc_a_at">A randomised, open labelled clinical trial to investigate synovial mechanisms determining response-resistance to rituximab versus tocilizumab in rheumatoid arthritis patients&nbsp;…</a><div class="gs_gray">F Humby, MH Buch, P Durez, M Lewis, M Bombardieri, H Rizvi, S Kelly, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 71<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1513271444255185946" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9LpHyFPp1DQC" class="gsc_a_at">Targeting IL-6: A review of data</a><div class="gs_gray">JS Smolen, D Aletaha, EH Choy, SA Jones, T Takeuchi, I McInnes</div><div class="gs_gray">Considerations in Medicine 2 (1), 12-18<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4736933522658003992" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Defining criteria for rheumatoid arthritis patient-derived disease activity score that correspond to Disease Activity Score 28 and Clinical Disease Activity Index based disease&nbsp;…</a><div class="gs_gray">AMH Leung, D Farewell, CS Lau, EHS Choy</div><div class="gs_gray">Rheumatology 55 (11), 1954-1958<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5779297789624584381,9196762522154575453" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:FiytvqdAVhgC" class="gsc_a_at">THU0083 Simplified Patient-Derived Disease Activity Score (SPDAS2): A Simplified Version without Early Morning Stiffness</a><div class="gs_gray">E Choy, AMH Leung</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 209-209<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6535214226011326498" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Translational Data and Phase 1 Study Results of a New Monoclonal Antibody Targeting Toll like Receptor 4 (TLR4) Developed for Rheumatoid Arthritis (RA) Treatment with a&nbsp;…</a><div class="gs_gray">E Monnet, L Shang, G Lapeyre, K De Graaf, E Hatterer, G Wambiekele, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 2051-2052<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14782222935234537329" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:FAceZFleit8C" class="gsc_a_at">THU0228 Validity of Omeract Preliminary Flare Questions in a Randomized Controlled Trial, that Assesses Impact of Disease Activity Guided Down-Titration of Anti-TNF Treatment&nbsp;…</a><div class="gs_gray">A Van Der Maas, N Van Herwaarden, T Woodworth, M Minten, D Furst, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 73 (Suppl 2), 260-261<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12154541588991317891" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">FRI0103 The Omeract Preliminary Flare Questionnaire (PFQ) is Responsive to Change and Able to Detect Clinically Important Worsening Indicating Need for Treatment Change in the&nbsp;…</a><div class="gs_gray">VP Bykerk, CO Bingham, EH Choy, G Boire, BP Haraoui, D Lin, JE Pope, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 73 (Suppl 2), 418-419<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16834063428433827906" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">THU0526 Tocilizumab is Less Dependent than Adalimumab on Supplementary Effects of Methotrexate for Immunoregulation: A Biomap® Profiling Study</a><div class="gs_gray">A O'mahony, EL Berg, MR John, K Ganeshalingam, EH Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 73 (Suppl 2), 365-365<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3650525211736428879" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">New biologics for rheumatoid arthritis.</a><div class="gs_gray">E Choy</div><div class="gs_gray">The journal of the Royal College of Physicians of Edinburgh 41 (3), 234-237<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10979880613725602371" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:U_HPUtbDl20C" class="gsc_a_at">Certolizumab pegol monotherapy provides sustained improvements in household productivity and daily activities in patients with active rheumatoid arthritis over 2 years</a><div class="gs_gray">O Purcaru, R van Vollenhoven, E Choy, R Fleischmann</div><div class="gs_gray">Value in Health 13 (7), A314-A314<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17617450566645512833" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:s85pQhAUCrAC" class="gsc_a_at">Adalimumab is effective against skin and joint disease in psoriatic arthritis patients: 48-week results of ADEPT</a><div class="gs_gray">PJ Mease, DD Gladman, CT Ritchlin, EM Ruderman, EHS Choy, ...</div><div class="gs_gray">Rheumatology 45, I68-I69<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7326146349090832397" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:sJPMR1oEGYQC" class="gsc_a_at">Efficacy of adalimumab in psoriatic arthritis as measured by the disease activity score 28</a><div class="gs_gray">EHS Choy, GR Burmester, S Bombardieri, F Van den Bosch, EH Sasso, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 52 (9), S214-S214<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10257411673064587808" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:L24QuVWYgZ0C" class="gsc_a_at">Therapeutics 1: OP5. 24-WEEK EFFICACY AND SAFETY RESULTS FROM THE ADALIMUMAB EFFECTIVENESS IN PSORIATIC ARTHRITIS TRIAL (ADEPT)</a><div class="gs_gray">PJ Mease, EHS Choy, DD Gladman, CT Ritchlin, EM Ruderman, ...</div><div class="gs_gray">Rheumatology 44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9264943212574385706" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Rheumatoid arthritis (RA) outcome in routine practice: a comparison of outcome assessments</a><div class="gs_gray">DA Houssien, EH Choy, AJ Carr, DL Scott</div><div class="gs_gray">Arthritis &amp; Rheumatism 40 (9)<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=604686045781875849" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WGv8Og3F3KgC" class="gsc_a_at">The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis</a><div class="gs_gray">R Davies, J Williams, K Sime, HS Jin, C Thompson, L Jordan, D Lang, ...</div><div class="gs_gray">Rheumatology 60 (6), 2852-2861<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8981520959980113490" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:IvSMUa3B7yYC" class="gsc_a_at">Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract&nbsp;…</a><div class="gs_gray">Y Loriot, CN Sternberg, DC Gauna, H Dumez, R Huddart, KM Vianna, ...</div><div class="gs_gray">Annals of Oncology 30, v368-v369<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14502067002572610621" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HqhvjgTjE9cC" class="gsc_a_at">Clinical outcomes according to PD-L1 status and age in the prospective international SAUL study of atezolizumab (atezo) for locally advanced or metastatic urothelial carcinoma&nbsp;…</a><div class="gs_gray">CN Sternberg, AS Merseburger, E Choy, DE Castellano, F Lopez-Rios, ...</div><div class="gs_gray">Journal of Clinical Oncology 37 (15_suppl), 4519-4519<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=624290763307911551" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hfzGNhXhx5MC" class="gsc_a_at">Dermatomyositis: a slow path towards targeted therapies or will conventional therapies prevail?</a><div class="gs_gray">V Piguet, E Choy</div><div class="gs_gray">The British journal of dermatology 179 (6), 1233-1234<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14747388944666200148" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:T8_be82Iz5gC" class="gsc_a_at">Considering new lessons about the use of IL-6 inhibitors in arthritis</a><div class="gs_gray">T Takeuchi, JS Smolen, EH Choy, D Aletaha, I McInnes, SA Jones</div><div class="gs_gray">Considerations in Medicine 2 (1), 7-11<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=845519911386875618" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:q0uBw5dMOAkC" class="gsc_a_at">AB0050 Biomap® phenotypic profiling of two batches of originator etanercept reveals equivalent activity signatures consistent with conserved biological activity</a><div class="gs_gray">A O’Mahony, EL Berg, HE Jones, B Fitzpatrick, B Hassett, SM Vicik, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 77 (Suppl 2), 1225-1225<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16124854319581635897" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:M_lZXyI38BkC" class="gsc_a_at">SAT0330 Changes in lymphocytes and lymphocyte subsets in tofacitinib-treated patients with psoriatic arthritis</a><div class="gs_gray">G Burmester, WFC Rigby, E Choy, P Nash, K Winthrop, PJ Mease, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 77 (Suppl 2), 1030-1030<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5551121024033528423" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rqnDXT1GswoC" class="gsc_a_at">Early phase and adaptive design clinical trials in rheumatoid arthritis: a systematic review of early phase trials</a><div class="gs_gray">T Pickles, R Christensen, LS Tam, LS Simon, EH Choy</div><div class="gs_gray">Rheumatology advances in practice 2 (2), rky045<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16649164023888680213" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:AYInfyleIOsC" class="gsc_a_at">Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials</a><div class="gs_gray">M Nurmohamed, E Choy, C Charles-Schoeman, G Kitas, P Accossato, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 69<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5250713595162402420" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">SAT0199 Subcutaneous tocilizumab monotherapy or combined with a csdmard in patients with rheumatoid arthritis: tozura, a pooled analysis of phase iv studies in 22 countries</a><div class="gs_gray">E Choy, R Caporali, R Xavier, B Fautrel, R Sanmarti, C Bernasconi, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 847-848<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8160379506240433053" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">FRI0110 Assessment of Immunogenicity of Live Zoster Vaccination in Rheumatoid Arthritis Patients on Background Methotrexate before and after Initiating Tofacitinib or Placebo</a><div class="gs_gray">K Winthrop, A Wouters, E Choy, K Soma, J Hodge, C Nduaka, P Biswas, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 468-468<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17576326885235858140" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:c1e4I3QdEKYC" class="gsc_a_at">Modified-release prednisone in rheumatoid arthritis: Rationale for chronotherapy, mechanistic considerations, and clinical implications</a><div class="gs_gray">V Ravindran, E Choy</div><div class="gs_gray">Indian Journal of Rheumatology 11 (4), 216-221<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=275716649239300075" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eAUscmXIlQ8C" class="gsc_a_at">Assessment of Immunogenicity of Live Zoster Vaccination (Zostavax (R)) in Rheumatoid Arthritis Patients on Background Methotrexate before and after Initiating Tofacitinib or&nbsp;…</a><div class="gs_gray">K Winthrop, A Wouters, EH Choy, K Soma, J Hodge, C Nduaka, P Biswas, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 67<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4025391883754076287" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:69ZgNCALVd0C" class="gsc_a_at">Serum Vascular Cell Adhesion Molecule-1 (VCAM-1) Levels Are Associated with Vascular Dysfunction and Increased Cardiovascular Risk in an Animal Model and Patients with&nbsp;…</a><div class="gs_gray">R Davies, D Iacono, L Jordan, J Williams, C Rawlings, D Lang, A Williams, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 1965-1967<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10989267994652358653" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Aul-kAQHnToC" class="gsc_a_at">IL-6R Blockade with Sarilumab Plus Methotrexate Results in Changes in Clinical and Laboratory Parameters Associated with Chronic Inflammation in Patients with Moderate-to&nbsp;…</a><div class="gs_gray">M Dougados, E Choy, H Kameda, J van Adelsberg, J Fay, S Fiore, C Fan, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 3336-3338<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13912434110287757202" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">Response to Comment on “Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis”</a><div class="gs_gray">JL Giles, E Choy, C van den Berg, BP Morgan, CL Harris</div><div class="gs_gray">The Journal of Immunology 195 (1), 4-4<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2403436568807396552" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Assessing significant flares in rheumatoid arthritis: Validity of the outcome measures in rheumatology preliminary flare questions in the Canadian early arthritis cohort</a><div class="gs_gray">S Bartlett, C Bingham, E Choy, J Xiong, G Boire, B Haraoui, J Pope, ...</div><div class="gs_gray">Journal of Rheumatology 41 (7), 1493-1493<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15929032484084159938,6333097530193494971" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Idiopathic inflammatory myopathy</a><div class="gs_gray">R Davies, E Choy</div><div class="gs_gray">Medicine 42 (3), 174-179<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15097949823953499757" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Changes in patient-reported joint counts and composite indices can identify flare of disease activity in recent onset rheumatoid arthritis</a><div class="gs_gray">K Visser, SJ Bartlett, CO Bingham, E Choy, DM Lin, J Xiong, G Boire, ...</div><div class="gs_gray">Arthritis and Rheumatism 65, S1230-S1231<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14168172129217059906" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">FRI0186 Long-term safety and efficacy of 4-weekly certolizumab pegol monotherapy and combination therapy in rheumatoid arthritis: 5-year results from an open-label extension study</a><div class="gs_gray">R Fleischmann, R Van Vollenhoven, J Vencovsky, R Alten, O Davies, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 72 (Suppl 3), A435-A435<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10268387503807059406" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vbGhcppDl1QC" class="gsc_a_at">THU0082 An evaluation of flare in patients with early rheumatoid arthritis using the omeract preliminary flare questionnaire</a><div class="gs_gray">VP Bykerk, SJ Bartlett, E Choy, G Boire, C Hitchon, J Pope, C Thorne, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 71 (Suppl 3), 180-181<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10113808691051171910" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vRqMK49ujn8C" class="gsc_a_at">A brief exercise and self-management programme improves upper limb disability in people with early rheumatoid arthritis</a><div class="gs_gray">VL Manning, M Hurley, DL Scott, E Choy, L Bearne</div><div class="gs_gray">Rheumatology 52, 147-148<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7887903274808626157" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4oJvMfeQlr8C" class="gsc_a_at">Long-term safety and efficacy of 4-weekly certolizumab pegol combination and monotherapy in rheumatoid arthritis: 5 year results from an open label extension study</a><div class="gs_gray">RM Fleischmann, RF van Vollenhoven, J Vencovsky, R Alten, O Davies, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 64 (10), S565-S566<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11657394576337107088" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Patient Self-Assessments and Selected Patient Reported Outcomes May Reliably Identify Rheumatoid Disease Flare in Early Rheumatoid Arthritis Patients.: 2099</a><div class="gs_gray">V Bykerk, E Choy, J Xiong, G Boire, C Hitchon, J Pope, C Thorne, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 64<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6028233323286386595" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ymY9cBF3mdcC" class="gsc_a_at">Muscle disorders 111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study</a><div class="gs_gray">R Campbell, D Hofmann, S Hatch, P Gordon, H Lempp, L Das, ...</div><div class="gs_gray">Rheumatology 51 (suppl_3), iii93-iii139<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13110160985836857888" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Treat to Target–tailoring therapy in rheumatoid arthritis</a><div class="gs_gray">P Emery, M Dougados, P Tak, A Kavanaugh, E Choy, A Rubbert-Roth</div><div class="gs_gray">European musculoskeletal review. Rheumatoid arthritis. Touch briefings, 1-7<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6993559386367654475" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Non‐pharmacological interventions for fatigue in rheumatoid arthritis</a><div class="gs_gray">S Hewlett, C Almeida, JR Kirwan, F Cramp, EHS Choy, T Chalder</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3168248374942995837" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">514 THE EFFECT OF MILNACIPRAN ON TENDERNESS IN FIBROMYALGIA: A PSYCHOPHYSICAL AND FMRI ANALYSIS</a><div class="gs_gray">F Petzke, RH Gracely, K Jensen, E Kosek, M Ingvar, H Marcus, E Choy, ...</div><div class="gs_gray">European Journal of Pain 13 (S1), S152-S152<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14819370072365802814" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">FATIGUE IN RHEUMATOID ARTHRITIS, WHAT ARE WE MEASURING?: A FACTOR ANALYSIS OF FATIGUE INSTRUMENTS</a><div class="gs_gray">LC Pollard, DL Scott, N Donaldson, EH Choy</div><div class="gs_gray">Rheumatology 48, I135-I135<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4611840843221730385" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">(186) Safety and tolerability of Duloxetine in the treatment of patients with Fibromyalgia: Analysis of 5 studies</a><div class="gs_gray">E Choy, P Mease, D Kajdasz, M Wohlreich, D Walker, A Chappell</div><div class="gs_gray">The Journal of Pain 9 (4), 22<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13625958152668257693" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:dshw04ExmUIC" class="gsc_a_at">FMRI evidence for modulation of pain by milnacipran in fibromyalgja</a><div class="gs_gray">F Petzke, H Marcus, K Jensen, E Kosek, M Ingvar, E Choy, SCR Williams, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 58 (9), S434-S434<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10955114991734111876" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Myositis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Medicine 34 (11), 489-492<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3737182654554211468" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">ten brummelhuis M, De Waal MM, Schreurs W, Looman M et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis and&nbsp;…</a><div class="gs_gray">TR Radstake, R van der Voort</div><div class="gs_gray">Ann Rheum Dis 64 (3), 359-67<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13662547302230295020" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LhH-TYMQEocC" class="gsc_a_at">CHIMERIC ANTI-CD4 ANTIBODY ACTS BY CAUSING APOPTOSIS (PROGRAMMED CELL-DEATH) OF HUMAN-LYMPHOCYTES</a><div class="gs_gray">E Choy, J ADJAYE, G KINGLSEY, G Panayi</div><div class="gs_gray">Arthritis and Rheumatism 35 (9), S44-S44<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15096928351824795322" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:XUAslYVNQLQC" class="gsc_a_at">Predicting a diagnosis of ankylosing spondylitis using primary care health records–a machine learning approach</a><div class="gs_gray">J Kennedy, N Kennedy, R Cooksey, E Choy, S Siebert, M Rahman, ...</div><div class="gs_gray">medRxiv<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15432497161535440658" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:2_BaaiyHPJIC" class="gsc_a_at">Long-term Opioid Use in Patients with Rheumatoid Arthritis Treated with Sarilumab</a><div class="gs_gray">J Pope, A Praestgaard, H van Hoogstraten, M Iglesias-Rodriguez, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10156092927925289367" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:71d7Y1FijdoC" class="gsc_a_at">Incidence and risk of venous thromboembolic events among patients with rheumatoid arthritis enrolled in the Upadacitinib clinical trial program</a><div class="gs_gray">E Choy, I McInnes, J Cush, J Aelion, W Rigby, Y Song, S Meerwein, J Liu, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8949727131228910990" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8JTMrWI6FdcC" class="gsc_a_at">AB0295 change in disease activity and treatment response after abatacept treatment for rheumatoid arthritis: real-world evidence from the UK</a><div class="gs_gray">S Henning, L Groves, M Hurst, D Sugrue, J Gordon, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 79 (Suppl 1), 1446-1447<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9202148227134742974" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:F9HO9s0W2bwC" class="gsc_a_at">CD28− Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status</a><div class="gs_gray">C Thompson, R Davies, A Williams, G Jones, EHS Choy</div><div class="gs_gray">Frontiers in Medicine 7, 129<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5992690865345068342" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Gpwnp1kGG20C" class="gsc_a_at">The need for comparative data in spondyloarthritis</a><div class="gs_gray">E Choy, X Baraliakos, F Behrens, S D’Angelo, K de Vlam, BW Kirkham, ...</div><div class="gs_gray">Arthritis research &amp; therapy 21 (1), 1-6<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2865988680115220248" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oldoQiaHq2UC" class="gsc_a_at">Pain measurement in rheumatic and musculoskeletal diseases: where to go from here? Report from a Special Interest Group at OMERACT 2018</a><div class="gs_gray">A Chiarotto, U Kaiser, E Choy, R Christensen, PG Conaghan, M Cowern, ...</div><div class="gs_gray">The Journal of rheumatology 46 (10), 1355-1359<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9784229452375633641" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:xyvS_IvSCKsC" class="gsc_a_at">257 IL-6 trans-signaling causes accelerated atherosclerosis in disease-prone animals</a><div class="gs_gray">R Davies, HS Jin, JO Williams, K Sime, K Allen-Redpath, C Thompson, ...</div><div class="gs_gray">Rheumatology 57 (suppl_3), key075. 481<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11951920178980123520,11919718525004644226" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:KI9T_ytC6pkC" class="gsc_a_at">179 Neuropathic-like pain is common in psoriatic arthritis</a><div class="gs_gray">A Ramjeeawon, E Choy</div><div class="gs_gray">Rheumatology 57 (suppl_3), key075. 403<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2759726101153977417" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:TGkaJS32XoUC" class="gsc_a_at">173 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase III clinical trial data</a><div class="gs_gray">H Tahir, W Maksymowych, E Choy, Y Yazici, J Walsh, H Thom, C Kalyvas, ...</div><div class="gs_gray">Rheumatology 57 (suppl_3), key075. 397<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1829065544698073392" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BOlwja0KXvYC" class="gsc_a_at">AB0358 Patients with early rheumatoid arthritis have increased cardiovascular risk at the time of diagnosis</a><div class="gs_gray">R Davies, CR Thompson, HS Jin, EA Ellins, JP Halcox, AS Williams, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 1173-1173<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10228542706041378617" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">THU0695 The RA FLARE questionnaire (RA-FQ) is responsive to change in ra symptoms and impacts in clinical and observational trials</a><div class="gs_gray">SJ Bartlett, VP Bykerk, B Fautrel, F Guillemin, A den Broeder, R Alten, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 470-470<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7135251720159075669" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:DrR-2ekChdkC" class="gsc_a_at">SAT0480 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data</a><div class="gs_gray">V Strand, I McInnes, P Mease, E Choy, P Nash, H Thom, C Kalyvas, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 957-957<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16686597518367966206" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">02.31 Targeted inhibition of macrophage inflammatory protein 1-alpha (ccl3) prevents pit formation by human osteoclasts and potently attenuates the erosion of bone in collagen&nbsp;…</a><div class="gs_gray">LA Jordan, BF Fenner, R Davies, AK Harvey, EH Choy, R Errington, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 1), A21-A21<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11789994306067663367" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:VRfTbSk87rEC" class="gsc_a_at">Coming Full Circle with the Omeract RA Flare Questionnaire (RA-FQ): Further Evaluation of the Properties, Meaningfulness, and Utility through Rasch Analysis and Feedback from&nbsp;…</a><div class="gs_gray">SJ Bartlett, S Barbic, VP Bykerk, B Fautrel, F Guillemin, A den Broeder, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 68<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3735813368392854456" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Juvenile dermatomyositis: new clinical trial evidence to underpin therapeutic shared decision making.</a><div class="gs_gray">ED Owen, EH Choy, V Piguet</div><div class="gs_gray">The British journal of dermatology 175 (4), 665-666<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2195775467647149034" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:QUX0mv85b1cC" class="gsc_a_at">FRI0045 Therapeutic Blockade of Interleukin-6 Trans-Signalling Restores Vascular Function in Murine Collagen Induced Arthritis</a><div class="gs_gray">R Davies, J Williams, K Sime, E Hughes, L Jordan, C Rawlings, D Lang, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 442-442<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8174882975587387958" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis of Randomised Trials</a><div class="gs_gray">S Tarp, DE Furst, A Døssing, M Østergaard, T Lorenzen, M Hansen, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 423-424<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13937904730495567622" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Ehil0879vHcC" class="gsc_a_at">Treatment of Rheumatoid Arthritis with an Anti-Tumor Necrosis Factor Agent or Tocilizumab As First Biologic Therapy in a Global Comparative Observational Study: Abstract Number&nbsp;…</a><div class="gs_gray">E Choy, C Bernasconi, M Aassi, J Molina, O Epis</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 3837-3839<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4097482306361809776" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">246. Development of a Modular-Based Ultrasound Training Programme for Rheumatologists and Allied Health Professionals in Wales</a><div class="gs_gray">E Humphreys, V Lim, A Kraus, E Choy, S Chitale</div><div class="gs_gray">Rheumatology 54 (suppl_1), i145-i145<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16867895915267744595" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">102. Tocilizumb did not Significantly Increase Serum Cholesterol Levels in Healthy Subjects</a><div class="gs_gray">S Grange, C Schmitt, K Ganeshalingam, EH Choy</div><div class="gs_gray">Rheumatology 53, i95-i96<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1740024432312754361" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Long Term Tolerability and Efficacy of a 4-week-administration of Certolizumab pegol as Monotherapy and Combination Therapie in rheumatoid Arthritis-5-Year-Data of an open&nbsp;…</a><div class="gs_gray">R Alten, R Fleischmann, R van Vollenhoven, J Vencovsky, O Davies, ...</div><div class="gs_gray">Zeitschrift Fur Rheumatologie 72, 111-111<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17436189195767056593" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:mKu_rENv82IC" class="gsc_a_at">FRI0204 Long-term benefits of 4-weekly certolizumab pegol monotherapy and combination therapy on household productivity and social participation in rheumatoid arthritis: 5-year&nbsp;…</a><div class="gs_gray">V Strand, O Purcaru, R Van Vollenhoven, E Choy, R Fleischmann</div><div class="gs_gray">Annals of the Rheumatic Diseases 72 (Suppl 3), A441-A442<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3619666525085904440" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:anf4URPfarAC" class="gsc_a_at">Reliability and Validity Of Patient-Reported Joint Counts and Determinants Of Disagreement With The Physician In Recent Onset Rheumatoid Arthritis</a><div class="gs_gray">K Visser, JE Pope, E Choy, CO Bingham, SJ Bartlett, G Boire, CA Hitchon, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18069653641685390323" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NDuN12AVoxsC" class="gsc_a_at">PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results&nbsp;…</a><div class="gs_gray">V Strand, O Purcaru, E Choy, R Fleischmann</div><div class="gs_gray">Value in Health 15 (7), A451-A452<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8572242843875161030" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">A Brief Exercise and Self Management Programme Improves Upper Limb Disability in People with Early Rheumatoid Arthritis.: 2439</a><div class="gs_gray">L Bearne, V Manning, D Scott, E Choy, M Hurley</div><div class="gs_gray">Arthritis &amp; Rheumatism 64<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16647592608042822661" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Exploration of OMERACT preliminary Rheumatoid Arthritis (RA) flare domains in a longitudinal observational study</a><div class="gs_gray">E Lie, TG Woodworth, R Christensen, V Bykerk, CO Bingham, DE Furst, ...</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 71, 140-140<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17471726155709523630" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">LONG-TERM SAFETY OF 4-WEEKLY CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS: 5 YEAR RESULTS FROM AN OPEN LABEL EXTENSION STUDY</a><div class="gs_gray">R Fleischmann, R van Vollenhoven, J Vencovsky, R Alten, O Davies, ...</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 71, 523-523<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1323274415470164719" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:cBPnxVikjH8C" class="gsc_a_at">Predicting ongoing active disease in early rheumatoid arthritis using clinical measures</a><div class="gs_gray">NJ Gullick, A Young, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 51, 74-74<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16253485878533592611" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SGW5VrABaM0C" class="gsc_a_at">Rheumatoid arthritis-clinical aspects: 134. Predictors of Joint Damage in South Africans with Rheumatoid Arthritis</a><div class="gs_gray">C Ickinger, E Musenge, M Tikly, J Barnes, C Donnison, M Scott, ...</div><div class="gs_gray">Rheumatology 50 (suppl_3), iii93-iii104<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1574267644225310279" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tYavs44e6CUC" class="gsc_a_at">Serological investigation of IgG levels and subclasses in rheumatoid arthritis patients following ingestion of bovine type II collagen: results of a double blind, randomised&nbsp;…</a><div class="gs_gray">A Farboud, E Choy</div><div class="gs_gray">Clinical rheumatology 30 (2), 193-199<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10499655380455017865" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Systematic review and meta-analyses of non-pharmacological interventions for fatigue in rheumatoid arthritis</a><div class="gs_gray">F Cramp, S Hewlett, C Almeida, J Kirwan, E Choy, T Chalder, J Pollock, ...</div><div class="gs_gray">Rheumatology 50, 99-100<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=402926687464323888" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:TNEldfgDb5MC" class="gsc_a_at">Patients and rheumatologists perspectives on glucocorticoids: An exercise to improve the implementation of the EULAR recommendations on the management of systemic&nbsp;…</a><div class="gs_gray">JWJ Jacobs, M Boers, T Andrews, BMAM Blom, F Buttgereit, N Caeyers, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 69, 1015-1021<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1077350663079320062" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Tamper-Resistant Properties and Bioavailability of a Novel, Multiparticulate, Extended-Release Formulation of Oxycodone for the Treatment of Moderate to Severe Pain: 188</a><div class="gs_gray">A Fleming, P Noonan, M Schiller, K Johnston, A Bush, S Saim</div><div class="gs_gray">Pain Medicine 11 (2)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=472417087273676458" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Kqc1aDSOPooC" class="gsc_a_at">PMS6 COMPARISON OF COST OF ALLOPURINOL VS FEBUXOSTAT AS A FIRST LINE TREATMENT FOR GOUT</a><div class="gs_gray">E Jutkowitz, L Pizzi, M Meltzer</div><div class="gs_gray">Value in Health 3 (13), A123<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11539356632064841216" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:t-hv7AR41mYC" class="gsc_a_at">Investigating the role of Interleukin 6 and Interleukin 17 in the pathogenesis of Rheumatoid arthritis</a><div class="gs_gray">DM Jayaraj, H Abozaid, NJ Gullick, HG Evans, DL Scott, E Choy, ...</div><div class="gs_gray">Immunology 131, 68-68<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6057408374441369370" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Non‐biologic pharmaceutical interventions for fatigue in rheumatoid arthritis</a><div class="gs_gray">C Almeida, T Chalder, F Cramp, EHS Choy, JR Kirwan, S Hewlett, ...</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7248888922916636580" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:738O_yMBCRsC" class="gsc_a_at">THE COST-EFFECTIVENESS OF PREGABALIN (LYRICA (R)) IN THE TREATMENT OF SEVERE FIBROMYALGIA IN THE UNITED STATES</a><div class="gs_gray">A Lloyd, E Castelnuovo, CS Boomershine, E Choy, A Chandran, ...</div><div class="gs_gray">Value in Health 13 (3), A126-A126<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=677842002598732290" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:CMvovTBb2okC" class="gsc_a_at">EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases</a><div class="gs_gray">P Kolar, F Buttgereit</div><div class="gs_gray">Zeitschrift fur Rheumatologie 68 (4), 349-352<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8504944394814373218" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">The effect of milnacipran on pain modulation in fibromyalgia: an fMRI analysis</a><div class="gs_gray">RH Gracely, F Petzke, H Marcus, KB Jensen, E Kosek, M Ingvar, E Choy, ...</div><div class="gs_gray">Neurology 72 (11), A213-A213<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8536249268425711690" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:jmjb1lOE9QIC" class="gsc_a_at">Predicting remission in trial of intensive therapy in early RA: HAQ and gender are key factors</a><div class="gs_gray">MH Ma, D Walker, A Hassell, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 48, I62-I62<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9180500962759153872" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Disease activity, quality of life and adverse events in the first two years of polymyalgia rheumatica</a><div class="gs_gray">B Dasgupta, A Hutchings, J Hollywood, D Lamping, N Gendi, ...</div><div class="gs_gray">Rheumatology 48, I17-I17<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11614783784495187043" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Improvement in psoriasis is associated with long-term inhibition of radiographic progression in patients with psoriatic arthritis receiving adalimumab (HUMIRA (R))</a><div class="gs_gray">E Choy, DD Gladman, P Mease, C Ritchlin, M Olds, R Wong, S Wang, ...</div><div class="gs_gray">Arthritis and rheumatism 58 (9), S575-S576<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8035269326583269323" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Risk factors for radiographic progression (RP) in patients with psoriatic arthritis (PSA): Subanalysis of ADEPT</a><div class="gs_gray">EH Choy, DD Gladman, PJ Mease, CT Ritchlin, R Perdok, EH Sasso</div><div class="gs_gray">RHEUMATOLOGY 47, II79-II79<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18300854841568657181" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Getting on with fibromyalgia</a><div class="gs_gray">SF Carville, EHS Choy</div><div class="gs_gray">Future Rheumatology 3 (2), 109-113<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=895442361017041022" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4vMrXwiscB8C" class="gsc_a_at">Relationship between C-reactive protein (CRP) concentration and joint damage in psoriatic arthritis (PSA): Subanalysis of placebo-and adalimumab-treated patients in adept</a><div class="gs_gray">D Gladman, R Measel, E Choy, E Sasso</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 66, 98-99<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4939588947533504852" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Does the Health Assessment Questionnaire predict 5-year quality of life in early RA?</a><div class="gs_gray">E Choy</div><div class="gs_gray">Nature Clinical Practice Rheumatology 3 (7), 380-381<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6789591265363932286" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8AbLer7MMksC" class="gsc_a_at">A systematic review and meta-analysis of disease modifying anti-rheuamtic drugs and tumour necrosis factor antagonists for treatment of psoriatic arthritis</a><div class="gs_gray">V Ravindran, DL Scott, EH Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 66, 419-420<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12246629961331476462" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:sSrBHYA8nusC" class="gsc_a_at">Comparative systematic review of TNF-inhibitors and intensive DMARD regimens in ra suggests similar efficacy</a><div class="gs_gray">GH Kingsley, A Saha, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 46, I30-I30<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11613361738426703252" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:unp9ATQDT5gC" class="gsc_a_at">Adalimumab radiographic efficacy in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use, and clinical response: Subanalysis&nbsp;…</a><div class="gs_gray">DD Gladman, PJ Mease, EHS Choy, CT Ritchlin, H Wang, EH Sasso</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 54 (9), S138-S139<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=375362237136998485" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">Phase I single and multiple ascending dose studies to investigate the safety, tolerance and pharmacokinetics of CH-1504 in healthy male subjects</a><div class="gs_gray">E Choy, T Mant, L Adams, S Jurcevic, N Landsman</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 65, 337-337<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4431880908612318697" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Adalimumab is efficacious in treating joint disease in early and established psoriatic arthritis: subanalysis of ADEPT</a><div class="gs_gray">E Choy, DD Gladman, E Sasso</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 65, 211-211<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16161920314830748603" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Comparing methods for the diagnosis of fibromyalgia</a><div class="gs_gray">E Choy</div><div class="gs_gray">Nature Clinical Practice Rheumatology 2 (5), 244-245<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16072811909045763331" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Non-steroidal anti-inflammatory drugs and myocardial infarctions: Systematic assessment of all available evidence</a><div class="gs_gray">PA Scott, GH Kingsley, CM Smith, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 45, I2-I2<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10695935313942736399" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Differences in disease expression and response to treatment between older and younger adults with rheumatoid arthritis</a><div class="gs_gray">GH Kingsley, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 45, I105-I105<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1777298416979102955" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:MLfJN-KU85MC" class="gsc_a_at">EULAR evidence based recommendations for the management of fibromyalgia</a><div class="gs_gray">SF Carville, L Arendt-Nielsen, H Bliddal, F Blotman, JC Branco, D Buskila, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 65 (Suppl. 2), 3<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10859540776490649897" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:35r97b3x0nAC" class="gsc_a_at">Antibiotics for reactive arthritis</a><div class="gs_gray">C Siva, ET Ghogomu, X Zhou, EHS Choy, JA Singh</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6550974589680534295" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:u9iWguZQMMsC" class="gsc_a_at">A patient-based disease activity score (PDAS) that can replace disease activity score in rheumatoid arthritis (RA) research and clinical practice</a><div class="gs_gray">B Khoshaba, D Cooper, A MacGregor, DL Scott, EH Choy</div><div class="gs_gray">Rheumatology 44, 66<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17297164987012419899" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LPZeul_q3PIC" class="gsc_a_at">RANDOMISED PLACEBO-CONTROLLED TRIAL OF INTRAMUSCULAR (IM) DEPOT METHYLPREDNISOLONE IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS</a><div class="gs_gray">EH Choy, GH Kingsley, B Khoshaba, N Pipitone, L Dolan, P Pitt, ...</div><div class="gs_gray">Rheumatology 43, 44-45<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13853142090800250914" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rmuvC79q63oC" class="gsc_a_at">Myositis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Medicine 30 (10), 42-44<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16636086526558449930" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">BLOCKING INTERLEUKING-6 (IL-6) BY AN ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) MONOCLONAL ANTIBODY IN RHEUMATOID ARTHRITIS (RA)</a><div class="gs_gray">E Choy, D Isenberg, T Garrood, S Farrow, Y Ioannou, H Bird, N Cheung, ...</div><div class="gs_gray">Rheumatology 41<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5429494758637337744" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:c59VksA5Vz4C" class="gsc_a_at">A meta-analysis of the efficacy and toxicity of combining disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA).</a><div class="gs_gray">EHS Choy, C Smith, DL Scott</div><div class="gs_gray">Arthritis &amp; Rheumatism 46 (9), S170-S170<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8869975271426571976" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Control of rheumatoid arthritis (RA) by oral tolerance with bovine type II collagen (CII).</a><div class="gs_gray">E Choy, D Scott, G Kingsley, S Thomas, T Murphy, N Staines, G Panayi</div><div class="gs_gray">Arthritis &amp; Rheumatism 42 (9)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10820474546702571402" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Engineered Human Anti-Tumor Necrosis Factor-Alpha (TNFoº) Antibody, CDP571</a><div class="gs_gray">EHS CHOY, GS PANAY</div><div class="gs_gray">Novel Therapeutic Agents for the Treatment of Autoimmune Diseases, 121<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11662471049551257041" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hGdtkIFZdKAC" class="gsc_a_at">INDUCTION OF APOPTOSIS IS ONE MECHANISM OF ACTION OF ANTI-CD4 MONOCLONAL-ANTIBODY</a><div class="gs_gray">GH Kingsley, EHS Choy, J Adjaye, L Forrest, GS Panayi</div><div class="gs_gray">JOURNAL OF IMMUNOLOGY 150 (8), A76-A76<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5636177977208950493" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Indications for starting or changing disease modifying anti-rheumatic drugs in rheumatoid arthritis patients</a><div class="gs_gray">G Yanni, EH Choy, GH Kingsley</div><div class="gs_gray">Clinical and experimental rheumatology 11 (6), 693<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7894621481474763395" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:KS-xo-ZNxMsC" class="gsc_a_at">Chimeric anti-CD4 monoclonal-antibody in rheumatoid-arthritis</a><div class="gs_gray">EHS Choy, IC Chikanza, GH Kingsley, H Bijl, ME Sanders, GS Panayi</div><div class="gs_gray">BRITISH JOURNAL OF RHEUMATOLOGY 31, 102-102<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15019671239769356475" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-LHtoeeytlUC" class="gsc_a_at">Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study</a><div class="gs_gray">E Choy, L Groves, D Sugrue, M Hurst, J Houghton, S Venkatachalam, ...</div><div class="gs_gray">BMC rheumatology 5 (1), 1-12<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:OlbiQ0ttILcC" class="gsc_a_at">The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2</a><div class="gs_gray">LJ Maxwell, DE Beaton, M Boers, MA D'Agostino, PG Conaghan, ...</div><div class="gs_gray">Seminars in Arthritis and Rheumatism<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Weau3kkTRIMC" class="gsc_a_at">EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis</a><div class="gs_gray">G Nagy, NMT Roodenrijs, PMJ Welsing, M Kedves, A Hamar, ...</div><div class="gs_gray">Annals of the rheumatic diseases<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:UY3hNwcQ290C" class="gsc_a_at">Anti-inflammatory and immunoregulatory effects of pinolenic acid in rheumatoid arthritis</a><div class="gs_gray">R Takala, DP Ramji, R Andrews, Y Zhou, J Burston, E Choy</div><div class="gs_gray">Rheumatology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yaBp1wUtcLsC" class="gsc_a_at">Comparing people who have and have not received a diagnosis of fibromyalgia: a cross‐sectional survey within the PACFiND study</a><div class="gs_gray">S Doebl, RJ Hollick, M Beasley, E Choy, GJ Macfarlane, ...</div><div class="gs_gray">Arthritis Care &amp; Research<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:0paDrhnEFY0C" class="gsc_a_at">POS0346 THE THERAPEUTIC EFFECTS OF OMEGA-6 PUFA (PINOLENIC ACID) ON THE TRANSCRIPTOMIC PROFILE OF ACTIVATED PERIPHERAL BLOOD MONONUCLEAR CELLS ISOLATED FROM HEALTHY CONTROLS&nbsp;…</a><div class="gs_gray">R Takala, D Ramji, R Andrews, Y Zhou, J Burston, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 80 (Suppl 1), 402-403<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:CKf5m1HYVjMC" class="gsc_a_at">POS0656 RELATIONSHIP BETWEEN CHANGES IN LIPID LEVELS AND IMPROVEMENT IN DISEASE ACTIVITY OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB TREATMENT: POOLED&nbsp;…</a><div class="gs_gray">C Charles-Schoeman, JT Giles, N Lane, E Choy, H Camp, Y Song, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 80 (Suppl 1), 569-569<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:w9ZB08sdvuUC" class="gsc_a_at">OP0128 INTEGRATED LABORATORY ABNORMALITY PROFILES OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN THE SELECT PHASE 3 PROGRAM</a><div class="gs_gray">C Charles-Schoeman, JT Giles, N Lane, E Choy, D Furst, J Vencovský, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 80 (Suppl 1), 72-73<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NKlx0PmyA3cC" class="gsc_a_at">SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1&nbsp;…</a><div class="gs_gray">A Bamias, AS Merseburger, Y Loriot, N James, E Choy, D Castellano, ...</div><div class="gs_gray">ESMO open 6 (3), 100152<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eJD0kABLposC" class="gsc_a_at">Fibromyalgia position paper</a><div class="gs_gray">P Sarzi-Puttini, V Giorgi, F Atzeni, R Gorla, E Kosek, EH Choy, L Bazzichi, ...</div><div class="gs_gray">Clin Exp Rheumatol 39 (130), S00-S00<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:J-ba04ztB30C" class="gsc_a_at">rheumatologists at a crossroads: blocking TNF or IL-6 in DMARD-IR patients</a><div class="gs_gray">L Quartuccio, EH Choy</div><div class="gs_gray">Rheumatology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:w5CyTnyFq80C" class="gsc_a_at">Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus</a><div class="gs_gray">F D'Amico, V Solitano, D Aletaha, A Hart, F Magro, C Selmi, SC Ng, ...</div><div class="gs_gray">Autoimmunity Reviews, 102849<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:AkvegQHRDQ8C" class="gsc_a_at">Mechanism of pain in rheumatoid arthritis</a><div class="gs_gray">EH Choy</div><div class="gs_gray">CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 39 (3), S200-S200<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:G7txJ4jiatkC" class="gsc_a_at">Biologic use in psoriatic arthritis and ankylosing spondylitis patients: a descriptive epidemiological study using linked, routine data in Wales, UK</a><div class="gs_gray">R Cooksey, MA Rahman, J Kennedy, S Brophy, E Choy</div><div class="gs_gray">Rheumatology Advances in Practice 5 (2), rkab042<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RgMnzfD6kpIC" class="gsc_a_at">Diagnostic and therapeutic care pathway for fibromyalgia</a><div class="gs_gray">P Sarzi-Puttini, V Giorgi, F Atzeni, R Gorla, E Kosek, EH Choy, L Bazzichi, ...</div><div class="gs_gray">Clinical and experimental rheumatology 39 (3), 120-127<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RmcNAhKkducC" class="gsc_a_at">Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritis</a><div class="gs_gray">R Pedley, LE Dean, E Choy, K Gaffney, T Ijaz, L Kay, K Lovell, C Molloy, ...</div><div class="gs_gray">Rheumatology Advances in Practice 5 (2), rkaa063<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eIKNFFVQvJAC" class="gsc_a_at">Feasibility, acceptability and change in health following a telephone-based CBT intervention for patients with axial spondyloarthritis</a><div class="gs_gray">R Pedley, LE Dean, E Choy, K Gaffney, T Ijaz, L Kay, K Lovell, C Molloy, ...</div><div class="gs_gray">Rheumatology Advances in Practice<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bkKuixW_xMkC" class="gsc_a_at">Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma</a><div class="gs_gray">J Bedke, AS Merseburger, Y Loriot, D Castellano, E Choy, I Duran, ...</div><div class="gs_gray">European Urology Focus<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-BKJ5vZJwzMC" class="gsc_a_at">Clinical, endoscopic, and histologic benefit with comprehensive type IV hypersensitivity patch testing in adults with eosinophilic esophagitis</a><div class="gs_gray">G Ghosh, C Parra, B Cressey, J Zippin, C Crawford</div><div class="gs_gray">Clinical Gastroenterology and Hepatology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:puFLaqDw8dcC" class="gsc_a_at">Patient-reported outcome measures for rheumatoid arthritis disease activity: a systematic review</a><div class="gs_gray">T Pickles, T Ijaz, M Horton, KB Christensen, R Phillips, D Gillespie, ...</div><div class="gs_gray">QUALITY OF LIFE RESEARCH 29 (SUPPL 1), S158-S158<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ibZ2AwG9z6wC" class="gsc_a_at">Patient-reported outcome measures for rheumatoid arthritis symptom severity: development of a computer-adaptive test from an item bank using Rasch measurement theory</a><div class="gs_gray">T Pickles, E Choy, M Horton, KB Christensen, R Phillips, D Gillespie</div><div class="gs_gray">QUALITY OF LIFE RESEARCH 29 (SUPPL 1), S159-S160<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:d6JCS5z0ckYC" class="gsc_a_at">Comparative Clinical Efficacy of Sarilumab versus Upadacitinib over 12 Weeks: Matching-Adjusted Indirect Comparison Analysis</a><div class="gs_gray">T Huizinga, E Choy, A Praestgaard, H van Hoogstraten, PR LaFontaine, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:7XUxBq3GufIC" class="gsc_a_at">Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data</a><div class="gs_gray">M Rehberg, C Giegerich, A Praestgaard, H van Hoogstraten, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:0Kh4an1R61UC" class="gsc_a_at">Relationship Between Changes in Lipid Levels and Improvement in Disease Activity Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib Treatment: Pooled&nbsp;…</a><div class="gs_gray">C Charles-Schoeman, J Giles, N Lane, E Choy, H Camp, Y Song, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4uoR24qA-WYC" class="gsc_a_at">Outcomes and Efficacy of Selective versus Automatic Switching from Etanercept to a Biosimilar in Inflammatory Arthritis Using Electronic Health Records from UK</a><div class="gs_gray">R Cooksey, S Brophy, M Azizur, J Kennedy, E Choy</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rDsFeusoTZkC" class="gsc_a_at">A Phase IIb, Randomized, Double-blind Study in Patients with Rheumatoid Arthritis Evaluating the Safety and Efficacy of Evobrutinib Compared with Placebo in Patients with an&nbsp;…</a><div class="gs_gray">C Peterfy, M Buch, E Choy, G Schett, D Parsons-Rich, A Patel, Y Zima, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:uQVPmWFBlwUC" class="gsc_a_at">Interleukin-6 inhibitors</a><div class="gs_gray">N Hassan, E Choy</div><div class="gs_gray">Oxford Textbook of Rheumatoid Arthritis, 389<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:aNch6Af-aFkC" class="gsc_a_at">748P Prognostic factors related to post-platinum atezolizumab for relapsed metastatic urothelial cancer (mUC) from the SAUL study</a><div class="gs_gray">A Bamias, A Merseburger, Y Loriot, N James, E Choy, DC Gauna, ...</div><div class="gs_gray">Annals of Oncology 31, S581<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:wlzmIqt2EaEC" class="gsc_a_at">Cumulative patient-based disease activity monitoring in rheumatoid arthritis–predicts sustained remission, flare and treatment escalation</a><div class="gs_gray">MH Leung, EHS Choy, CS Lau</div><div class="gs_gray">Seminars in Arthritis and Rheumatism 50 (4), 749-758<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ZqLB7dQ1iF4C" class="gsc_a_at">SAT0409 BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOPATHY REDUCES SICKNOTES ISSUED BY GPS, DESPITE DELAYS IN DIAGNOSIS: A REAL-LIFE STUDY IN WALES.</a><div class="gs_gray">E Choy, S Brophy, R Cooksey, L Hanson, A Halliday</div><div class="gs_gray">Annals of the Rheumatic Diseases 79 (Suppl 1), 1156-1157<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4tNoA7Af41QC" class="gsc_a_at">SAT0609-HPR DELPHI CONSENSUS FOR THE OPTIMAL TREATMENT &amp; MANAGEMENT OF COMPLEX RHEUMATOID ARTHRITIS (RA) PATIENTS</a><div class="gs_gray">G Dulay, E Choy, T Barnes, D Chagadama, Z Cole, A Malaviya, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 79 (Suppl 1), 1264-1265<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Mx5hWS9ctUkC" class="gsc_a_at">SAT0102 NONINFLAMMATORY PAIN IS A FREQUENT PHENOMENON IN RHEUMATOID ARTHRITIS AND RESPONDS WELL TO TREATMENT WITH SARILUMAB</a><div class="gs_gray">E Choy, V Bykerk, Y Lee, G St John, H Van Hoogstraten, K Ford, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 79 (Suppl 1), 984-985<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:JdL-Xu2nR38C" class="gsc_a_at">FRI0108 ASSOCIATION BETWEEN CHANGES IN C-REACTIVE PROTEIN AT WEEK 12 AND PATIENT-REPORTED OUTCOMES AT WEEK 24 WITH SARILUMAB THERAPY ACROSS THREE PIVOTAL PHASE 3 STUDIES</a><div class="gs_gray">J Tesser, GC Wright, V Strand, J Kaine, K Maslova, G St John, K Ford, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 79 (Suppl 1), 634-634<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lSLsV1MU4ZUC" class="gsc_a_at">Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the TAIL study.</a><div class="gs_gray">T Newsom-Davis, B Rubio Viqueira, D Rodriguez-Abreu, ...</div><div class="gs_gray">Journal of Clinical Oncology 38 (15_suppl), e21628-e21628<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Oj-SLI0tZTcC" class="gsc_a_at">Individual therapeutic DAS28-d crit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective&nbsp;…</a><div class="gs_gray">M Koehm, MJ McIntosh, MW Hofmann, V Abraham, C Gabay, EH Choy, ...</div><div class="gs_gray">Rheumatology international 40 (5), 747-755<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:dhpJJ7xvgBgC" class="gsc_a_at">P201 Anti-inflammatory and immunologic actions of pinolenic acid in rheumatoid arthritis</a><div class="gs_gray">R Takala, D Ramji, E Choy</div><div class="gs_gray">Rheumatology 59 (Supplement_2), keaa111. 196<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RgznTc0nqo4C" class="gsc_a_at">O07 Randomised, open labelled clinical trial to investigate synovial mechanisms determining response: resistance to rituximab versus tocilizumab in RA patients failing TNF&nbsp;…</a><div class="gs_gray">FC Humby, M Lewis, P Durez, MH Buch, M Bombardieri, H Rizvi, ...</div><div class="gs_gray">Rheumatology 59 (Supplement_2), keaa110. 006<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:6Zm5LS9gQ5UC" class="gsc_a_at">Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma&nbsp;…</a><div class="gs_gray">J Bedke, AS Merseburger, Y Loriot, D Castellano, E Choy, I Duran, ...</div><div class="gs_gray">Journal of Clinical Oncology 38 (6_suppl), 492-492<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SPgmg5JLkoEC" class="gsc_a_at">Clinical Outcomes According to PD-L1 Status and Age in the Prospective International Saul Study of atezolizumab (ATEZO) for Locally Advanced or Metastatic Urothelial Carcinoma&nbsp;…</a><div class="gs_gray">F Zengerling, CN Sternberg, AS Merseburger, E Choy, D Castellano, ...</div><div class="gs_gray">ONCOLOGY RESEARCH AND TREATMENT 43, 73-74<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:aCwMkEyfDy8C" class="gsc_a_at">Peripheral regulatory CD8+ CD28-KLRG1+ T cells as markers of disease and treatment response in rheumatoid arthritis.</a><div class="gs_gray">C Thompson, R Beatson, R Davies, C Greenhill, SA Jones, AS Williams, ...</div><div class="gs_gray">medRxiv<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:TiIbgCYny7sC" class="gsc_a_at">Economic evaluation: methods and results</a><div class="gs_gray">S Hewlett, C Almeida, N Ambler, PS Blair, E Choy, E Dures, A Hammond, ...</div><div class="gs_gray">Group cognitive–behavioural programme to reduce the impact of rheumatoid&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yCjxvIMm6_oC" class="gsc_a_at">Trial design and methods</a><div class="gs_gray">S Hewlett, C Almeida, N Ambler, PS Blair, E Choy, E Dures, A Hammond, ...</div><div class="gs_gray">Group cognitive–behavioural programme to reduce the impact of rheumatoid&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:o9ULDYDKYbIC" class="gsc_a_at">Qualitative evaluation: methods and results</a><div class="gs_gray">S Hewlett, C Almeida, N Ambler, PS Blair, E Choy, E Dures, A Hammond, ...</div><div class="gs_gray">Group cognitive–behavioural programme to reduce the impact of rheumatoid&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hKjooKYXoHIC" class="gsc_a_at">Using biologics safely</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Rheumatology 58 (9), 1515-1516<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rpSJNIKeXWsC" class="gsc_a_at">Primary results from the SAUL study: atezolizumab for locally advanced or metastatic urothelial carcinoma (UC) or non-UC</a><div class="gs_gray">R Cathomas, AS Merseburger, Y Loriot, N James, E Choy, D Castellano, ...</div><div class="gs_gray">SWISS MEDICAL WEEKLY 149, 12S-13S<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:s1ouQE5r0WUC" class="gsc_a_at">Generalised musculoskeletal problems</a><div class="gs_gray">C Baerwald, E Choy</div><div class="gs_gray">Best practice &amp; research. Clinical rheumatology 33 (3), 101441<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:j8pvxH-kN2QC" class="gsc_a_at">SP0119 SEARCHING FOR PATHOLOGY; HOW HARD SHOULD WE LOOK?</a><div class="gs_gray">E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 78 (Suppl 2), 34-35<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:GUYAmugLYisC" class="gsc_a_at">Biopsychosocial rehabilitation for inflammatory arthritis and osteoarthritis: Protocol for a systematic review and meta-analysis of randomised trials</a><div class="gs_gray">ML Pedersen, P Thinggard, R Geenen, MU Rasmussen, M de Wit, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hEXC_dOfxuUC" class="gsc_a_at">UNFINISHED BUSINESS IN TREATING CHRONIC INFLAMMATORY ARTHRITIS</a><div class="gs_gray">E Choy</div><div class="gs_gray">RHEUMATOLOGY 58, 19-19<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vxA22ZmNLkoC" class="gsc_a_at">E024 Invariant natural killer T cells in RA and CVD</a><div class="gs_gray">J Bakshi, A Rahman, E Choy, R Davis, E Jury</div><div class="gs_gray">Rheumatology 58 (Supplement_3), kez110. 023<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:adHtZc2wMuEC" class="gsc_a_at">I048 Mechanisms of development of fibromyalgia in the context of inflammatory arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Rheumatology 58 (Supplement_3), kez109. 047<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:3BvdIg-l-ZAC" class="gsc_a_at">I123 Unfinished Business in Treating Chronic Inflammatory Arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Rheumatology 58 (Supplement_3), kez109. 122<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:sfsSB7lKuh0C" class="gsc_a_at">Primary results from SAUL, a prospective multinational single-arm study of Atezolizumab (atezo) for locally advanced or metastatic urothelial carcinoma (UC) or non-UC of the&nbsp;…</a><div class="gs_gray">M Retz, AS Merseburger, Y Loriot, N James, E Choy, D Castellano, ...</div><div class="gs_gray">ONCOLOGY RESEARCH AND TREATMENT 42, 104-105<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bbjcffOLshcC" class="gsc_a_at">Pain measurement in rheumatic and musculoskeletal diseases: where to go</a><div class="gs_gray">LSS Kirkham, JA Singh, P Tugwell, DC Turk, J Philip, M Cowern, M Gill, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:cdwqcPQS8ssC" class="gsc_a_at">Fibromyalgia: state-of-the-art overview</a><div class="gs_gray">EH Choy</div><div class="gs_gray">CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 37 (1), S117-S117<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NtGNdKbuCngC" class="gsc_a_at">皮肌炎的发病机制</a><div class="gs_gray">C Thompson, V Piguet, E Choy</div><div class="gs_gray">British Journal of Dermatology 179 (6), e261-e261<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:3MwzVuqRcA0C" class="gsc_a_at">IL-6: To immunity and beyond</a><div class="gs_gray">EH Choy, SA Jones, D Aletaha, T Takeuchi, I McInnes, J Smolen</div><div class="gs_gray">Considerations in Medicine 2 (1), 19-23<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:qCaWouos7ogC" class="gsc_a_at">4M106 ACR Abstract: RA–Treatments III: New Compounds &amp; Biosimilars (1935–1940)</a><div class="gs_gray">E Choy, MC Genovese</div><div class="gs_gray">2018 ACR/ARHP Annual Meeting<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:as0KMg8qHbkC" class="gsc_a_at">SAT0343 Cardiovascular disease risk in clinical subtypes of psoriatic arthritis</a><div class="gs_gray">N Hassan, M Bradley, R Davies, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 77 (Suppl 2), 1036-1037<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:v_tt_AnqfNMC" class="gsc_a_at">FRI0027 Patient-based disease activity score predicts flare better than improvement–blood test provides insignificant contribution</a><div class="gs_gray">MHA Leung, CS Lau, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 77 (Suppl 2), 560-561<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vVJNg6_NJEsC" class="gsc_a_at">167 Cardiovascular risk in clinical subtypes of psoriatic arthritis</a><div class="gs_gray">N Hassan, M Bradley, R Davies, E Choy</div><div class="gs_gray">Rheumatology 57 (suppl_3), key075. 391<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:3lUAU8Oskd0C" class="gsc_a_at">175 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal Phase III clinical trial data</a><div class="gs_gray">A Kaul, V Strand, I McInnes, P Mease, E Choy, P Nash, H Thom, ...</div><div class="gs_gray">Rheumatology 57 (suppl_3), key075. 399<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:0sTkTiv_uMkC" class="gsc_a_at">DO PATIENTS WITH AXIAL SPONDYLOARTHRITIS WHO MEET RESEARCH CRITERIA FOR FIBROMYALGIA BENEFIT FROM BIOLOGIC THERAPY?</a><div class="gs_gray">GJ Macfarlane, RIR MacDonald, E Choy, J Packham, S Siebert, E Pathan, ...</div><div class="gs_gray">RHEUMATOLOGY 57<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Ej9njvOgR2oC" class="gsc_a_at">滑膜組織研究: 最新レビュー</a><div class="gs_gray">C Orr, E Vieira-Sousa, DL Boyle, MH Buch, CD Buckley, JD Canete, ...</div><div class="gs_gray">Nature reviews. Rheumatology 11 (4), 142-154<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:I858iXPj1OkC" class="gsc_a_at">P097 ANTI-TNF treatment improves vascular function via suppression of GALECTIN-3 expression during inflammatory arthritis</a><div class="gs_gray">K Sime, E Hughes, EH Choy, AS Williams</div><div class="gs_gray">Annals of the Rheumatic Diseases 77 (Suppl 1), A54-A55<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hB2aVRuWZNwC" class="gsc_a_at">CONSIDERING PATIENTS’NEEDS: ACTION AND REACTION OF INTERLEUKIN-6 BLOCKADE</a><div class="gs_gray">C Pitzalis, JS Smolen, E Choy</div><div class="gs_gray">RHEUMATOLOGY<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:L_l9e5I586QC" class="gsc_a_at">Infliximab/tocilizumab</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Reactions 1677, 162-11<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yIeBiWEAh44C" class="gsc_a_at">The Effectiveness of Zoster Vaccine in Patients Subsequently Treated With Tofacitinib: 748</a><div class="gs_gray">KL Winthrop, A Wouters, EH Choy, CI Nduaka, P Biswas, L Wang, ...</div><div class="gs_gray">Official journal of the American College of Gastroenterology| ACG 112, S416-S417<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9shLKfS_uJEC" class="gsc_a_at">Randomized Controlled Trial Evaluating the Effectiveness of Pictogram Intervention in Identification and Reporting Adverse Drug Reactions in Naïve Hiv Patients in Ethiopia</a><div class="gs_gray">AS Bhagavathula, EA Gebreyohannes, TM Abegaz, TB Abebe, ...</div><div class="gs_gray">Value in Health 20 (9), A933<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RJOyoaXV5v8C" class="gsc_a_at">Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis: Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect&nbsp;…</a><div class="gs_gray">P Mease, E Choy, H Thom, C Kalyvas, N Lopes, L Pricop, K Gandhi, ...</div><div class="gs_gray">Value in Health 20 (9), A936<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Sf6vrWCRp3YC" class="gsc_a_at">The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated with Tofacitinib</a><div class="gs_gray">KL Winthrop, A Wouters, EH Choy, C Nduaka, P Biswas, L Wang, ...</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 76, 148-149<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1YatL4jblGcC" class="gsc_a_at">IL-6 TRANS-SIGNALING CAUSES ACCELERATED ATHEROSCLEROSIS IN DISEASE PRONE ANIMALS</a><div class="gs_gray">R Davies, HS Jin, K Sime, JO Williams, CR Thompson, GW Jones, ...</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 76, 208-209<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">The OMERACT RA Flare Questionnaire (RA-FQ) is Responsive to Change in RA Symptoms and Impacts</a><div class="gs_gray">S Bartlett, V Bykerk, B Fautrel, F Guillemin, A den Broeder, R Alten, ...</div><div class="gs_gray">JOURNAL OF RHEUMATOLOGY 44 (6), 889-890<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:k_7cPK9k7w8C" class="gsc_a_at">FRI0118 Clinical utility of area-under-curve (AUC) of patient-derived disease activity score (PDAS2) between clinic visits on remission, flare up and rheumatologist's decision&nbsp;…</a><div class="gs_gray">MHA Leung, E Choy, CS Lau</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 525-525<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:UuEBAcK4md4C" class="gsc_a_at">OP0230 The effectiveness of zoster vaccine in RA patients subsequently treated with TOFACITINIB</a><div class="gs_gray">KL Winthrop, A Wouters, EH Choy, C Nduaka, P Biswas, L Wang, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 148-149<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">THU0180 Systems based investigation of the anti-immunogenic potential of dmards for rheumatoid arthritis using human primary cell-based biomap® phenotypic profiling</a><div class="gs_gray">A O'Mahony, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 269-270<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:jSAVyFp_754C" class="gsc_a_at">AB0011 KLRG1 as a marker of CD28 negativity in rheumatoid arthritis, comparison with CD57 and CD45RA</a><div class="gs_gray">C Rawlings, E Choy, R Davies, G Jones, A Williams</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 1050-1050<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rbm3iO8VlycC" class="gsc_a_at">SP0125 Inflammation and cardiovascular disease–relevant metabolic biomarkers</a><div class="gs_gray">E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 31-31<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">SAT0132 The rheumatoid arthritis flare questionnaire (RA-FQ): results of rasch analysis and feedback on real-world applications from international RA patients and clinicians</a><div class="gs_gray">SJ Bartlett, SP Barbic, VP Bykerk, B Fautrel, F Guillemin, A den Broeder, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 2), 818-819<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">04.06 Alterations to adipose tissue-associated vasculopathology during inflammatory arthritis causes vascular dysfunction in dba/1 mice that is resolved by anti-tnf treatment</a><div class="gs_gray">K Sime, EH Choy, AS Williams</div><div class="gs_gray">Annals of the Rheumatic Diseases 76 (Suppl 1), A43-A44<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Yw6v6SrDvuUC" class="gsc_a_at">Roxanne Cooksey, Sinead Brophy, Jonathan Kennedy, Fabiola Fernandez Gutierrez, Tim Pickles, Ruth</a><div class="gs_gray">VP Davies, E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8gBurD7jEYQC" class="gsc_a_at">Content and construct validity, reliability, and responsiveness of the rheumatoid arthritis flare questionnaire: OMERACT 2016 workshop report</a><div class="gs_gray">L March, R Alten, SP Barbic, SJ Bartlett, VP Bykerk, E Choy, ...</div><div class="gs_gray">Journal of Rheumatology Publishing Co. Ltd<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:TesyEGJKHF4C" class="gsc_a_at">International Journal of Population Data Science</a><div class="gs_gray">F Fernández-Gutiérrez, J Kennedy, R Cooksey, M Atkinson, E Choy, ...</div><div class="gs_gray">International Journal of Population Data Science 1, 067<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Development of data-driven framework for automatically identifying patient cohorts from linked electronic health records</a><div class="gs_gray">F Fern'andez-Guti'errez, J Kennedy, R Cooksey, M Atkinson, E Choy, ...</div><div class="gs_gray">International Journal of Population Data Science 1 (1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Cardiovascular risk in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a prospective study of data from the Secure Anonymised Information Linkage databank</a><div class="gs_gray">R Cooksey, S Brophy, J Kennedy, FF Guiterrez, T Pickles, R Davies, ...</div><div class="gs_gray">The Lancet 388, S37<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:U0iAMwwPxtsC" class="gsc_a_at">Cardiovascular Risk in Patients with Psoriasis, Psoriatic and Rheumatoid Arthritis: A Prospective Study Using Secured Anonymised Information Technology Databank in Wales&nbsp;…</a><div class="gs_gray">EH Choy, R Cooksey, S Brophy, J Kennedy, F Fernandez-Gutierrez, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 68<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rTD5ala9j4wC" class="gsc_a_at">AB0940 Comparison of US7 and US10 Risk Scores in Early Inflammatory Arthritis (EIA)</a><div class="gs_gray">C Rawlings, R Davies, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 1223-1223<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-jrNzM816MMC" class="gsc_a_at">SP0051 Pain Management</a><div class="gs_gray">E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 14-14<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:7wO8s98CvbsC" class="gsc_a_at">AB1063 A Survey of Musculoskeletal Ultrasound (MSUS) Training amongst Rheumatologists and Trainees across Wales</a><div class="gs_gray">F Sheikh, E Humphreys, V Lim, E Choy, S Chitale</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 1265-1265<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kw52XkFRtyQC" class="gsc_a_at">AB1130-HPR Cognitive Therapy for Reducing The Impact of Rheumatoid Arthritis Fatigue: Sucessful Strategies for Meeting Targets in A Complex Health Care Intervention</a><div class="gs_gray">Z Plummer, C Almeida, N Ambler, P Blair, E Choy, E Dures, A Hammond, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 1318-1318<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1taIhTC69MYC" class="gsc_a_at">AB0227 Validation of Patient-Derived Disease Activity Score in Chinese Rheumatoid Arthritis Patients</a><div class="gs_gray">MHA Leung, E Choy, CS Lau</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 975-976<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Optimal management of RA patients who require Biologic Therapy (ORBIT)–a randomised controlled, non-inferiority study</a><div class="gs_gray">D Porter, J van Melckebeke, J Dale, CM Messow, A McConnachie, ...</div><div class="gs_gray">The Lancet<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:mWEH9CqjF64C" class="gsc_a_at">Serum Vascular Cell Adhesion Molecule 1 levels are associated with vascular Dysfunction and increased cardiovascular risk in an animal model and patients with Rheumatoid Arthritis</a><div class="gs_gray">R Davies, D Iacono, L Jordan, JO Williams, K Sime, C Rawlings, D Lang, ...</div><div class="gs_gray">Rheumatology 55 (Supp 1), 54-54<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Defining chronic pain reply</a><div class="gs_gray">A Taylor, JO Taylor, JA Singh, PG Conaghan, E Choy, PS Tugwell, ...</div><div class="gs_gray">Journal of Rheumatology 43 (4), 826-827<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:0CzhzZyukY4C" class="gsc_a_at">224 Waiting Time for Musculoskeletal Ultrasound is Highly Variable in Wales and is Significantly Lower where Rheumatology Departments Deliver this Service In-House: Results&nbsp;…</a><div class="gs_gray">F Sheikh, E Humphreys, V Lim, E Choy, S Chitale</div><div class="gs_gray">Rheumatology 55 (suppl_1), i152-i153<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:AHdEip9mkN0C" class="gsc_a_at">096 Treatment of Rheumatoid Arthritis with an Anti-Tumour Necrosis Factor Agent or Tocilizumab as First Biologic Therapy: Act-Ion, A Global Comparative Observational Study</a><div class="gs_gray">E Choy, C Bernasconi, M Aassi, J Fernando Molina, O Massimiliano Epis</div><div class="gs_gray">Rheumatology 55 (suppl_1), i101-i102<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">147 Successful Strategies Supporting Recruitment, Intervention Delivery and Retention Targets in a Randomized Controlled Trial of a Complex Intervention</a><div class="gs_gray">Z Plummer, C Almeida, N Ambler, P Blair, E Choy, E Dures, A Hammond, ...</div><div class="gs_gray">Rheumatology 55 (suppl_1), i121-i121<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lvd772isFD0C" class="gsc_a_at">Ms. AM Taylor, et al reply</a><div class="gs_gray">AM Taylor, JO Taylor, JA Singh, PG Conaghan, EH Choy, PS Tugwell, ...</div><div class="gs_gray">The Journal of rheumatology 43 (4), 826-827<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Clinically important worsening (CIW) of rheumatoid arthritis disease activity requiring an increase in therapy can be identified using a combined patient and physician report&nbsp;…</a><div class="gs_gray">R Alten, CO Bingham III, EH Choy</div><div class="gs_gray">ZEITSCHRIFT FUR RHEUMATOLOGIE 75, S2-S2<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:gI9wzKcniAoC" class="gsc_a_at">The Roles For IL-6 In Both Innate And Adaptive Immunity In RA</a><div class="gs_gray">LH Calabrese, E Choy</div><div class="gs_gray">Fonte: https://www. raandil6. com/-/media/EMS/Conditions/Rheumatoid&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RJNGbXJAtMsC" class="gsc_a_at">Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set</a><div class="gs_gray">L March, R Alten, CO Bingham, VP Bykerk, E Choy, R Christensen</div><div class="gs_gray">BMJ Group<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:cSdaV2aYdYsC" class="gsc_a_at">Fibromyalgia and Chronic Pain Syndromes: A White Paper Detailing Current Challenges in the Field</a><div class="gs_gray">E Choy, DJ Clauw</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Xl6nMSl579sC" class="gsc_a_at">Advances in Rheumatoid Arthritis Drugs</a><div class="gs_gray">M Schiff, CS Moura, EH Choy, WP Kennedy, R Sakai, NCN Coy</div><div class="gs_gray">Advances in Rheumatoid Arthritis Drugs, 330<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">ANN M. TAYLOR, JUSTIN O. TAYLOR, JASVINDER A. SINGH, PHILIP G. CONAGHAN</a><div class="gs_gray">EH CHOY, PS TUGWELL, U KAISER, V STRAND</div><div class="gs_gray">The Journal of Rheumatology 43 (4), 826-827<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:6yz0xqPARnAC" class="gsc_a_at">I137 The Role of Sleep in the Management of Fibromyalgia</a><div class="gs_gray">E Choy</div><div class="gs_gray">RHEUMATOLOGY-LONDON THEN OXFORD-BRITISH SOCIETY FOR RHEUMATOLOGY- 55 (1&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Inhibition of Macrophage Inflammatory Protein 1-Alpha (CCL3) Significantly Reduced Bone Resorption in Vitro and the Development of Erosive Joint Pathology in Collagen-Induced&nbsp;…</a><div class="gs_gray">L Jordan, R Davies, A Robertson, A Harvey, E Choy, M Erlandsson, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 2491-2492<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Clinically Important Worsening (CIW) of RA Disease Activity Requiring an Increase in Therapy Can be Identified Using a Combined Patient and Physician Report of Flare: Abstract&nbsp;…</a><div class="gs_gray">V Bykerk, C Bingham, E Choy, D Lin, R Alten, R Christensen, D Furst, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 3203-3206<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SpbeaW3--B0C" class="gsc_a_at">I31. Economic Evaluation of a Brief Education, Self-Management and Upper Limb Exercise Training Programme in People With Rheumatoid Arthritis</a><div class="gs_gray">LM Bearne, B Kaambwa, J Ratcliffe, E Choy, DL Scott, MV Hurley, ...</div><div class="gs_gray">Rheumatology 54 (suppl_1), i6-i6<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">AN AUDIT OF THE TREATMENT OF PSORIATIC ARTHRITIS WITH BIOLOGICS</a><div class="gs_gray">C Rawlings, A Negi, E Choy</div><div class="gs_gray">RHEUMATOLOGY 54, 198-199<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:sJK75vZXtG0C" class="gsc_a_at">Functional Analysis of a Complement</a><div class="gs_gray">JL Giles, E Choy, C van den Berg, B Paul</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">Functional analysis of a complement polymorphism (rs17611) associated with Rheumatoid Arthritis</a><div class="gs_gray">JL Giles, E Choy, C van den Berg, BP Morgan, CL Harris</div><div class="gs_gray">Immunology 143 (s2), 181-182<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:2l5NCbZemmgC" class="gsc_a_at">Inhibiting Autocrine Interleukin-6 (IL-6) Trans-Signalling in Human CD14+ VE Monocultures Reduces Osteoclast Differentiation.: 30</a><div class="gs_gray">L Jordan, F Collins, S Jones, E Choy, A Harvey, A Williams</div><div class="gs_gray">Arthritis &amp; Rheumatology 66<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:EkHepimYqZsC" class="gsc_a_at">Methotrexate Impacts the Effects of Tofacitinib, but Not Tocilizumab, on Clinically Relevant Biomarkers in Human Primary Cell-Based Bio-MAP® Disease Models: Can We Utilize in&nbsp;…</a><div class="gs_gray">A O'Mahony, E Berg, X Li, M John, K Ganeshalingam, E Choy</div><div class="gs_gray">Arthritis &amp; Rheumatology 66<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">The future of biological agents in the treatment of rheumatoid arthritis</a><div class="gs_gray">C Rawlings, E Choy</div><div class="gs_gray">International Journal of Clinical Rheumatology 9 (5), 475<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-FonjvnnhkoC" class="gsc_a_at">SAT0097 Assessing Significant Flares in Rheumatoid Arthritis: Validity of the Omeract Preliminary Flare Questionnaire (PFQ) in the Canadian Early Arthritis Cohort</a><div class="gs_gray">SJ Bartlett, CO Bingham, E Choy, G Boire, B Haraoui, D Lin, JE Pope, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 73 (Suppl 2), 625-625<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">THU0273 Changes in Patient-Reported Joint Counts and Composite Indices Can Identify Flare of Disease Activity in Recent Onset</a><div class="gs_gray">K Visser, S Bartlett, CO Bingham, EH Choy, D Lin, G Boire, B Haraoui, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 73 (Suppl 2), 277-278<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:zwpXiJ37cpgC" class="gsc_a_at">INVESTIGATION OF A COMPLEMENT POLYMORPHISM ASSOCIATED WITH RHEUMATOID ARTHRITIS</a><div class="gs_gray">JL Giles, E Choy, BP Morgan, CL Harris</div><div class="gs_gray">RHEUMATOLOGY 53, 149-149<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">Long-term benefits of CZP on productivity/social participation in RA: APLAR-0260</a><div class="gs_gray">M HATHIAL, V STRAND, O PURCARU, R VOLLENHOVEN, E CHOY, ...</div><div class="gs_gray">International Journal of Rheumatic Diseases 17, 105-106<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">5-year safety and efficacy of CZP monotherapy and combination therapy: APLAR-0259</a><div class="gs_gray">R FLEISCHMANN, R VAN VOLLENHOVEN, J VENCOVSKY, R ALTEN, ...</div><div class="gs_gray">International Journal of Rheumatic Diseases 17<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:p__nRnzSRKYC" class="gsc_a_at">I18. Obtaining Patient and Professional Consensus on Flare, and Testing its Accuracy in Drug Trials</a><div class="gs_gray">E Choy</div><div class="gs_gray">Rheumatology 53 (suppl_1), i4-i4<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Updating the OMERACT Filter: Implications for</a><div class="gs_gray">PM Brooks, E Choy, M de Wit, F Guillemin, S Hewlett, TK Kvien, ...</div><div class="gs_gray">The Journal of Rheumatology 41 (5), 1011-1015<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Outcome measures in rheumatoid arthritis</a><div class="gs_gray">SF Bari, EH Choy</div><div class="gs_gray">Indian Journal of Rheumatology 8, S31-S35<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Death Receptor 3 Increases Region-Specific, Osteoblast-Dependent Aberrant New Bone Formation In The Axial Skeleton Of Mice In a Spontaneous Model Of Ankylosing Enthesopathy.: 535</a><div class="gs_gray">F Collins, J Williams, A Bloom, M Stone, E Choy, E Wang, A Williams</div><div class="gs_gray">Arthritis &amp; Rheumatism 65<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">AB0320 Patient-assessed disease activity score (PDAS) corresponds to standard disease statuses and response criteria defined by disease activity score 28 (DAS28) and clinical&nbsp;…</a><div class="gs_gray">MHA Leung, D Farewell, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 71 (Suppl 3), 656-656<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">OP0250 Exploration of omeract preliminary rheumatoid arthritis (RA) flare domains in a longitudinal observational study</a><div class="gs_gray">E Lie, TG Woodworth, R Christensen, V Bykerk, CO Bingham, DE Furst, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 71 (Suppl 3), 140-140<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">OP0237-HPR Upper Limb Exercise, Education and Self Management in Early Rheumatoid Arthritis (The Extra Programme)-Results from a Randomised Controlled Trial</a><div class="gs_gray">V Manning, M Hurley, DL Scott, E Choy, L Bearne</div><div class="gs_gray">Annals of the Rheumatic Diseases 72 (Suppl 3), A132-A133<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hCrLmN-GePgC" class="gsc_a_at">SP0071 How to treat: Fibromyalgia</a><div class="gs_gray">E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 71 (Suppl 3), 18-18<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:XoXfffV-tXoC" class="gsc_a_at">SAT0151 Long-term safety of 4-weekly certolizumab pegol in rheumatoid arthritis: 5 year results from an open label extension study</a><div class="gs_gray">R Fleischmann, R van Vollenhoven, J Vencovsky, R Alten, O Davies, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 71 (Suppl 3), 523-523<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">SAT0117 Early RA patients reporting a flare identify more tender than swollen joints</a><div class="gs_gray">VP Bykerk, SJ Bartlett, E Choy, G Boire, C Hitchon, J Pope, C Thorne, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 71 (Suppl 3), 509-510<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">SAT0130 Defining the Optimal Biological Monotherapy in Rheumatoid Arthritis (RA): Network Meta-Analysis of Randomized Trials</a><div class="gs_gray">R Christensen, S Tarp, DE Furst, M Østergaard, T Lorenzen, MS Hansen, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 72 (Suppl 3), A625-A625<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Self Management Strategies of Rheumatoid Arthritis Patients Experiencing a Disease Flare</a><div class="gs_gray">S Bartlett, C Bingham, J Xiong, E Choy, G Boire, C Hitchon, J Pope, ...</div><div class="gs_gray">JOURNAL OF RHEUMATOLOGY 40 (6), 1017-1017<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1qzjygNMrQYC" class="gsc_a_at">SAT0018 Establishing the Content Validity of Omeract Preliminary Flare Questions (PFQ) for Detecting and Measuring Disease Exacerbations in Rheumatoid Arthritis</a><div class="gs_gray">SJ Bartlett, CO Bingham, E Choy, J Xiong, G Boire, B Haraoui, JE Pope, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 72 (Suppl 3), A585-A585<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">THU0563 “I Definitely would Recommend It… I Think It’s been Quite Amazing Really”: Experiences of an Upper Limb Education, Self-Management, and Exercise Training Programme&nbsp;…</a><div class="gs_gray">VL Manning, MV Hurley, DL Scott, E Choy, LM Bearne</div><div class="gs_gray">Annals of the Rheumatic Diseases 72 (Suppl 3), A354-A354<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:VLnqNzywnoUC" class="gsc_a_at">'I THINK HAVING A PROGRAMME LIKE THAT FOR PEOPLE WHO HAVE GOT RHEUMATOID ARTHRITIS IS WELL WORTH DOING': EXPERIENCES OF AN UPPER LIMB EDUCATION, SELF-MANAGEMENT AND EXERCISE&nbsp;…</a><div class="gs_gray">VL Manning, M Hurley, DL Scott, E Choy, L Bearne</div><div class="gs_gray">RHEUMATOLOGY 52, 102-102<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">BHPR: Audit and Clinical Evaluation 103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care</a><div class="gs_gray">P Cornell, A Trehane, P Thompson, F Rahmeh, M Greenwood, TJ Baqai, ...</div><div class="gs_gray">Rheumatology 52 (suppl_1), i95-i134<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Basic Science 208. Stem Cell Factor Expression is Increased in the Skin of Patients with Systemic Sclerosis and Promotes Proliferation and Migration of Fibroblasts in vitro</a><div class="gs_gray">S Karrar, X Shiwen, J Nikotorowicz-Buniak, DJ Abraham, C Denton, ...</div><div class="gs_gray">Rheumatology 52 (suppl_1), i135-i172<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Responsiveness Of The Outcomes Measures In Rheumatology Clinical Trials Initiative's Preliminary Flare Questions To Detect Flares Within Patients In The Canadian Early&nbsp;…</a><div class="gs_gray">VP Bykerk, K Visser, E Choy, CO Bingham, DM Lin, J Xiong, G Boire, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">PMS65 Detecting Potential Fibromyalgia Patients in Primary Care Settings: Validation of the Fibrodetect Screening Tool</a><div class="gs_gray">H Gilet, C Dias-barbosa, I Guillemin, R Baron, S Perrot, C Alegre, E Choy, ...</div><div class="gs_gray">Value in Health 15 (7), A451<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Flare Self Management Strategies Used by Patients with Rheumatoid Arthritis.: 1216</a><div class="gs_gray">S Bartlett, C Bingham, J Xiong, E Choy, G Boire, C Hitchon, J Pope, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 64<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Defining Criteria for Rheumatoid Arthritis Patient-Derived Disease Activity Score That Corrresponds to Disease Activity Score 28 and Clnical Disease Activity Index Based&nbsp;…</a><div class="gs_gray">A Leung, D Farewell, C Lau, E Choy</div><div class="gs_gray">Arthritis &amp; Rheumatism 64<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Construct and Criterion Validity of Several Proposed DAS28 Based Rheumatoid Arthritis Flare Criteria: A Cohort Validation Study.: 2609</a><div class="gs_gray">A van der Maas, E Lie, R Christensen, E Choy, Y de Man, P van Riel, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 64<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:geHnlv5EZngC" class="gsc_a_at">Long-Term Safety and Efficacy of 4-Weekly Certolizumab Pegol Combination and Monotherapy in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study.: 1316</a><div class="gs_gray">R Fleischmann, R van Vollenhoven, J Vencovsky, R Alten, O Davies, ...</div><div class="gs_gray">Arthritis &amp; Rheumatism 64<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NXYAu82O0W8C" class="gsc_a_at">A longitudinal study to investigate the role of IL-6 and IL-17 in the pathogenesis of early rheumatoid arthritis: 703264</a><div class="gs_gray">N FATHI, H ABOZAID, E CHOY</div><div class="gs_gray">International Journal of Rheumatic Diseases 15<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">HOW TO TREAT: FIBROMYALGIA</a><div class="gs_gray">E Choy</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 71, 18-18<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:QsKbpXNoaWkC" class="gsc_a_at">COMBINATION ANTI-RHEUMATIC DRUGS IN EARLY RHEUMATOID ARTHRITIS: COMPARISON OF FINDINGS IN TWO RANDOMIZED CONTROLLED TRIALS</a><div class="gs_gray">DL Scott, F Ibrahim, H Abozaid, E Choy, A Hassell, M Plant, S Richards, ...</div><div class="gs_gray">RHEUMATOLOGY 51, 132-133<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">CONVENTIONAL THERAPY FOR EARLY INFLAMMATORY ARTHRITIS DOES NOT MODIFY PERIPHERAL BLOOD CYTOKINE PROFILES</a><div class="gs_gray">NJ Gullick, HS Abozaid, DM Jayaraj, HG Evans, DL Scottt, EH Choy, ...</div><div class="gs_gray">Rheumatology 51, 146-146<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">BHPR research: qualitative 1. Complex reasoning determines patients’ perception of outcome following foot surgery in rheumatoid arhtritis</a><div class="gs_gray">MR Backhouse, KA Vinall, A Redmond, P Helliwell, AM Keenan, RM Dale, ...</div><div class="gs_gray">Rheumatology 51 (suppl_3), iii52-iii92<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HE397vMXCloC" class="gsc_a_at">VARIATION IN THE USE OF BIOLOGICS IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS ACROSS THE UNITED KINGDOM</a><div class="gs_gray">E Choy, S McAuliffe, K Roberts, I Sargeant</div><div class="gs_gray">RHEUMATOLOGY 51, 130-130<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bnK-pcrLprsC" class="gsc_a_at">DEFECTIVE CD8+ CD28: REGULATORY T CELL SUPPRESSOR FUNCTION IN RHEUMATOID ARTHRITIS IS DUE TO SOLUBLE MEDIATORS AND REDUCED SENSITIVITY OF RESPONDER CELLS</a><div class="gs_gray">S Ceeraz, J Spencer, E Choy, V Corrigall</div><div class="gs_gray">RHEUMATOLOGY 51, 148-148<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kF1pexMAQbMC" class="gsc_a_at">Basic (PS01–PS58)</a><div class="gs_gray">A Sulli, B Ruaro, C Pizzorni, M Parodi, C Ferrone, G Zampogna, ...</div><div class="gs_gray">Rheumatology 51 (suppl_2)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">SSc IN EGYPT</a><div class="gs_gray">NF Awad, EH Choy</div><div class="gs_gray">RHEUMATOLOGY 51, 99-99<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:iyewoVqAXLQC" class="gsc_a_at">TNF-like protein 1A/death receptor 3 pathway regulates osteoclastogenesis and is associated with erosive disease in rheumatoid arthritis</a><div class="gs_gray">F Collins, MD Stone, RM Goodfellow, EHS Choy, ECY Wang, AS Williams</div><div class="gs_gray">Arthritis and Rheumatism 64 (10), S768-S768<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ipzZ9siozwsC" class="gsc_a_at">24-Week Study to Assess the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate Compared to Methotrexate Alone in the Treatment of the Signs and Symptoms&nbsp;…</a><div class="gs_gray">E Choy, F McKenna, J Vencovsky</div><div class="gs_gray">Rheumatology (Oxford) 51, 1226-1234<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Non-Pharmacological Interventions for Fatigue in Rheumatoid Arthritis: A Cochrane Review.</a><div class="gs_gray">F Hewlett, S Almeida, C Kirwan, J Choy, E Chalder, T Pollock</div><div class="gs_gray">Arthritis &amp; Rheumatism 63<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">One Year Randomised Controlled Trial of SEcond Line Agents in Myositis (SELAM): Late Additional immunosuppression is Ineffective in Patients Who Have Partially Responded to&nbsp;…</a><div class="gs_gray">E Choy, P Gordon, B White-Alao, F Ibrahim, A Kowal-czyk, A Hakim, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 63 (10), S83-S83<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Concurrent Oral 1–Therapy of rheumatic disease: OP4. Effectiveness of Rituximab in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register&nbsp;…</a><div class="gs_gray">MM Soliman, DM Ashcroft, KD Watson, M Lunt, D Symmons, KL Hyrich, ...</div><div class="gs_gray">Rheumatology 50 (suppl_3), iii31-iii34<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">Compromised expression of the complement membrane inhibitor CD59a propagates age-related joint degeneration in mice</a><div class="gs_gray">V Paringe, AC Bloom, EHS Choy, BP Morgan, AS Williams</div><div class="gs_gray">Arthritis and Rheumatism 63 (s10), S947-S947<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:RtRctb2lSbAC" class="gsc_a_at">Inhibiting IL-6 trans-signalling with soluble gp130Fc potently reduces the incidence and severity of collagen-induced experimental arthritis</a><div class="gs_gray">S Smale, SM Carty, RM Goodfellow, EHS Choy, S Rose-John, SA Jones, ...</div><div class="gs_gray">Arthritis and Rheumatism 63 (s10), S446-S447<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">ONE-YEAR RANDOMISED CONTROLLED TRIAL OF SECOND LINE AGENTS IN MYOSITIS (SELAM): ADDITIONAL IMMUNOSUPPRESSION IS INEFFECTIVE IN PATIENTS WHO HAVE PARTIALLY RESPONDED TO STEROIDS</a><div class="gs_gray">E Choy, B White-Alao, F Ibrahim, A Kowalczyk, P Gordon, A Hakim, ...</div><div class="gs_gray">Rheumatology 50, 33-34<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Tocilizumab for the Treatment of Adults with Moderate to Severe Rheumatoid Arthritis.</a><div class="gs_gray">MOY Pang, E Choy</div><div class="gs_gray">Clinical Medicine Reviews in Therapeutics 3<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Concurrent Oral 9–Rheumatoid Arthritis: Aetiopathogenesis [OP59–OP64] OP59. The Value of Interleukin-17 Serum Level in Rheumatoid Arthritis Immunopathogenesis</a><div class="gs_gray">IV Biliavska, OP Bortkevych, S Ceeraz, J Spencer, EH Choy, V Corrigall, ...</div><div class="gs_gray">Rheumatology 49 (suppl_1), i26-i28<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Rheumatoid Arthritis: Clinical Aspects [322–355] 322. The Effect of Biologics on Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Systematic Literature Review</a><div class="gs_gray">SL Westlake, AN Colebatch, J Baird, P Kiely, M Quinn, E Choy, AJ Ostor, ...</div><div class="gs_gray">Rheumatology 49 (suppl_1), i155-i167<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Rheumatoid Arthritis: Treatment [151–201] 151. Should we be Looking More Carefully for Methotrexate Induced Liver Disease?</a><div class="gs_gray">M Lloyd, R Makadsi, A Ala, P Connor, C Gwynne, B Rhys Dillon, ...</div><div class="gs_gray">Rheumatology 49 (suppl_1), i89-i111<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Sodium Oxybate Reduces Pain and Improves Function and PGIC in Fibromyalgia: Results from an International, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial</a><div class="gs_gray">T Swick, M Spaeth, E Choy, S Alvarez-Horine, YG Wang, B Benson, ...</div><div class="gs_gray">NEUROLOGY 74 (9), A280-A280<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Pregabalin cost effective for severe fibromyalgia in the UK</a><div class="gs_gray">E Choy</div><div class="gs_gray">PharmacoEconomics &amp; Outcomes News 599, 20<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8p8iYwVyaVcC" class="gsc_a_at">Effects of Sodium Oxybate on Pain, Function, and PGIc in Fibromyalgia: Results From an International, 14-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial: 186</a><div class="gs_gray">R Bennett, B Benson, R Bennett, E Choy, K Hackshaw, S Alvarez-Horine, ...</div><div class="gs_gray">Pain Medicine 11 (2)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:W5xh706n7nkC" class="gsc_a_at">Idiopathic inflammatory myopathy</a><div class="gs_gray">E Choy, P Gordon</div><div class="gs_gray">Medicine 38 (2), 116-120<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:wyM6WWKXmoIC" class="gsc_a_at">Clinical and epidemiological research-Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: A systematic literature&nbsp;…</a><div class="gs_gray">JL Nam, KL Winthrop, RF van Vollenhoven, K Pavelka, G Valesini, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 69 (6), 976<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:sszUF3NjhM4C" class="gsc_a_at">PMS62 CERTOLIZUMAB PEGOL MONOTHERAPY PROVIDES SUSTAINED IMPROVEMENTS IN HOUSEHOLD PRODUCTIVITY AND DAILY ACTIVITIES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS OVER 2 YEARS</a><div class="gs_gray">V Strand, O Purcaru, R van Vollenhoven, E Choy, R Fleischmann</div><div class="gs_gray">Value in Health 7 (13), A314<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">THE EFFECT OF BIOLOGICS ON CARDIOVASCULAR DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW</a><div class="gs_gray">SL Westlake, AN Colebatch, J Baird, P Kiely, M Quinn, E Choy, AJ Ostor, ...</div><div class="gs_gray">Rheumatology 49, I155-I155<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">DEFECTIVE CD3+ CD8+ CD28 SUPPRESSOR FUNCTION IN RA PATIENTS IS PARTIALLY RESTORED AFTER ANTI-TNF alpha INHIBITOR THERAPY AND MAY BE ASSOCIATED WITH REDUCED ICOS AND PD-1 EXPRESSION</a><div class="gs_gray">S Ceeraz, J Spencer, EH Choy, V Corrigall</div><div class="gs_gray">Rheumatology 49, I26-I26<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Dysfunctional CD3 (+) CD8 (+) CD28 (-) regulatory T cells in patients with rheumatoid arthritis are partially corrected following TNF inhibitor therapy</a><div class="gs_gray">S Ceeraz, J Spencer, EH Choy, VM Corrigall</div><div class="gs_gray">Immunology 131, 65-65<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">Adalimumab for Psoriatic Arthritis: Improvement in Psoriasis Is Associated with Long-term Inhibition of Radiographic Progression</a><div class="gs_gray">EHS Choy, DD Gladman, PJ Mease, CT Ritchlin, M Olds, RL Wong, ...</div><div class="gs_gray">JOURNAL OF RHEUMATOLOGY 36 (11), 2571-2571<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Certolizumab pegol: a new option for rheumatoid arthritis</a><div class="gs_gray">M HY, EHS Choy</div><div class="gs_gray">Future Prescriber 10 (4), 15-20<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:3htObqc8RwsC" class="gsc_a_at">603 ANXIETY AND DEPRESSION IN FIBROMYALGIA IS RELATED TO LOW HEALTH ESTEEM BUT NOT TO PAIN‐SENSITIVITY OR CEREBRAL PROCESSING OF PAIN</a><div class="gs_gray">K Jensen, F Petzke, S Carville, P Fransson, H Marcus, SCR Williams, ...</div><div class="gs_gray">European Journal of Pain 13 (S1), S175c-S176<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">497 FACTORS TO HELP PRIMARY CARE PHYSICIANS DETECTING FIBROMYALGIA IN ROUTINE PRACTICE</a><div class="gs_gray">R Baron, B Arnould, C Alegre, E Choy, G Cruccu, J Desmeules, ...</div><div class="gs_gray">European Journal of Pain 13 (S1), S147b-S147<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Sensory symptoms in fibromyalgia patients suggest a nervous system involvement: P1070</a><div class="gs_gray">G Cruccu, S Perrot, B Arnould, C Alegre, E Choy, J Desmeules, ...</div><div class="gs_gray">European Journal of Neurology 16<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">518 CLUSTER ANALYSIS OF DATA FROM FOUR DULOXETINE STUDIES IN FIBROMYALGIA</a><div class="gs_gray">P Van Wambeke, EH Choy, LA Bradley, IA Lipkovich, W Deberdt</div><div class="gs_gray">European Journal of Pain 13 (S1), S153a-S153<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:e_rmSamDkqQC" class="gsc_a_at">What makes fibromyalgia patients feel better? Correlations between patient global impressions and changes in clinical symptoms and function</a><div class="gs_gray">L Arnold, J Hudson, L Bradley, E Choy, P Mease, F Wang, J Ahl, ...</div><div class="gs_gray">The Journal of Pain 10 (4), S61<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Does baseline severity of symptoms in fibromyalgia impact the pain response? A pooled analysis of four placebo-controlled trials</a><div class="gs_gray">I Russell, F Wang, J Ahl, E Choy, M Wohlreich</div><div class="gs_gray">The Journal of Pain 10 (4), S40<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9NZAP19TdFAC" class="gsc_a_at">FATIGUE IS AN INDEPENDENT DRIVER OF DISABILITY IN RHEUMATOID ARTHRITIS</a><div class="gs_gray">LC Pollard, DL Scott, N Donaldson, E Choy</div><div class="gs_gray">Rheumatology 48, I131-I132<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:rCNdntzdTkkC" class="gsc_a_at">EXPERIMENTAL RHEUMATOLOGY 2009.</a><div class="gs_gray">L Unit, UKEH Choy, EH Choy</div><div class="gs_gray">Clin Exp Rheumatol 27, 510-518<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">ARD</a><div class="gs_gray">TK Kvien, F Berenbaum, H Bijlsma, D Boumpas, G Burmester, M Crow, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bKqednn6t2AC" class="gsc_a_at">IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING ADALIMUMAB, IMPROVEMENT IN PSORIASIS IS ASSOCIATED WITH LONG-TERM INHIBITION OF RADIOGRAPHIC PROGRESSION</a><div class="gs_gray">E Choy, D Gladman, PJ Mease, C Ritchlin, M Olds, RL Wong, S Wang, ...</div><div class="gs_gray">Rheumatology 48, I56-I57<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">THE EFFECT OF MILNACIPRAN ON EVOKED PAIN IN FIBROMYALGIA: A PSYCHOPHYSICAL AND FUNCTIONAL MRI ANALYSIS</a><div class="gs_gray">E Choy, S Carville, S Williams, K Jensen, E Kosek, M Ingvar, P Fransson, ...</div><div class="gs_gray">Rheumatology 48, I13-I13<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:hMsQuOkrut0C" class="gsc_a_at">CD3+ CD8+ CD28-CELLS ARE INCREASED IN RHEUMATOID ARTHRITIS (RA) PATIENTS BUT HAVE DEFICIENT ACTIVITY AND UPREGULATION OF NEGATIVE COSTIMULATORY MOLECULES</a><div class="gs_gray">S Ceeraz, J Spencer, EH Choy, VM Corrigall</div><div class="gs_gray">Rheumatology 48, I36-I36<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Rheumatoid Arthritis Patients With Approved &amp; New Biologic Agents</a><div class="gs_gray">LH Calabrese, E Choy, M Cohen, P Emery</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Improving Patient Outcomes: Emerging Data in the Treatment of Rheumatoid Arthritis</a><div class="gs_gray">LH Calabrese, E Choy, WE Center, P Emery, J Kay</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NJ774b8OgUMC" class="gsc_a_at">ANTIBIOTICS TREATMENT OF REACTIVE ARTHRITIS: A SYSTEMATIC REVIEW OF THE LITERATURE</a><div class="gs_gray">H Linklater, E Choy</div><div class="gs_gray">Rheumatology 48, I50-I50<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">METHOTREXATE REDUCES THE RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): A SYSTEMATIC LITERATURE REVIEW</a><div class="gs_gray">S Westlake, A Colebatch, J Baird, E Choy, P Kiely, A Ostor, M Quinn, ...</div><div class="gs_gray">Rheumatology 48, I142-I143<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:olpn-zPbct0C" class="gsc_a_at">PMS74 DEVELOPMENT OF A TOOL TO HELP IN THE EARLY DETECTION OF FIBROMYALGIA (FM) IN GENERAL PRACTICE IN EUROPE</a><div class="gs_gray">C Dias-Barbosa, I Guillemin, S Perrot, R Baron, C Alegre, E Choy, ...</div><div class="gs_gray">Value in Health 7 (12), A447<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-ZoC36zw86wC" class="gsc_a_at">Fibromyalgia and myofascial pain: mechanisms to management</a><div class="gs_gray">EH Choy</div><div class="gs_gray">Clinical Pain Management, 599-613<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:QYmifXMdJWgC" class="gsc_a_at">Fibromyalgia and myofascial pain: mechanisms to management</a><div class="gs_gray">SF Carville, EH Choy</div><div class="gs_gray">Clinical Pain Management, 599-613<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:0izLItjtcgwC" class="gsc_a_at">Impact of duloxetine treatment on concentration and mental fatigue in patients with fibromyalgia</a><div class="gs_gray">D Clauw, E Choy, P Mease, M Spaeth, L Bradley, IJ Russsell, D Kajdasz, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 58 (9), S385-S385<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Improved psychological well-being associated with improved pain severity: A multi-state transition model for Osteoarthritis pain change</a><div class="gs_gray">B Zhang, H Lin, D Hunter, T Neogi, B Wise, E Choy, J Niu, Y Zhang</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 58 (9), S869-S870<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:z8nqeaKD1nsC" class="gsc_a_at">Intensive combination therapy beneficial for early active RA</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">Inpharma 1643, 21<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vofGIMt6cyEC" class="gsc_a_at">Drug use and toxicity in psoriatic disease: Focus on methotrexate</a><div class="gs_gray">GG Krueger, NJ McHugh, E Choy, E Korendowych, WJ Taylor, ...</div><div class="gs_gray">Journal of Rheumatology<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:oYLFIHfuHKwC" class="gsc_a_at">EULAR evidence-based recommendations for the</a><div class="gs_gray">MS Silman, EH Choy</div><div class="gs_gray">Ann Rheum Dis 67, 536-541<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:W2uZP3ddy8sC" class="gsc_a_at">Evidence for chronic pain in rheumatoid arthritis (RA) resulting in central sensitisation</a><div class="gs_gray">LC Pollard, DL Scott, EH Choy</div><div class="gs_gray">Rheumatology 47, II8-II8<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:R-LXmdHK_14C" class="gsc_a_at">SF-36 scores, vitality and intensive treatment in early rheumatoid arthritis (RA)</a><div class="gs_gray">EH Choy, CM Smith, D Walker, A Hassell, DL Scott</div><div class="gs_gray">Rheumatology 47, II120-II120<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:dAp6zn-oMfAC" class="gsc_a_at">Fatigue is an independent driver of disability in rheumatoid arthritis (RA)</a><div class="gs_gray">LC Pollard, DL Scott, N Donaldson, EH Choy</div><div class="gs_gray">Arthritis &amp; Rheumatism 58 (9), S278-S279<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:X0DADzN9RKwC" class="gsc_a_at">Predicting two year outcomes in early rheumatoid arthritis (RA)</a><div class="gs_gray">EH Choy, CM Smith, D Walker, A Hassell, DL Scott</div><div class="gs_gray">Rheumatology 47, II38-II38<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:nPT8s1NX_-sC" class="gsc_a_at">Nottingham health profile (NHP) and responses to disease modifying drugs (DMARDs), steroids and tnf inhbitors in active rheumatoid arthritis</a><div class="gs_gray">L Pollard, B Khoshaba, GH Kingsley, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 47, II44-II44<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Remission and Theumatoid Arthritis: Data from 24 countries in the QUEST-RA Study</a><div class="gs_gray">H Mäkinen, ML Hetland, H Kautiainen, K Hørslev-Petersen, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Biomarkers and windows of opportunity in rheumatoid arthritis</a><div class="gs_gray">E Choy</div><div class="gs_gray">Scandinavian Journal of Rheumatology 37, 37-37<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:gsN89kCJA0AC" class="gsc_a_at">P. 8. a. 023 The effect of milnacipran on tenderness in fibromyalgia: a psychophysical and fMRI analysis</a><div class="gs_gray">RH Gracely, K Jensen, E Kosek, M Ingvar, P Fransson, H Marcus, E Choy, ...</div><div class="gs_gray">European Neuropsychopharmacology, S580<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Dysfunctional CD3+ CD8+ CD28-and CD3+ CD8+ CD28-CD16-regulatory cells from rheumatoid arthritis (RA) patients</a><div class="gs_gray">S Ceeraz, J Spencer, EH Choy, VM Corrigall</div><div class="gs_gray">Immunology 125, 129-130<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:zGWyAL6qfKUC" class="gsc_a_at">Evaluating cardiovascular and gastrointestinal risks and benefits of COX-2 selective inhibitors and non-selective nsaids in osteoarthritis patients using a decision analytic model</a><div class="gs_gray">N Mittmann, N Risebrough, E Choy, S Knowles, C Chen, A Lising, ...</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 66, 504-504<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Adalimumab is efficacious in treating skin disease of psoriatic arthritis patients with mild-to-severe baseline skin involvement: Subanalysis of ADEPT</a><div class="gs_gray">PJ Mease, DD Gladman, E Choy, S Steinfeld, R Perdok, MM Okun</div><div class="gs_gray">JOURNAL OF INVESTIGATIVE DERMATOLOGY 127 (7), 1819-1819<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Efficacy in moderate-to-severe psoriatic arthritis patients who have escalated dosing due to subtherapeutic response to adalimumab eow</a><div class="gs_gray">C Ritchlin, E Choy, S Steinfeld, MM Okun</div><div class="gs_gray">JOURNAL OF INVESTIGATIVE DERMATOLOGY 127 (7), 1820-1820<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Radiographic efficacy of adalimumab in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use and clinical response&nbsp;…</a><div class="gs_gray">EHS Choy, DD Gladman, PJ Mease, P Wordsworth, CT Ritchlin, H Wang, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:TaaCk18tZOkC" class="gsc_a_at">Factors influencing DMARD prescription in early RA</a><div class="gs_gray">SM Rachapalli, C Mayes, D Walsh, A Young, PD Kiely, EH Choy</div><div class="gs_gray">RHEUMATOLOGY 46, I37-I37<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">A study of auto-antibodies to cyclic citrullinated peptide in a polymyalgia rheumatica inception cohort from the UKPMR outcomes study</a><div class="gs_gray">B Dasgupta, A Hutchings, J Hollywood, L Nutter, D Lamping, C Pease, ...</div><div class="gs_gray">RHEUMATOLOGY 46, I82-I83<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:86PQX7AUzd4C" class="gsc_a_at">A systematic review and metaanalysis of slow acting anti-rheuamtic drugs and tumour necrosis factor antagonists for treatment of psoriatic arthritis</a><div class="gs_gray">V Ravindran, DL Scott, EH Choy</div><div class="gs_gray">RHEUMATOLOGY 46, I53-I53<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Assessing agreement and sensitivity to change of two international response criteria for rheumatoid arthritis in routine clinical practice</a><div class="gs_gray">AK Saha, G Coakley, E Choy</div><div class="gs_gray">RHEUMATOLOGY 46, I84-I84<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ojlX30-wUrgC" class="gsc_a_at">Concise reports-Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: Questionable validity of deriving quality adjusted&nbsp;…</a><div class="gs_gray">DL Scott, B Khoshaba, EH Choy, GH Kingsley</div><div class="gs_gray">Annals of the Rheumatic Diseases 66 (11), 1534-1537<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bXQfdp6S9ecC" class="gsc_a_at">Consensus on a core set of domains for psoriatic arthritis</a><div class="gs_gray">A Cauli, E Choy, E Husni, L Espinoza, A Adebajo, A Qureshi, V Strand, ...</div><div class="gs_gray">Journal of Rheumatology<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LK8CI43ZvvMC" class="gsc_a_at">Radiographic damage in British black Africans with rheumatoid arthritis</a><div class="gs_gray">V Ravindran, M Seah, D Elias, EH Choy, DL Scott, PA Gordon</div><div class="gs_gray">Annals of the Rheumatic Diseases 66, 366-366<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">" A window of opportunity" in early rheumatoid arthritis: Sustained effect of step-down prednisolone on joint damage</a><div class="gs_gray">EH Choy, CM Smith, L Chau, D Walker, A Hassell, V Farewell, DL Scott</div><div class="gs_gray">Annals of the Rheumatic Diseases 66, 52-52<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Health status measures in rheumatoid arthritis: Non-equivalent assessments of status and treatment effects</a><div class="gs_gray">GH Kingsley, B Khoshaba, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 46, I7-I8<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Longitudinal examination of arthritis pain (LEAP) pilot study: Relationship between self-rated joint pain fluctuations and health outcomes.</a><div class="gs_gray">A Hutchings, M Calloway, E Choy, DJ Hunter, JM Jordan, Y Zhang, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 54 (9), S154-S154<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PZE8UkGerEcC" class="gsc_a_at">Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK: Abstract Number: P128</a><div class="gs_gray">J JANSEN, S GAUGRIS, E CHOY, A OSTOR, J NASH, P BACON, ...</div><div class="gs_gray">Aplar Journal of Rheumatology 9<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">Changing prognosis in fibromyalgia-Is it possible?</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 65, 33-34<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Effectiveness and compatibility of adalimumab in patients with psoriasis-arthritis (PsA): Results of the ADEPT study over 48 weeks</a><div class="gs_gray">B Manger, P Mease, D Gladman, C Ritchlin, E Ruderman, E Choy, ...</div><div class="gs_gray">MEDIZINISCHE KLINIK 101 (4), A86-A86<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:JWITY9-sCbMC" class="gsc_a_at">Combination therapy in early rheumatoid arthritis: Cardera trial</a><div class="gs_gray">EH Choy, CM Smith, L Chau, D Walker, A Hassell, V Farewell, DL Scott</div><div class="gs_gray">RHEUMATOLOGY 45, I55-I55<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:H_jBuBxbQIAC" class="gsc_a_at">Efficacy evaluation of adalimumab in psoriatic arthritis by the disease activity score 28 (DAS28)</a><div class="gs_gray">EHS Choy, GR Burmester, S Bombardieri, F Van den Bosch, E Sasso</div><div class="gs_gray">RHEUMATOLOGY 45, I67-I68<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Randomised double blind, placebo-controlled trial of MM-093, a recombinant version of human Alpha Fetoprotein (AFP), in patients with active Rheumatoid Arthritis (RA)</a><div class="gs_gray">LC Pollard, J Murray, EH Choy</div><div class="gs_gray">RHEUMATOLOGY 45, I47-I48<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:M7yex6snE4oC" class="gsc_a_at">Analgesic use in Rheumatoid Arthritis (RA) does not improve pain</a><div class="gs_gray">LC Pollard, EH Choy, DL Scott</div><div class="gs_gray">RHEUMATOLOGY 45, I104-I104<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lYAcb2jw7qUC" class="gsc_a_at">The" Window of opportunity" in early rheumatoid arthritis (RA): A factorial randomised control trial (RCT) adding prednisolone (PRED) and/or ciclosporin (CiA) to Methotrexate (MTX)</a><div class="gs_gray">EH Choy, C Smith, C Lucia, W David, A Hassell, F Vern, DL Scott</div><div class="gs_gray">Arthritis &amp; Rheumatism 54 (9), S367-S367<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">425 Pain Representation In Fibromyalgia Patients And Healthy Controls Using Event‐Related Fmri</a><div class="gs_gray">K Jensen, E Kosek, T Giesecke, F Petzke, P Fransson, S Williams, ...</div><div class="gs_gray">Blackwell Publishing Ltd<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HIFyuExEbWQC" class="gsc_a_at">Quality of life, outcomes and diagnostic uncertainty in the first year in polymyalgia rheumatica</a><div class="gs_gray">B Dasgupta, A Hutching, J Hollywood, D Lamping, C Pease, ...</div><div class="gs_gray">Annals of the rheumatic diseases 65, 368-368<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_axFR9aDTf0C" class="gsc_a_at">A randomized double-blind, placebo-controlled trial of MM-093, a recombinant version of human alpha-fetoprotein, in patients with active rheumatoid arthritis (RA).</a><div class="gs_gray">LC Pollard, J Murray, EH Choy</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 52 (9), S132-S132<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Dermatomyositis-Discussion</a><div class="gs_gray">E Choy</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 64, 45-45<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1paMEeroeoQC" class="gsc_a_at">The ultrasound and MRI appearances of the hand and wrist from a busy Rheumatology practice: A pictorial review</a><div class="gs_gray">J Berry, K Satchithananda, JC Wilkins, J Totman, L Pollard, E Choy, ...</div><div class="gs_gray">European Congress of Radiology-ECR 2005<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lRPiJ3GhvscC" class="gsc_a_at">Rheumatoid arthritis–treatment: 144. ARE CLINICAL TRIALS IN RHEUMATOID ARTHRITIS GENERALISABLE TO ROUTINE PRACTICE? A RE-EVALUATION OF TRIAL ENTRY CRITERIA</a><div class="gs_gray">GH Kingsley, B Khoshaba, CM Smith, EH Choy, DL Scott</div><div class="gs_gray">Rheumatology 44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ehoypfNsBj8C" class="gsc_a_at">Health services research, economics and outcomes research: 66. A PATIENT-BASED DISEASE ACTIVITY SCORE (PDAS) THAT CAN REPLACE DISEASE ACTIVITY SCORE IN RHEUMATOID ARTHRITIS (RA&nbsp;…</a><div class="gs_gray">B Khoshaba, D Cooper, A MacGregor, DL Scott, EH Choy</div><div class="gs_gray">Rheumatology 44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:xii_ZKWM4-0C" class="gsc_a_at">Spondylarthropathies (including psoriatic arthritis): 279. A SYSTEMATIC REVIEW OF TREATMENT OPTIONS IN ANKYLOSING SPONDYLITIS (AS)</a><div class="gs_gray">S Levy, CM Smith, EH Choy</div><div class="gs_gray">Rheumatology 44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:g_UdREhPGEoC" class="gsc_a_at">Health services research, economics and outcomes research: 92. MUSCULOSKELETAL ULTRASOUND (MSUS) BY RHEUMATOLOGISTS IS PREDOMINANTLY PERFORMED FOR JOINT AND SOFT TISSUE&nbsp;…</a><div class="gs_gray">G Raftery, D Kane</div><div class="gs_gray">Rheumatology 44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:YohjEiUPhakC" class="gsc_a_at">Rheumatoid arthritis–clinical aspects: 229. FATIGUE IN RHEUMATOID ARTHRITIS (RA) ITS CAUSES AND CONSEQUENCES</a><div class="gs_gray">LC Pollard, EH Choy, DL Scott, JG Gonzalez</div><div class="gs_gray">Rheumatology 44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Are clinical trials in rheumatoid arthritis generalisable to routine practice? A re-evaluation of trial entry criteria</a><div class="gs_gray">GH Kingsley, B Khoshaba, CM Smith, EH Choy, DL Scott</div><div class="gs_gray">RHEUMATOLOGY 44, I74-I75<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:uWiczbcajpAC" class="gsc_a_at">Spondylarthropathies (including psoriatic arthritis): 270. ANAKINRA (KINERET) IN PSORIASIS AND PSORIATIC ARTHRITIS: A SINGLE CENTER, OPEN-LABEL, PILOT STUDY</a><div class="gs_gray">A Gibbs, C Walsh, B Bresnihan, DJ Veale, O FitzGerald</div><div class="gs_gray">Rheumatology 44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Outcomes in the first year in polymyalgia rheumatica (PMR): Results from a multi-centre prospective cohort study</a><div class="gs_gray">B Dasgupta, A Hutchings, J Hollywood, G Lamping, C Pease, ...</div><div class="gs_gray">Joint Meeting of the British-Society-for-Rheumatology/Deutsche-Gesellschaft&nbsp;…<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Combination therapy</a><div class="gs_gray">E Choy, HE Paulus</div><div class="gs_gray">Antirheumatic Therapy: Actions and Outcomes, 293-318<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Development and validation of a patient based disease activity score (PDAs) in rheumatoid arthritis (RA)</a><div class="gs_gray">EH Choy, B Khoshaba, D Cooper, A MacGregor, DL Scott</div><div class="gs_gray">ANNALS OF THE RHEUMATIC DISEASES 63, 175-175<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Fibromyalgia: from Complaints to Evidence</a><div class="gs_gray">H Bliddal, F BLOTMAN, D BUSKILA, E CHOY, A CIEZA, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:lg2tdxc6qMwC" class="gsc_a_at">USING PATIENT SELF-ASSESSMENT IN RHEUMATOID ARTHRITIS TO CONSTRUCT A PATIENT DISEASE ACTIVITY SCORE (PDAS)</a><div class="gs_gray">B Khoshaba, DJ Cooper, AJ MacGregor, DL Scott, EHS Choy</div><div class="gs_gray">RHEUMATOLOGY 43, 138-139<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BmWJbWwHJAwC" class="gsc_a_at">QUALITY OF LIFE, FUNCTIONAL STATUS AND CLINICAL FEATURES AT PRESENTATION IN POLYMYALGIA RHEUMATICA (PMR): RESULTS FROM A MULTI-CENTRE PROSPECTIVE COHORT STUDY</a><div class="gs_gray">B Dasgupta, A Hutchings, J Hollywood, DL Lamping, C Pease, ...</div><div class="gs_gray">RHEUMATOLOGY 43, 25-25<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Y0-TYkg6YM4C" class="gsc_a_at">Disease activity, functional status and quality of life in polymyalgia rheumatica (PMR): A multi-centre prospective cohort study.</a><div class="gs_gray">B Dasgupta, A Hutchings, J Hollywood, D Lamping, C Pease, ...</div><div class="gs_gray">68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Clinical features at presentation in pulymyalgia rheumatica (PMR): Results from a multi-centre prospective cohort study</a><div class="gs_gray">B Dasgupta, A Hutchings, J Hollywood, C Pease, K Chakravarty, ...</div><div class="gs_gray">Annals of the rheumatic diseases 63, 322-322<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WZBGuue-350C" class="gsc_a_at">Intramuscular (IM) depot methylprednisolone in established rheumatoid arthritis: A randomised placebo-controlled trial</a><div class="gs_gray">EH Choy, GH Kingsley, B Khoshaba, N Pipitone, L Dolan, P Pitt, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 63, 257-257<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">The clinical use of anti-cytokine therapy in rheumatic diseases</a><div class="gs_gray">E Choy</div><div class="gs_gray">Cytokines and Joint Injury, 107-125<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Development and validation of a patient-based disease activity score (PDAS) that can replace disease activity score in rheumatoid arthritis (RA) clinical trials and routine&nbsp;…</a><div class="gs_gray">EH Choy, B Khoshaba, D Cooper, A MacGregor, DL Scott</div><div class="gs_gray">Arthritis &amp; Rheumatism 50 (9), 1843<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:5ugPr518TE4C" class="gsc_a_at">GENERAL HEALTH STATUS INSTRUMENTS ARE INSENSITIVE TO CHANGE IN RHEUMATOID ARTHRITIS (RA)</a><div class="gs_gray">B Khoshaba, D Scott, E Choy, D Cooper</div><div class="gs_gray">Rheumatology 42<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:YB4bud6kWLwC" class="gsc_a_at">MRA well tolerated in active RA</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">Inpharma 1373, 8<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:n3vGvpFsckwC" class="gsc_a_at">CDP 870 shows promise in rheumatoid arthritis</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">Inpharma 1364, 16<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:natZJ_-F0IUC" class="gsc_a_at">Measuring general health status in rheumatoid arthritis (RA)-Nottingham Health Profile (NHP) may be superior to short form-36 (SF-36)</a><div class="gs_gray">BB Khoshaba, DL Scott, ES Choy</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 46 (9), S120-S120<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:QoJ_w57xiyAC" class="gsc_a_at">RELATIONSHIP BETWEEN DISABILITY MEASURED USING THE HEALTH ASSESSMENT QUESTIONNAIRE AND THE SF-36</a><div class="gs_gray">B Khoshaba, E Choy, D Houssein, D Scott</div><div class="gs_gray">Rheumatology 41<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:37UQlXuwjP4C" class="gsc_a_at">THE NOTTINGHAM HEALTH PROFILE AND HEALTH ASSESSMENT QUESTIONNAIRE IN ASSESSING RHEUMATOID DISABILITY</a><div class="gs_gray">B Khoshaba, E Choy, D Houssein, D Scott</div><div class="gs_gray">Rheumatology 41<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:mS4qin7VKjkC" class="gsc_a_at">Combination disease modifying anti-rheumatic drugs</a><div class="gs_gray">E Choy, D Scott</div><div class="gs_gray">The Year in Rheumatology 2002, 285-300<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:nPTYJWkExTIC" class="gsc_a_at">Attitudes of patients with rheumatoid arthritis (RA) to clinical trials</a><div class="gs_gray">T Garrood, S Farrow, D Scott, E Choy</div><div class="gs_gray">Rheumatology 40<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:N4u4nq0IxgcC" class="gsc_a_at">Improving therapies for RA</a><div class="gs_gray">EHS Choy</div><div class="gs_gray">Inpharma 1281, 31<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:yY3RG6sOEgwC" class="gsc_a_at">Editor’s acknowledgement</a><div class="gs_gray">D Abrahams, A Adebajo, D Adu, MJ Ahern, K Ahmadi, K Aho, M Al Janabi, ...</div><div class="gs_gray">Rheumatology 40, 1436-1438<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">ANTIBODIES AND MEDIATORS OF IMMUNITY-Use of Two-Dimensional Gel Electrophoresis To Measure Changes in Synovial Fluid Proteins from Patients with Rheumatoid Arthritis Treated&nbsp;…</a><div class="gs_gray">MA Smith, SK Bains, JC Betts, EHS Choy, ED Zanders</div><div class="gs_gray">Clinical and Diagnostic Laboratory Immunology 8 (1), 105-111<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Audits of prevention and management of corticosteroid induced osteoporosis in primary and secondary care</a><div class="gs_gray">H Abaecheta, S Richards, M Rowland, E Choy, C Moniz</div><div class="gs_gray">OSTEOPOROSIS INTERNATIONAL 11, S52-S52<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:OTTXONDVkokC" class="gsc_a_at">Discussion. Section 2: immunomodulatory intervention</a><div class="gs_gray">B Catchpole, A Kavanaugh, K Hobbs, EH Choy</div><div class="gs_gray">Drugs of today (Barcelona, Spain: 1998) 35 (4-5), 405-406<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:_9Xh93LWpsYC" class="gsc_a_at">Overview of pathogenesis of rheumatoid arthritis with relevance to treatment</a><div class="gs_gray">GS Panayi, V Corrigall, M Awad, E Choy</div><div class="gs_gray">Annals of the Rheumatic Diseases 57 (3)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:XtJa11BXPS4C" class="gsc_a_at">The clinical effect of a humanised non-depleting anti-CD4 monoclonal antibody (mAb) in rheumatoid arthritis (RA)</a><div class="gs_gray">EHS Choy, DJA Connolly, VK Manna, T Regan, N Rapson, GH Kingsley, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 57 (3)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BJrgspguQaEC" class="gsc_a_at">Immunological consequences of 4162W94 therapy in humans</a><div class="gs_gray">NT Rapson, DJA Connolly, EHS Choy, S Brett, J Tite, M Bartholemew, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 57 (3)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Fourth International Symposium on the Immunotherapy of the Rheumatic Diseases</a><div class="gs_gray">C PITZALIS, E CHOY</div><div class="gs_gray">Annals of the Rheumatic Diseases 57 (3), 177-179<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Fourth International Symposium on the Immunotherapy of the Rheumatic Diseases. 21-25 May 1997, Cyprus</a><div class="gs_gray">C Pitzalis, E Choy</div><div class="gs_gray">Annals of the rheumatic diseases 57 (3), 1779<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:OzeSX8-yOCQC" class="gsc_a_at">SOX Syndrome: Comparison of a group of patients with osteoarthritis and those attending a Sjogren's clinic: 77</a><div class="gs_gray">P Shirlaw, D Kissimos, E Choy, G Panayi, S Challacombe</div><div class="gs_gray">Scandinavian Journal of Immunology 45 (5)<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-yGd096yOn8C" class="gsc_a_at">Rheumatoid Arthritis in the 1990s</a><div class="gs_gray">EHS Choy, DL Scott</div><div class="gs_gray">MEDICAL PROGRESS-HONG KONG- 24, 25-30<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">What is the likely role of monoclonal antibody therapy in the treatment of rheumatoid arthritis?</a><div class="gs_gray">EHS Choy, GH Kingsley, GS Panayi</div><div class="gs_gray">Controversies in Rheumatology, 47<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:beqBT5984LEC" class="gsc_a_at">T cell hypothesis in rheumatoid arthritis (RA) tested by humanised non-depleting anti-CD4 monoclonal antibody (mAb) treatment. 2. Clinical activity is related to&nbsp;…</a><div class="gs_gray">EHS Choy, DJA Connolly, T Regan, VK Manna, N Rapson, GH Kingsley, ...</div><div class="gs_gray">IMMUNOLOGY 89, OG378-OG378<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:x21FZCSn4ZoC" class="gsc_a_at">Cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment. 2. Clinical activity is related to pharmacodynamic&nbsp;…</a><div class="gs_gray">EHS Choy, DJA Connolly, T Regan, VK Manna, N Rapson, GH Kingsley, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 39 (9), 1301-1301<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4E1Y8I9HL1wC" class="gsc_a_at">Treatment of rheumatoid arthritis with engineered human antibody to tumour necrosis factor alpha: CDP571</a><div class="gs_gray">EHS Choy, ECC Rankin, D Kassimos, GH Kingsley, S Stephens, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 54 (9)<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PQEM9vzQD9gC" class="gsc_a_at">THE EFFECT OF AN ENGINEERED HUMAN ANTITUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) ANTIBODY (AB) ON INTERLEUKIN-6 (IL-6) AND BONE MARKERS IN RHEUMATOID-ARTHRITIS (RA) PATIENTS</a><div class="gs_gray">EHS CHOY, D KASSIMOS, GH KINGSLEY, GS PANAYI, ECC RANKIN, ...</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 38 (9), 198-198<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ijdKiLOsEJMC" class="gsc_a_at">Human chimaeric antibody response in rheumatoid arthritis patients after treatment with a chimaeric anti-CD4 monoclonal antibody CM-T412</a><div class="gs_gray">EHS Choy, A Schantz, J Woody, GH Kingsley, GS Panayi</div><div class="gs_gray">Annals of the Rheumatic Diseases 54 (9)<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Irish association of rheumatology &amp; rehabilitation</a><div class="gs_gray">D Mulherin, O FitzGerald, B Bresnihan, G Yanni, M Farahat, R Posten, ...</div><div class="gs_gray">Irish Journal of Medical Science 162 (8), 321-332<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:jFemdcug13IC" class="gsc_a_at">Indications for Starting or Changing Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Patients</a><div class="gs_gray">G Yanni, E Choy, GH Kingsley</div><div class="gs_gray">IRISH JOURNAL OF MEDICAL SCIENCE 162, 329-329<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:TlpoogIpr_IC" class="gsc_a_at">INTRAMUSCULAR (IM) METHYLPREDNISOLONE ACETATE (MPA) IS SUPERIOR TO PULSE ORAL METHYLPREDNISOLONE (MP) DURING INDUCTION OF CHRYSOTHERAPY IN RHEUMATOID-ARTHRITIS (RA)</a><div class="gs_gray">E CHOY, G KINGSLEY, M CORKILL, G PANAYI</div><div class="gs_gray">ARTHRITIS AND RHEUMATISM 35 (9), S234-S234<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:__bU50VfleQC" class="gsc_a_at">INTRAMUSCULAR AND ORAL METHYLPREDNISOLONE DURING INDUCTION OF CHRYSOTHERAPY IN RHEUMATOID-ARTHRITIS</a><div class="gs_gray">EHS Choy, GH Kingsley, MM Corkill, GS Panayi</div><div class="gs_gray">BRITISH JOURNAL OF RHEUMATOLOGY 31, 35-35<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:8rLWgkbgOXQC" class="gsc_a_at">Adalimumab/methotrexate/upadacitinib</a><div class="gs_gray">E Choy</div><div class="gs_gray">Reactions 14 (5), 2020<span class="gs_oph">, 1833</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1833</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:bxPAEoiBajcC" class="gsc_a_at">The Contributions of IL-6 to Disease Manifestations of RA</a><div class="gs_gray">LH Calabrese, E Choy</div><div class="gs_gray">Google Scholar<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:tL5YfqkXb3gC" class="gsc_a_at">A Review of the Dual Signaling Mechanism of IL-6</a><div class="gs_gray">LH Calabrese, E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-w1eE4La9_EC" class="gsc_a_at">The Contributions of IL-6 to Bone Resorption in RA</a><div class="gs_gray">LH Calabrese, E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4Wrxgq2JVp0C" class="gsc_a_at">The Role of IL-6 in RA Pain</a><div class="gs_gray">LH Calabrese, E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:vkz5F8TaVKkC" class="gsc_a_at">Reporting of effect modifying contextual factors in trials: A protocol for an overview and tutorial</a><div class="gs_gray">SM Nielsen, H Bliddal, M Henriksen, K Amris, EE Wæhrens, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:eLRq4zTgah0C" class="gsc_a_at">Equivalencia ABP-501 respecto de Adalimumab originador en artritis reumatoidea: resultados de un ensayo pivotal Fase 3</a><div class="gs_gray">S Cohen, MC Genovese, E Choy, F Perez-Ruiz, A Matsumoto, K Pavelka, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:htyGaKyDgHMC" class="gsc_a_at">CONGRESS PROGRAM</a><div class="gs_gray">WAW Heading, P Sarzi-Puttini, EH Choy, J Ablin, W Häuser, F Wars, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:BPS1z4jHU5cC" class="gsc_a_at">Patient-reported outcomes and safety in patients undergoing synovial biopsy</a><div class="gs_gray">SA Just, F Humby, H Lindegaard, L Meric de Bellefon, P Durez, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:DIubQTN3OvUC" class="gsc_a_at">A systematic review and meta-analysis of efficacy</a><div class="gs_gray">V Ravindran, DL Scott, EH Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:PlWzFYVEG4EC" class="gsc_a_at">Review type: Intervention Review number: C194-R</a><div class="gs_gray">EHS Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:KWzIFqRkAKkC" class="gsc_a_at">OP54. RADIOGRAPHIC EFFICACY OF ADALIMUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS ACCORDING TO DEMOGRAPHICS, BASELINE CLINICAL STATUS, METHOTREXATE USE AND CLINICAL RESPONSE&nbsp;…</a><div class="gs_gray">EHS Choy, DD Gladman, PJ Mease, P Wordsworth, CT Ritchlin, H Wang, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">Neutrophils in RA and the Role of IL-6</a><div class="gs_gray">LH Calabrese, E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:SIv7DqKytYAC" class="gsc_a_at">Abstract Reviewers</a><div class="gs_gray">D Abraham, Y Ahmad, N Arden, E Baildam, R Bessant, A Bhalla, F Birrell, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Abstract Reviewers</a><div class="gs_gray">D Abraham, Y Ahmad, N Amft, M Anderson, J Andrews, E Baildem, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:QsaTk4IG4EwC" class="gsc_a_at">Abstract Reviewers</a><div class="gs_gray">D Abraham, N Amft, ML Bearne, R Bessant, A Bhalla, F Birrell, S Bowman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">Abstract Reviewers</a><div class="gs_gray">D Abraham, S Allard, N Arden, J Axford, A Bamji, A Bhalla, F Birrell, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Abstract Reviewers</a><div class="gs_gray">D Abraham, N Amft, A Bamji, A Bhalla, F Birrell, MD Bond, S Bowman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">Abstract Reviewers</a><div class="gs_gray">Y Ahmad, N Amft, M Anderson, J Andrews, N Arden, E Baildem, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:43bX7VzcjpAC" class="gsc_a_at">PRECISION MEDICINE: MAXIMISING TREATMENT BENEFIT FOR RHEUMATOID ARTHRITIS PATIENTS</a><div class="gs_gray">E Choy, E Choy, E Ruderman, C Gabay, G Schett</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Our thanks to all those who have helped with this issue of Future Rheumatology. Listed below are authors, referees and others who have kindly given their time, effort and&nbsp;…</a><div class="gs_gray">D Aletaha, A Asakura, HM Belmont, MC Boissier, SF Carville, EHS Choy, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Ключевые слова</a><div class="gs_gray">JN Hoes, JWG Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:foquWX3nUaYC" class="gsc_a_at">Abstract Reviewers</a><div class="gs_gray">D Abraham, Y Ahmad, N Amft, M Anderson, J Andrews, N Arden, J Axford, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Targeting IL-6 in the Treatment of Rheumatoid Arthritis</a><div class="gs_gray">LH Calabrese, E Choy, L Moreland, JS Smolen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Fibromyalgia: Reality and Recent Advances in Management</a><div class="gs_gray">JC Branco, E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:URolC5Kub84C" class="gsc_a_at">Marjorie A. Smith, Satbinder K. Bains, Joanna C. Betts</a><div class="gs_gray">EHS Choy, ED Zanders</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Treatment of Rheumatoid Arthritis in the New Millennium</a><div class="gs_gray">EHS Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Is Chronic Pain a Disease in Its Own Right? Discussions</a><div class="gs_gray">EH Choy, PS Tugwell, U Kaiser, V Strand, LS Simon, PJ Mease</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:2KloaMYe4IUC" class="gsc_a_at">PASI-100 is associated with better dermatology-specific patient reported outcomes compared with PASI-75e99: Subanalysis of a phase II psoriasis trial of adalimumab Kenneth&nbsp;…</a><div class="gs_gray">E Choy, D Gladman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=OziPPvMAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=OziPPvMAAAAJ:ye4kPcJQO24C" class="gsc_a_at">ARTICULAR AND SYSTEMIC THERAPY FOR RHEUMATOID DISEASE</a><div class="gs_gray">E Choy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–740</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>